ï»¿
<!DOCTYPE html>
<html lang="en-us" class="cdc-2022 theme-indigo cdc-tp5" >
<head>
	<meta charset="utf-8" />
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta content="width=device-width, initial-scale=1, shrink-to-fit=no" name="viewport" />
<meta name="mobile-web-app-capable" content="yes" />
<meta name="apple-mobile-web-app-capable" content="yes" />
<meta name="theme-color" content="#075290">

<link rel="apple-touch-icon" sizes="180x180" href="/TemplatePackage/4.0/assets/imgs/favicon/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/TemplatePackage/4.0/assets/imgs/favicon/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/TemplatePackage/4.0/assets/imgs/favicon/favicon-16x16.png">
<link rel="mask-icon" href="/TemplatePackage/4.0/assets/imgs/favicon/safari-pinned-tab.svg" color="#0056b3">
<meta name="msapplication-TileColor" content="#0056b3">
<meta name="theme-color" content="#0056b3">

<link rel="stylesheet prefetch" href="/TemplatePackage/contrib/libs/bootstrap/latest/css/bootstrap.min.css?_=35435" />
<link rel="stylesheet prefetch" href="/TemplatePackage/4.0/assets/css/app.tp5.min.css?_=35435" />
<link rel="stylesheet" media="print" href="/TemplatePackage/4.0/assets/css/print.min.css?_=35435" />

<!-- @prismcss@ -->
<script src="https://www.cdc.gov/JScript/dmat/cdc-dmat.min.js?account=cdcgov&_=35435"></script>
	<title>Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19âAssociated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults â VISION Network, Nine States, SeptemberâNovember 2022  | MMWR</title>
		<meta name="description" content="The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC)."/>						<meta property="og:title" content="Early Estimates of Bivalent mRNA Vaccine Effectiveness ...">
		<meta property="og:description" content="This report describes the effectiveness of the updated (bivalent) COVID-19 vaccines for prevention of COVID-19 associated emergency department and urgent care visits and hospitalization among adults ages 18 years or older without a weakened immune system.">
		<meta property="fb:app_id" content="205691699516606">
		<meta property="og:url" content="https://www.cdc.gov/mmwr/volumes/71/wr/mm7153a1.htm">

					<meta property="og:image" content="https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm715152e1_BivalentVaccineEffectiveness_IMAGE_16Dec2022_1200x675.jpg">
							<meta property="og:image:type" content="image/jpeg">
						<meta property="article:published_time" content="2023-03-17">
		<meta property="og:author" content="CDC">
		<meta property="article:author" content="CDCMMWR">
		<meta property="og:site_name" content="Centers for Disease Control and Prevention">
		<meta property="og:type" content="article">
		<meta name="twitter:card" content="summary_large_image">		<meta name="twitter:site" content="@CDCMMWR">
		<meta name="twitter:creator" content="@CDCgov">
		
			<meta name="twitter:title" content="Early Estimates of Bivalent mRNA Vaccine Effectiveness ...">
			<meta name="twitter:description" content="This report describes the effectiveness of the updated (bivalent) COVID-19 vaccines for prevention of COVID-19 associated emergency department and urgent care visits and hospitalization among adults a">
							<meta name="twitter:domain" content="https://www.cdc.gov/mmwr/volumes/71/wr/mm7153a1.htm?s_cid=mm7153a1_w">
									<meta name="twitter:image:src" content="https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm715152e1_BivalentVaccineEffectiveness_IMAGE_16Dec2022_1200x675.jpg">
						<meta name="robots" content="index, archive" />
		
		<meta property="cdc:template_version" content="4.0"/>	<meta property="cdc:first_published" content="March 15, 2023"/>
	<meta property="cdc:last_updated" content="March 17, 2023, 01:00 PM"/>
	<meta property="cdc:last_reviewed" content="March 17, 2023"/>
	<meta property="cdc:content_source" content="DEPUTY DIRECTOR FOR PUBLIC HEALTH SCIENCE AND SURVEILLANCE"/>
	<meta property="cdc:maintained_by" content="DEPUTY DIRECTOR FOR PUBLIC HEALTH SCIENCE AND SURVEILLANCE"/>
	<meta property="cdc:content_id" content="103292" />
	<meta property="cdc:build" content="3257" />
	<meta property="cdc:version" content="4.24.3" />
	<meta property="cdc:page_type" content="cdc_mmwr" />
	<meta property="cdc:page_origin" content="wcms"/>
	<meta name="citation_categories" content="Full Report"/><meta name="citation_title" content="Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19âAssociated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults â VISION Network, Nine States, SeptemberâNovember 2022"/><meta name="citation_author" content="Mark W. Tenforde"/><meta name="citation_publication_date" content="2023"/><meta name="citation_journal_title" content="MMWR. Morbidity and Mortality Weekly Report"/><meta name="citation_journal_abbrev" content="MMWR Morb Mortal Wkly Rep"/><meta name="citation_issn" content="0149-21951545-861X"/><meta name="citation_volume" content="71"/><meta name="citation_doi" content="10.15585/mmwr.mm7153a1"/><meta name="Description" content="The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC)."/>			<link rel="canonical" href="https://www.cdc.gov/mmwr/volumes/71/wr/mm7153a1.htm"/>
	<meta property="cdc:wcms_build" content="4.24.3 - b.3257" />
		<link rel="stylesheet" type="text/css" href="/mmwr/volumes/wcms-inc/local.css?v=3257"/>
 				<!-- CSS Added Dynamically Here -->		<meta name="DC.date" content="2023-03-15T01:36:40Z" />
				<meta name="cdc:last_published" content="2024-04-23T15:23:41Z" />
				
</head>
<body class="no-js cdc-mmwr">
	<div id="skipmenu">
		<a class="skippy sr-only-focusable" href="#content">Skip directly to site content</a>
		<a class="skippy sr-only-focusable" href="#headerSearch">Skip directly to search</a>
	</div>
					<div class="header-language-bar container text-right pt-1 pb-1 fs0875">
											<a href="/spanish/"><span lang="es-us">EspaÃ±ol</span></a><span class="link-divider"> | </span>
						<a href="https://wwwn.cdc.gov/pubs/other-languages/">Other Languages</a>
										</div>
				<script src="/TemplatePackage/5.0/js/modules/banner.js"></script>
<div class="cdc-header-official-notice container noindex">
	<div class="cdc-header-official-notice-header d-flex">
		<img src="/TemplatePackage/4.0/assets/imgs/uswds/us_flag_small.png" width="16" height="11" alt="" aria-hidden="true" />
		<small class="ml-2">An official website of the United States government <button class="cdc-header-official-notice-header-btn">Here's how you know <span class="cdc-header-official-notice-header-icon x12 fill-p cdc-icon-arrow-down"></span></button></small>
	</div>

	<div class="cdc-header-official-notice-body row" style="display: none;">
		<figure class="col-lg-6 d-flex">
			<img class="cdc-header-official-notice-body-img" src="/TemplatePackage/4.0/assets/imgs/uswds/icon-dot-gov.svg" alt="" aria-hidden="true" />
			<figcaption class="cdc-header-official-notice-body-info ml-3">
				<p class="cdc-header-official-notice-body-title mb-1"><strong>Official websites use .gov</strong></p>
				<p>A .gov website belongs to an official government organization in the United States.</p>
			</figcaption>
		</figure>
		<figure class="col-lg-6 d-flex">
			<img class="cdc-header-official-notice-body-img" src="/TemplatePackage/4.0/assets/imgs/uswds/icon-https.svg" alt="" aria-hidden="true" />
			<figcaption class="cdc-header-official-notice-body-info ml-3">
				<p class="cdc-header-official-notice-body-title mb-1"><strong>Secure .gov websites use HTTPS</strong></p>
				<p>A lock ( <span class="x16 fill-black cdc-icon-lock-alt-solid"></span> ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.</p>
			</figcaption>
		</figure>
	</div>
</div>
<header id="page_banner" role="banner" aria-label="Banner">			<div class="container-fluid header-wrapper">
				<div class="container">
					<div class="row py-2">
						<div class="col cdc-logo">
															<a href="https://www.cdc.gov/">
	<span class="sr-only">Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People</span>
	<img src="/TemplatePackage/4.0/assets/imgs/logo/logo-notext.svg" alt="CDC Logo" class="cdc-logo--desktop">
	<img src="/TemplatePackage/4.0/assets/imgs/logo/logo-notext.svg" alt="CDC Logo" class="cdc-logo--mobile">
</a>
													</div>
													<div class="col-2 col-md-3 col-xl-5 col-xxl-4 tp-search">
								<div class="headerSearch cdc-header-search">
	<form accept-charset="UTF-8" action="https://search.cdc.gov/search/" class="cdc-header-search-form" method="get" autocomplete="off">

		<!-- fallback mobile search -->
		<button class="btn btn-primary dropdown-toggle no-toggle search-button ssi d-xl-none"
				type="button"
				data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" aria-label="search"><span>Search</span>
			<i class="fi cdc-icon-magnify dropdown-menu-medium-search-icon x24" aria-hidden="true"></i>
			<i class="fi cdc-icon-close dropdown-menu-medium-close-icon x24" aria-hidden="true"></i>
		</button>

		<div class="dropdown-menu dropdown-menu-right dropdown-menu-search dropdown-menu-medium-search">
			<div class="input-group">
				<input id="headerSearch" type="text" class="form-control" maxlength="300" placeholder="Search" aria-label="Search" name="query">
				<span class="form-control-clear cdc-icon-close"></span>
				<div class="input-group-append">
					<button class="btn search-submit" type="button">
						<span class="sr-only">Submit</span>
						<i class="fi cdc-icon-magnify x24 search-submit" aria-hidden="true"></i>
					</button>
				</div>
			</div>
		</div>
		<input type="hidden" name="affiliate" value="cdc-main">
	</form>
</div>

							</div>
												</div>
				</div>
			</div>
					<div class="container-fluid site-title">
				<div class="container">
							<div class="row">
		<div class="col">
			<div class="display-6 text-white fw-500 pt-1 pb-1 site-title-inner ">
				<a href="/mmwr/index.html"> Morbidity and Mortality Weekly Report (<em>MMWR</em>)</a>
			</div>
					</div>
			</div>
					</div>
			</div>
						<nav role="navigation" aria-label="Mobile Nav" id="mobilenav" class="sticky-top">
							</nav>
			
		<!-- Global Above Feature -->

		<div class="container-fluid feature-area">
			<div class="container"></div>		</div>

		</header>
				<div class="container d-flex flex-wrap body-wrapper bg-white">
						<main  class="col-12 order-lg-2"  role="main" aria-label="Main Content Area">
									<div class="row visual-element">
						<div class="col">
																				</div>
					</div>
								<div class="section-nav-area">
					<nav role="navigation" aria-label="Section Nav" class="w-100 sticky-top"></nav>
				</div>

				<div class="row">
					<div  class="col content content-fullwidth">			<h1>Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19âAssociated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults â VISION Network, Nine States, SeptemberâNovember 2022</h1>
							<div class="dateline">
	<p><em>Weekly</em> / March 17, 2023 / 71(53);1637â1646	</p>
</div>


						<div class="title-bar">
														<a href="#print" class="print-link" aria-label="print this page" onclick="window.print()">Print</a>
						</div>
																<div class="mb-3 card tp-related-pages fourth-level-nav d-none">
						<div class="card-header collapse-icon">
							<a class="collapse-link float-right nav-minus fs0875" data-toggle="collapse" href="#collapse_1032926627d27d53a05" aria-expanded="false" aria-controls="collapse_1032926627d27d53a05">
								<svg viewBox="0 0 24 24" focusable="false" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
									<title>Minus</title>
									<path d="M19,13H5V11H19V13Z"></path>
								</svg>
							</a>
							<div class="h4">Related Pages</div>
						</div>
						<div class="card-body collapse show" id="collapse_1032926627d27d53a05"></div>
					</div>
										<div class="syndicate">

							<div class="d-flex flex-wrap d-md-block">
	<div class="order-3 mb-3"><p><span style="color: #ff0000"><b>This report has been corrected and republished. Below is the republished report. Please click <a href="https://stacks.cdc.gov/view/cdc/125679">here</a> to view the detailed changes to the report.</b></span></p>
<p>Mark W. Tenforde, MD, PhD<sup>1</sup>; Zachary A. Weber, PhD<sup>2</sup>; Karthik Natarajan, PhD<sup>3</sup><sup>,4</sup>; Nicola P. Klein, MD, PhD<sup>5</sup>; Anupam B. Kharbanda, MD<sup>6</sup>; Edward Stenehjem, MD<sup>7</sup>; Peter J. Embi, MD<sup>8</sup><sup>,9</sup>; Sarah E. Reese, PhD<sup>2</sup>; Allison L. Naleway, PhD<sup>10</sup>; Shaun J. Grannis, MD<sup>9</sup><sup>,11</sup>; Malini B. DeSilva, MD<sup>12</sup>; Toan C. Ong, PhD<sup>13</sup>; Manjusha Gaglani, MBBS<sup>14</sup><sup>,15</sup>; Jungmi Han<sup>3</sup>; Monica Dickerson<sup>1</sup>; Bruce Fireman, MA<sup>5</sup>; Kristin Dascomb, MD, PhD<sup>7</sup>; Stephanie A. Irving, MHS<sup>10</sup>; Gabriela Vazquez-Benitez, PhD<sup>12</sup>; Suchitra Rao, MBBS<sup>13</sup>; Deepika Konatham<sup>16</sup>; Palak Patel, MBBS<sup>1</sup>; Kristin E. Schrader, MA<sup>2</sup>; Ned Lewis, MPH<sup>5</sup>; Nancy Grisel, MPP<sup>7</sup>; Charlene McEvoy, MD<sup>12</sup>; Kempapura Murthy, MBBS<sup>16</sup>; Eric P. Griggs, MPH<sup>1</sup>; Elizabeth A. K. Rowley, DrPH<sup>2</sup>; Ousseny Zerbo, PhD<sup>5</sup>; Julie Arndorfer, MPH<sup>7</sup>; Margaret M. Dunne, MSc<sup>2</sup>; Kristin Goddard, MPH<sup>5</sup>; Caitlin Ray, MPH<sup>1</sup>; Yan Zhuang, PhD<sup>2</sup>; Julius Timbol, MS<sup>5</sup>; Morgan Najdowski, MPH<sup>17</sup>; Duck-Hye Yang, PhD<sup>2</sup>; John Hansen, MPH<sup>5</sup>; Sarah W. Ball, ScD<sup>2</sup>; Ruth Link-Gelles, PhD<sup>17</sup> (<a class="h6" style="font-weight: normal" href="#contribAff">View author affiliations</a>)</p>
<a class="mb-md-3" href="#suggestedcitation">View suggested citation</a></div><div class="bg-gray-l2 col-md-9 float-left mb-3 order-0 "><h3><strong>Summary</strong></h3>
<p><strong>What is already known about this topic?</strong></p>
<p>Bivalent mRNA COVID-19 booster doses containing an Omicron BA.4/BA.5 sublineage component were recommended on September 1, 2022. The effectiveness of these updated vaccines against COVID-19&ndash;associated medical encounters has not been established.</p>
<p><strong>What is added by this report?</strong></p>
<p>Bivalent booster doses provided additional protection against COVID-19&ndash;associated emergency department/urgent care encounters and hospitalizations in persons who previously received 2, 3, or 4 monovalent vaccine doses. Because of waning of monovalent vaccine-conferred immunity, relative effectiveness of bivalent vaccines was higher with increased time since the previous monovalent dose.</p>
<p><strong>What are the implications for public health practice?</strong></p>
<p>All persons should stay up to date with recommended COVID-19 vaccinations, including receiving a bivalent booster dose if eligible.</p>
</div><div class="col-md-3 float-right order-12 mt-3 mt-md-0 no-syndicate "><!-- START METRICS BOX -->
<script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script>
<style type="text/css">
.altmetric-embed.mt-2.mb-3 > div {
display: flex;
}
</style>
<div class="card mb-3" data-mmwr-metrics="article">
  <div class="card-header h4 bg-primary">Article Metrics</div>
    <div class="card-body bg-white">
      <h5>Altmetric:</h5>
      <div class="altmetric-embed mt-2 mb-3" data-badge-details="right" data-badge-type="donut" data-condensed="true" data-hide-no-mentions="true" data-link-target="_blank"></div>
      <div class="border-top mt-2 mb-2"></div>
      <h5>Citations: <span class="mmwr_citations"></span></h5>
      <div class="border-top mt-2 mb-3"></div>
      <h5>Views: <span class="mmwr_total_views"></span>
        <p class="small pt-1"><em>Views equals page views plus PDF downloads</em></p>
      </h5>
      <div class="text-right">
        <a href="#" class="btn btn-primary btn-sm" role="button" data-toggle="modal" data-target="#articleMetricModal">Metric Details</a>
      </div>
    </div>
</div>
<!-- END METRICS BOX --></div><div class="col-md-3 float-right d-none d-md-block cr mb-3"><div class="card theme-cyan bg-gray-l2"><div class="card-header"><strong>Tables</strong></div><div class="card-body"><p><a href="#T1_down">Table 1</a></p><p><a href="#T2_down">Table 2</a></p><p><a href="#T3_down">Table 3</a></p></div></div></div><div class="col-md-3 float-right mb-3 cr order-1"><div class="card mb-3"><div class="card-header h4 bg-primary">Related Materials</div><div class="card-body"><ul class="mb-0 block-list"><li><a href="/mmwr/volumes/71/wr/pdfs/mm7153a1-H.pdf" target="_blank">Article PDF<span aria-label="pdf icon" class="sr-only" role="img"></span><span class="fi cdc-icon-pdf x16 fill-pdf" alt="" aria-hidden="true"></span><span class="file-details"></span></a></li></ul></div></div></div><div class="order-4 w-100"><div class="mb-3"><img decoding="async" class="img-fluid" alt="This figure is a photo of two boxes with the title reading, &ldquo;Most U.S. adults have not yet received an updated (bivalent) COVID-19 booster.&rdquo; In the left box is a photo of a band-aid with text that reads, &ldquo;An updated booster may reduce your risk of severe COVID-19 by 50% or more.&rdquo; In the left box is a symbol with text that reads, &ldquo;For the best protection, get an updated booster.&rdquo;" title="Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations among Immunocompetent Adults &mdash; VISION Network, 9 States, September&ndash;November 2022" src="/mmwr/volumes/71/wr/social-media/mm715152e1_BivalentVaccineEffectiveness_IMAGE_16Dec2022_1200x675-medium.jpg?_=42783"><div class="liv"><div class="pt-2 mb-2"><a data-target="#modalIMG1032926627d27db383e" data-toggle="modal" href="#"><span aria-label="resize icon" class="sr-only" role="img"></span><span class="fi cdc-icon-resize icon x20 align-top mr-2" alt="" aria-hidden="true"></span>View Larger</a></div></div><div aria-hidden="true" aria-label="Large Image" class="modal large-img fade" id="modalIMG1032926627d27db383e" role="dialog" tabindex="-1"><div class="modal-dialog modal-image-enlargement" role="document"><div class="modal-content "><button type="button" class="close rounded-circle" data-dismiss="modal" aria-label="Close" style="width: 34px;height:34px;margin-top:0px;"><span class="sr-only">Close</span><span class="fi cdc-icon-close x24" aria-hidden="true"></span></button><div class="modal-body"><img decoding="async" class="img-fluid" alt="This figure is a photo of two boxes with the title reading, &ldquo;Most U.S. adults have not yet received an updated (bivalent) COVID-19 booster.&rdquo; In the left box is a photo of a band-aid with text that reads, &ldquo;An updated booster may reduce your risk of severe COVID-19 by 50% or more.&rdquo; In the left box is a symbol with text that reads, &ldquo;For the best protection, get an updated booster.&rdquo;" style="width:100% !important;" title="Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations among Immunocompetent Adults &mdash; VISION Network, 9 States, September&ndash;November 2022" src="/mmwr/volumes/71/wr/social-media/mm715152e1_BivalentVaccineEffectiveness_IMAGE_16Dec2022_1200x675-medium.jpg?_=42783"></div><div class="modal-footer fj-start bg-gray-l3"><span aria-label="download icon" class="sr-only" role="img"></span><span class="fi cdc-icon-download_01 icon x20 align-top mr-2 fill-blue-p" alt="" aria-hidden="true"></span><a href="/mmwr/volumes/71/wr/social-media/mm715152e1_BivalentVaccineEffectiveness_IMAGE_16Dec2022_1200x675-medium.jpg?_=42783?noicon" target="_blank" rel="noopener noreferrer" class="mr-2 text-blue">Download Image</a>[JPG]</div></div></div></div></div>
<p>During June&ndash;October 2022, the SARS-CoV-2 Omicron BA.5 sublineage accounted for most of the sequenced viral genomes in the United States, with further Omicron sublineage diversification through November 2022.* Bivalent mRNA vaccines contain an ancestral SARS-CoV-2 strain component plus an updated component of the Omicron BA.4/BA.5 sublineages. On September 1, 2022, a single bivalent booster dose was recommended for adults who had completed a primary vaccination series (with or without subsequent booster doses), with the last dose administered &ge;2 months earlier (<i>1</i>). During September 13&ndash;November 18, the VISION Network evaluated vaccine effectiveness (VE) of a bivalent mRNA booster dose (after 2, 3, or 4 monovalent doses) compared with 1) no previous vaccination and 2) previous receipt of 2, 3, or 4 monovalent-only mRNA vaccine doses, among immunocompetent adults aged &ge;18 years with an emergency department/urgent care (ED/UC) encounter or hospitalization for a COVID-19&ndash;like illness.<sup>&dagger;</sup> VE of a bivalent booster dose (after 2, 3, or 4 monovalent doses) against COVID-19&ndash;associated ED/UC encounters was 56% compared with no vaccination, 32% compared with monovalent vaccination only with last dose 2&ndash;4 months earlier, and 50% compared with monovalent vaccination only with last dose &ge;11 months earlier. VE of a bivalent booster dose (after 2, 3, or 4 monovalent doses) against COVID-19&ndash;associated hospitalizations was 59% compared with no vaccination, 42% compared with monovalent vaccination only with last dose 5&ndash;7 months earlier, and 48% compared with monovalent vaccination only with last dose &ge;11 months earlier. Bivalent vaccines administered after 2, 3, or 4 monovalent doses were effective in preventing medically attended COVID-19 compared with no vaccination and provided additional protection compared with past monovalent vaccination only, with relative protection increasing with time since receipt of the last monovalent dose. All eligible persons should stay up to date with recommended COVID-19 vaccinations, including receiving a bivalent booster dose. Persons should also consider taking additional precautions to avoid respiratory illness this winter season, such as masking in public indoor spaces, especially in areas where COVID-19 community levels are high.</p>
<p>Monovalent COVID-19 mRNA vaccines were developed against the spike protein of the ancestral SARS-CoV-2 virus and were found to provide cross-reactive immune protection against Alpha and Delta SARS-CoV-2 variants (<i>2</i>). The SARS-CoV-2 Omicron variant emerged in November 2021 and diversified into sublineages. These Omicron sublineages were associated with decreased protection from vaccination with monovalent vaccine (<i>3</i>). A single booster dose of bivalent mRNA vaccine (Pfizer-BioNTech or Moderna) containing an updated BA.4/BA.5 component was recommended by CDC on September 1, 2022, (<i>1</i>) for adults who had completed a primary series with any Food and Drug Administration&ndash;approved or &ndash;authorized monovalent vaccine or who had previously received a monovalent booster dose &ge;2 months earlier.<sup>&sect;</sup></p>
<p>The VISION Network<sup>&para;</sup> evaluated the effectiveness of a bivalent booster dose among immunocompetent adults during September 13&ndash;November 18, 2022, a period during which the Omicron BA.5 sublineage predominated and additional Omicron sublineages emerged. Seven health systems in nine states contributed data for this analysis. VISION methods have been described (<i>3</i>). Briefly, ED/UC encounters and hospitalizations associated with a COVID-19&ndash;like illness among adults who received a SARS-CoV-2 molecular test result during the 14 days before through 72 hours after the encounter were included.** Patients were classified as unvaccinated (zero doses received), vaccinated with 2, 3, or 4 doses of a monovalent-only mRNA vaccine, or vaccinated with 2, 3, or 4 monovalent doses plus a bivalent booster dose &ge;60 days after receipt of their last monovalent dose. Encounters were excluded if 1) the patient likely had an immunocompromising condition (<i>4</i>); 2) only one mRNA monovalent vaccine dose was received, a second monovalent vaccine dose was received &lt;14 days before the encounter date, or a third or fourth monovalent vaccine dose or a bivalent booster dose was received &lt;7 days before the encounter date; 3) any dose of a non-mRNA vaccine (e.g., Janssen [Johnson &amp; Johnson]) was received; or 4) a vaccine dose was received before being recommended by CDC.<sup>&dagger;&dagger;</sup> VE was estimated using a test-negative case-control design, comparing the odds of having received versus having not received a bivalent booster dose among case-patients (those who received a positive SARS-CoV-2 test result) and control patients (those who received a negative SARS-CoV-2 test result).</p>
<p>Odds ratios and 95% CIs were calculated using multivariable logistic regression, adjusting for age, race and ethnicity, sex, calendar day (days since January 1, 2021), geographic region, and local SARS-CoV-2 circulation (percentage of SARS-CoV-2&ndash;positive results from testing within the counties surrounding the facility on the date of the encounter). Age, calendar day, and local circulation were modeled as natural cubic splines. A single, combined model was fit for each outcome (ED/UC encounters and hospitalizations) with those who had received a bivalent booster dose (after 2, 3, or 4 monovalent doses) as the referent group with the following vaccination groups: those who had received no vaccine doses (unvaccinated) (i.e., absolute VE) and those who had received 2, 3, or 4 monovalent doses but not a bivalent booster dose (i.e., relative VE). Varying time intervals between the last dose and the index date (2&ndash;4, 5&ndash;7, 8&ndash;10, or &ge;11 months)<sup>&sect;&sect;</sup> were used to calculate relative VE. Analyses were conducted using R (version 4.2.2; R Foundation). This study was conducted consistent with applicable federal law and CDC policy and was reviewed and approved by Institutional Review Boards at participating sites or under reliance agreement with the Institutional Review Board of Westat, Inc.<sup>&para;&para;</sup></p>
<p>Among 78,170 ED/UC encounters with COVID-19&ndash;like illness that met inclusion criteria, 8,986 (12%) case-patients and 69,184 (89%) control patients were identified (<a id="T1_up"></a><a href="#T1_down">Table 1</a>). Overall, 24,130 (31%) were unvaccinated. Among persons who had not received a bivalent dose, 18,724 (24%), 22,539 (29%), and 8,080 (10%) had received 2, 3, and 4 doses of monovalent mRNA vaccine, respectively. Among the 4,697 (6%) adults who had received a bivalent booster dose (median interval since receipt of bivalent booster&nbsp;dose =&nbsp;25 days), 292 (6%) had received 2 monovalent doses, 2,115 (45%) had received 3 monovalent doses, and 2,290 (49%) had received 4 monovalent vaccine doses. Bivalent booster dose recipients were older (median age&nbsp;=&nbsp;68 years) than were those who had not received a bivalent booster dose (median age = 55 years). VE of a bivalent booster dose (after 2, 3, or 4 monovalent doses) against ED/UC encounters for COVID-19&ndash;associated illness was 56% (95% CI&nbsp;=&nbsp;50%&ndash;61%) compared with no vaccination, 32% (95% CI&nbsp;=&nbsp;21%&ndash;42%) compared with receipt of last monovalent dose 2&ndash;4 months earlier, and 50% (95% CI&nbsp;=&nbsp;44%&ndash;56%) compared with receipt of last monovalent dose &ge;11 months earlier (<a id="T2_up"></a><a href="#T2_down">Table 2</a>).</p>
<p>Among 15,502 hospitalizations with COVID-19&ndash;like illness that met inclusion criteria, 1,452 (9%) case-patients and 14,050 (91%) control patients were identified (<a id="T3_up"></a><a href="#T3_down">Table 3</a>). Overall, 4,092 (26%) were unvaccinated. Among those who had not received a bivalent dose, 3,343 (22%), 4,704 (30%), and 2,479 (16%) had received 2, 3, and 4 doses of monovalent mRNA vaccine, respectively. Among the 884 (6%) adults who had received a bivalent booster dose (median interval since receipt of bivalent booster&nbsp;dose =&nbsp;23 days), 58 (7%) had received 2 monovalent doses, 299 (34%) had received 3 monovalent doses, and 527 (60%) had received 4 monovalent doses. Bivalent booster dose recipients were similar in age to vaccinated adults who had not received a bivalent booster dose (median age = 76 and 73 years, respectively). VE of a bivalent booster dose (after 2, 3, or 4 monovalent doses) against hospitalization for COVID-19&ndash;associated illness was 59% (95% CI&nbsp;=&nbsp;44%&ndash;70%) compared with no vaccination and 48% (95% CI&nbsp;=&nbsp;30%&ndash;62%) compared with receipt of last monovalent doses, with last dose &ge;11 months earlier (Table 2).</p>
</div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><div class="order-4 w-100"><div>
<h2><a id="discussion" class="onThisPageAnchor" title="Discussion"></a>Discussion</h2>
<p>Analysis of data from the multistate VISION Network found that during September&ndash;November 2022, when the BA.5 and other Omicron sublineages were the predominant circulating SARS-CoV-2 variants in the United States, bivalent booster doses (after receipt of 2, 3, or 4 monovalent doses) were effective in preventing medically attended COVID-19 compared with no previous vaccination among immunocompetent adults and provided additional protection when compared with previous monovalent mRNA vaccine doses only. VE was similar against COVID-19&ndash;associated ED/UC encounters and hospitalizations, which might reflect changing severity of hospitalized cases over time (<i>5</i>). Additional studies are needed to evaluate VE against outcomes such as COVID-19&ndash;associated severe respiratory illness or death. The IVY Network, an adult inpatient VE network, recently found higher estimated VE in adults aged &ge;65 years compared with estimates for those aged &ge;18 years included in this analysis (<i>6</i>). This might reflect differences in population subgroups evaluated. Long-term durability of bivalent booster vaccination protection also could not be assessed because of the short period of observation since bivalent dose receipt. In a recent analysis from VISION, during BA.4/BA.5&ndash;predominant circulation, 3-dose monovalent VE against COVID-19&ndash;associated hospitalization was observed to wane from 68% at 7&ndash;119 days after vaccination to 36% at &ge;120 days (<i>5</i>). This might explain why, among patients who had received 2, 3, or 4 monovalent vaccine doses only, a longer interval since the most recent dose was associated with more relative protection after receipt of the bivalent booster dose.</p>
<p>Bivalent COVID-19 booster vaccines were developed to improve protection against circulating Omicron sublineages because of immune escape potentially associated with these subvariants and waning of monovalent vaccine-conferred protection over time (<i>7</i>). Real-world data suggest that bivalent boosters provide a modest degree of protection against symptomatic infection among adults compared with receipt of 2, 3, or 4 doses of monovalent vaccines only (<i>8</i>). Results from this study also demonstrate protection against ED/UC encounters and hospitalization during a period when BA.5 and other Omicron sublineage viruses predominated in the United States. With co-circulation of multiple respiratory viruses, including SARS-CoV-2, influenza, and respiratory syncytial virus, vaccination against respiratory diseases for which vaccines are available is especially important to prevent illnesses resulting in health care encounters and to reduce strain on the health care system (<i>9</i>). Additional studies will be critical to evaluating the durability of added protection, especially with circulation of sublineages of the BA.4/BA.5 Omicron variants such as BQ.1 and BQ.1.1.</p>
<p>The findings in this study are subject to at least six limitations. First, previous SARS-CoV-2 infection was not accounted for in this analysis. A large proportion of the population has now experienced SARS-CoV-2 infection which decreases the risk of future medically attended COVID-19 illness and might affect observed VE due to background immunity (<i>10</i>). Second, although models adjusted for relevant confounders, residual confounding is possible, including by behavioral differences and use of COVID-19 treatments such as nirmatrelvir/ritonavir (Paxlovid). Third, sublineage-specific VE could not be estimated. Fourth, this analysis did not compare product-specific bivalent booster VE estimates. Fifth, relative VE was estimated using the interval since receipt of last monovalent dose; this study was not statistically powered to estimate whether relative VE differed by number of previous monovalent vaccine doses received. Finally, because these data are from nine states, the patients in this analysis might not be representative of the entire population of the United States. Further, this analysis included adults who received bivalent booster doses shortly after authorization who might not be fully representative of the vaccine-eligible population. For example, over one half of bivalent booster recipients had previously received 4 monovalent vaccine doses. Additional VE studies are needed as coverage of bivalent boosters increases.</p>
<p>In this early study of immunocompetent adults, significant protection from a booster dose of bivalent mRNA COVID-19 vaccine (after receipt of 2, 3, or 4 monovalent doses) compared with no vaccination was found, as well as significant relative benefits of a bivalent booster dose when compared with previous receipt of monovalent doses only. These findings support efforts to improve coverage with bivalent vaccines, although optimal timing for receipt of bivalent vaccine booster doses needs to be established. All eligible persons should stay up to date with recommended COVID-19 vaccination, including receiving a bivalent booster dose. In addition, persons should consider taking other precautions to avoid respiratory illness this winter season, including masking in public indoor spaces, especially in areas where COVID-19 community levels are high, to protect themselves and others and reduce strain on the health care system during an ongoing surge in multiple respiratory viruses.</p>
</div>
</div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><div class="order-4 w-100"><p>Corresponding author: Mark W. Tenforde, <a href="mailto:media@cdc.gov">media@cdc.gov</a>.</p>
</div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><hr style="border-top:1px solid"><div class="order-4 w-100"><p><a id="contribAff"></a><sup>1</sup>Influenza Division, National Center for Immunization and Respiratory Diseases, CDC; <sup>2</sup>Westat Inc., Rockville, Maryland; <sup>3</sup>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York; <sup>4</sup>New York Presbyterian Hospital, New York, New York; <sup>5</sup>Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California Division of Research, Oakland, California; <sup>6</sup>Children&rsquo;s Minnesota, Minneapolis, Minnesota; <sup>7</sup>Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah; <sup>8</sup>Vanderbilt University Medical Center, Nashville, Tennessee; <sup>9</sup>Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana; <sup>10</sup>Kaiser Permanente Center for Health Research, Portland, Oregon; <sup>11</sup>School of Medicine, Indiana University, Indianapolis, Indiana; <sup>12</sup>HealthPartners Institute, Minneapolis, Minnesota; <sup>13</sup>School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado; <sup>14</sup>Department of Pediatrics, Section of Pediatric Infectious Diseases, Baylor Scott &amp; White Health, Temple, Texas; <sup>15</sup>Department of Medical Education, Texas A&amp;M University College of Medicine, Temple, Texas; <sup>16</sup>Department of Research Analytics and Development, Baylor Scott &amp; White Research Institute, Baylor Scott &amp; White Health, Temple Texas; <sup>17</sup>National Center for Immunization and Respiratory Diseases, CDC.</p>
</div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><div class="order-4 w-100"><div class="footnote-text">
<p class="Footnote">All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Nicola P. Klein received grants from Pfizer, Merck, GlaxoSmithKline, and Sanofi Pasteur. Allison L. Naleway received grants from Pfizer and Vir Biotechnology. Suchitra Rao received grants from GlaxoSmithKline. Charlene McEvoy received grants from AztraZeneca. No other potential conflicts of interest were disclosed.</p>
</div>
</div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><br><div class="order-4 w-100"><div class="footnote-text">
<p class="Footnote">* SARS-CoV-2 variant proportions are monitored by CDC, and available online. <a href="https://covid.cdc.gov/covid-data-tracker/#variant-proportions">https://covid.cdc.gov/covid-data-tracker/#variant-proportions</a></p>
<p class="Footnote"><sup>&dagger;</sup> Medical events with a discharge code consistent with COVID-19&ndash;like illness were included. COVID-19&ndash;like illness diagnoses were obtained from <i>International Classification of Diseases, Tenth Revision</i> (ICD-10) discharge codes. The specific codes used were: COVID-19 pneumonia: J12.81 and J12.82; influenza pneumonia: J09.X1, J10.0, J10.00, J10.01, J10.08, J11.0, J11.00, and J11.08; other viral pneumonia: J12*; bacterial and other pneumonia: J13, J14, J15*, J16*, J17, and J18*; influenza disease: J09*, J10.1, J10.2, J10.8*, J11.1, J11.2, and J11.8*; acute respiratory distress syndrome: J80; chronic obstructive pulmonary disease with acute exacerbation: J44.1; asthma acute exacerbation: J45.21, J45.22, J45.31, J45.32, J45.41, J45.42, J45.51, J45.52, J45.901, and J45.902; respiratory failure: J96.0*, J96.2*, and R09.2; other acute lower respiratory tract infections: J20*, J21*, J22, J40, J44.0, J41*, J42, J43*, J47*, J85, J85.0, J85.2, J85.3, J85.1, and J86*; acute and chronic sinusitis: J01* and J32*; acute upper respiratory tract infections: J00*, J02*, J03*, J04*, J05*, and J06*; acute respiratory illness signs and symptoms: R04.2, R05, R05.1, R05.2, R05.4, R05.8, R05.9, R06.00, R06.02, R06.03, R06.1, R06.2, R06.8, R06.81, R06.82, R06.89, R07.1, R09.0*, R09.01, R09.02, R09.1, R09.2, R09.3, and R09.8*; acute febrile illness signs and symptoms: R50*, R50.81, R50.9, and R68.83; acute nonrespiratory illness signs and symptoms: R19.7, R43*, R43.9, R51*, R51.9, M79.1*, M79.10, M79.18, R65*, R53.81, R53.83, R57.9, R41.82, R40*, R40.0, R40.1, R53.1, R11*, R11.0, R11.1, R11.10, R11.11, R11.15, R11.2, R21*, R10*, R10.0, R10.1*, R10.2, R10.3*, R10.8, R10.81, R10.81*, R10.84, and R10.9. All ICD-10 codes with * include all child codes under the specific parent code.</p>
<p class="Footnote"><sup>&sect;</sup> <a href="https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html">https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html</a></p>
<p class="Footnote"><sup>&para;</sup> Sites from the CDC-funded VISION Network that contributed data for this analysis were Baylor Scott &amp; White Health (Texas), Columbia University Irving Medical Center (New York), HealthPartners (Minnesota and Wisconsin), Intermountain Healthcare (Utah), Kaiser Permanente Northern California (California), Kaiser Permanente Center for Health Research (Oregon and Washington), and University of Colorado (Colorado).</p>
<p class="Footnote">** The encounter date was either the date of collection of a respiratory specimen associated with the most recent positive or negative SARS-CoV-2 test result before the admission or visit date, or the date of the medical visit if testing occurred only after the admission or visit.</p>
<p class="Footnote"><sup>&dagger;&dagger;</sup> Encounters were excluded if a first mRNA booster dose (third dose) was received before it was recommended by CDC on September 23, 2021; the interval between the second and third doses was &lt;5 months, a second mRNA booster dose (fourth dose) was received before it was authorized for adults aged &ge;50 years on March 29, 2022; the interval between the third and fourth doses was &lt;4 months; a bivalent booster dose was received before recommended and generally available to the public (September 6, 2022); or the interval between the last monovalent vaccine dose (second, third, or fourth dose) and the bivalent booster dose was &lt;2 months. <a href="https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html">https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html</a></p>
<p class="Footnote"><sup>&sect;&sect;</sup> Sixty&ndash;149 days was classified as 2&ndash;4 months, 150&ndash;239 days as 5&ndash;7 months, 240&ndash;329 days as 8&ndash;10 months, and &ge;330 days as &ge;11 months.</p>
<p class="Footnote"><sup>&para;&para;</sup> 45 C.F.R. part 46.102(l)(2), 21 C.F.R. part 56; 42 U.S.C. Sect. 241(d); 5 U.S.C. Sect. 552a; 44 U.S.C. Sect. 3501 et seq.</p>
</div>
</div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><div class="order-4 w-100"><h2><a id="References" class="onThisPageAnchor" title="References"></a>References</h2>
<ol>
<li>Rosenblum HG, Wallace M, Godfrey M, et al. Interim recommendations from the Advisory Committee on Immunization Practices for the use of bivalent booster doses of COVID-19 vaccines&mdash;United States, October 2022. MMWR Morb Mortal Wkly Rep 2022;71:1436&ndash;41. <a href="http://doi.org/10.15585/mmwr.mm7145a2" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">https://doi.org/10.15585/mmwr.mm7145a2<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/36355612" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="gov">PMID:36355612<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li>
<li>Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. N Engl J Med 2021;385:585&ndash;94. <a href="http://doi.org/10.1056/NEJMoa2108891" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">https://doi.org/10.1056/NEJMoa2108891<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/34289274" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="gov">PMID:34289274<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li>
<li>Thompson MG, Natarajan K, Irving SA, et al. Effectiveness of a third dose of mRNA vaccines against COVID-19&ndash;associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance&mdash;VISION Network, 10 states, August 2021&ndash;January 2022. MMWR Morb Mortal Wkly Rep 2022;71:139&ndash;45. <a href="http://doi.org/10.15585/mmwr.mm7104e3" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">https://doi.org/10.15585/mmwr.mm7104e3<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/35085224" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="gov">PMID:35085224<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li>
<li>Britton A, Embi PJ, Levy ME, et al. Effectiveness of COVID-19 mRNA vaccines against COVID-19&ndash;associated hospitalizations among immunocompromised adults during SARS-CoV-2 Omicron predominance&mdash;VISION Network, 10 states, December 2021&ndash;August 2022. MMWR Morb Mortal Wkly Rep 2022;71:1335&ndash;42. <a href="http://doi.org/10.15585/mmwr.mm7142a4" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">https://doi.org/10.15585/mmwr.mm7142a4<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/36264840" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="gov">PMID:36264840<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li>
<li>Link-Gelles R, Levy ME, Natarajan K, et al. Association between COVID-19 mRNA vaccination and COVID-19 illness and severity during BA.4 and BA.5 sublineage periods. medRxiv [Preprint posted online October 5, 2022. <a href="http://doi.org/10.1101/2022.10.04.22280459" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">https://doi.org/10.1101/2022.10.04.22280459<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li>
<li>Surie D, DeCuir J, Zhu Y, et al. Early effectiveness estimates of bivalent mRNA vaccines in preventing COVID-19&ndash;associated hospitalization among immunocompetent adults aged &ge;65 years&mdash;IVY Network, 18 states, September 8&ndash;November 30, 2022. MMWR Morb Mortal Wkly Rep 2022;71. Epub December 16, 2022. <a href="https://www.cdc.gov/mmwr/volumes/71/wr/mm715152e2.htm?s_cid=mm715152e2_w">https://www.cdc.gov/mmwr/volumes/71/wr/mm715152e2.htm?s_cid=mm715152e2_w</a></li>
<li>Chalkias S, Harper C, Vrbicky K, et al. A bivalent Omicron-containing booster vaccine against Covid-19. N Engl J Med 2022;387:1279&ndash;91. <a href="http://doi.org/10.1056/NEJMoa2208343" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">https://doi.org/10.1056/NEJMoa2208343<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/36112399" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="gov">PMID:36112399<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li>
<li>Link-Gelles R, Ciesla AA, Fleming-Dutra KE, et al. Effectiveness of bivalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection&mdash;Increasing Community Access to Testing program, United States, September&ndash;November 2022. MMWR Morb Mortal Wkly Rep 2022;71:1526&ndash;30. <a href="http://doi.org/10.15585/mmwr.mm7148e1" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">https://doi.org/10.15585/mmwr.mm7148e1<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/36454688" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="gov">PMID:36454688<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li>
<li>CDC. Health Alert Network. Increased respiratory virus activity, especially among children, early in the 2022&ndash;2023 fall and winter. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. <a href="https://emergency.cdc.gov/han/2022/han00479.asp">https://emergency.cdc.gov/han/2022/han00479.asp</a></li>
<li>Clarke KEN, Jones JM, Deng Y, et al. Seroprevalence of infection-induced SARS-CoV-2 antibodies&mdash;United States, September 2021&ndash;February 2022. MMWR Morb Mortal Wkly Rep 2022;71:606&ndash;8. <a href="http://doi.org/10.15585/mmwr.mm7117e3" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">https://doi.org/10.15585/mmwr.mm7117e3<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/35482574" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="gov">PMID:35482574<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li>
</ol>
</div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><div class="order-4 w-100"><table class="table table-bordered table-responsive">
<caption class="caption-top h4 text-black" style="text-align: left"><a id="T1_down"></a>
<h5><strong>TABLE 1. Characteristics of emergency department and urgent care encounters among immunocompetent adults aged &ge;18 years with COVID-19&ndash;like illness,* by mRNA COVID-19 vaccination status and SARS-CoV-2 test result &mdash; nine states,<b><b><sup>&dagger;</sup></b></b> September&ndash;November 2022</strong><a href="#T1_up"><img loading="lazy" decoding="async" class="float-right" title="Return to your place in the text" src="//www.cdc.gov/images/arrow_up.gif" alt="Return to your place in the text" width="58" height="34" border="0"></a></h5>
</caption>
<thead>
<tr>
<th class="row1left" rowspan="3" scope="col" align="left" valign="bottom">Characteristic</th>
<th class="row1" rowspan="3" scope="col" align="center" valign="bottom">Overall,<br>
no.<br>
(column %)</th>
<th class="row1" colspan="2" scope="col" align="center" valign="bottom">SARS-CoV-2 test result status,<br>
no. (row %)</th>
<th class="row1" rowspan="3" scope="col" align="center" valign="bottom">SMD<sup>&para;</sup></th>
<th class="row1" colspan="6" scope="col" align="center" valign="bottom">mRNA COVID-19 vaccination status,<sup>&sect;</sup> no. (row %)</th>
<th class="row1" rowspan="3" scope="col" align="center" valign="bottom">SMD<sup>&para;</sup></th>
</tr>
<tr>
<th class="row1" colspan="1" rowspan="2" scope="col" align="center" valign="bottom">Case-patients (positive)</th>
<th class="row1" rowspan="2" scope="col" align="center" valign="bottom">Control patients (negative)</th>
<th class="row1" colspan="1" rowspan="2" scope="col" align="center" valign="bottom">Unvaccinated</th>
<th class="row1" colspan="4" scope="col" align="center" valign="bottom">Received 2, 3, or 4 MV doses only, interval since last dose (mos)</th>
<th class="row1" rowspan="2" scope="col" align="center" valign="top">Received BV booster dose &ge;7 days earlier</th>
</tr>
<tr>
<th class="row1" colspan="1" scope="col" align="left" valign="bottom">2&ndash;4</th>
<th class="row1" scope="col" align="left" valign="bottom">5&ndash;7</th>
<th class="row1" scope="col" align="left" valign="bottom">8&ndash;10</th>
<th class="row1" scope="col" align="left" valign="bottom">&ge;11</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="bottom"><b><b>All ED/UC encounters</b></b></td>
<td align="center" valign="bottom"><b><b>78,170 (100.0)</b></b></td>
<td align="center" valign="bottom"><b><b>8,986 (11.5)</b></b></td>
<td align="center" valign="bottom"><b><b>69,184 (88.5)</b></b></td>
<td align="center" valign="bottom"><b><b>&mdash;</b></b></td>
<td align="center" valign="bottom"><b><b>24,130 (30.9)</b></b></td>
<td align="center" valign="bottom"><b><b>5,571 (7.1)</b></b></td>
<td align="center" valign="bottom"><b><b>6,623 (8.5)</b></b></td>
<td align="center" valign="bottom"><b><b>14,050 (18.0)</b></b></td>
<td align="center" valign="bottom"><b><b>23,099 (29.5)</b></b></td>
<td align="center" valign="bottom"><b><b>4,697 (6.0)</b></b></td>
<td align="center" valign="bottom"><b><b>&mdash;</b></b></td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>Site</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Baylor Scott &amp; White Health</td>
<td align="center" valign="top"><b><b>13,516<br>
(17.3)</b></b></td>
<td align="center" valign="top">1,390<br>
(10.3)</td>
<td align="center" valign="top">12,126<br>
(89.7)</td>
<td rowspan="7" align="center" valign="top">0.37</td>
<td align="center" valign="top">7,014<br>
(51.9)</td>
<td align="center" valign="top">288<br>
(2.1)</td>
<td align="center" valign="top">374<br>
(2.8)</td>
<td align="center" valign="top">1,244<br>
(9.2)</td>
<td align="center" valign="top">4,513<br>
(33.4)</td>
<td align="center" valign="top">83<br>
(0.6)</td>
<td rowspan="7" align="center" valign="top">3.81</td>
</tr>
<tr>
<td align="left" valign="top">Columbia University</td>
<td align="center" valign="top"><b><b>3,243<br>
(4.1)</b></b></td>
<td align="center" valign="top">253<br>
(7.8)</td>
<td align="center" valign="top">2,990<br>
(92.2)</td>
<td colspan="1" align="center" valign="top">1,421<br>
(43.8)</td>
<td align="center" valign="top">110<br>
(3.4)</td>
<td align="center" valign="top">209<br>
(6.4)</td>
<td align="center" valign="top">508<br>
(15.7)</td>
<td align="center" valign="top">941<br>
(29.0)</td>
<td align="center" valign="top">54<br>
(1.7)</td>
</tr>
<tr>
<td align="left" valign="top">HealthPartners</td>
<td align="center" valign="top"><b><b>14,214<br>
(18.2)</b></b></td>
<td align="center" valign="top">1,637<br>
(11.5)</td>
<td align="center" valign="top">12,577<br>
(88.5)</td>
<td colspan="1" align="center" valign="top">3,523<br>
(24.8)</td>
<td align="center" valign="top">1,236<br>
(8.7)</td>
<td align="center" valign="top">1,296<br>
(9.1)</td>
<td align="center" valign="top">3,006<br>
(21.1)</td>
<td align="center" valign="top">3,683<br>
(25.9)</td>
<td align="center" valign="top">1,470<br>
(10.3)</td>
</tr>
<tr>
<td align="left" valign="top">Intermountain Healthcare</td>
<td align="center" valign="top"><b><b>15,977 (20.4)</b></b></td>
<td align="center" valign="top">2,723 (17.0)</td>
<td align="center" valign="top">13,254 (83.0)</td>
<td colspan="1" align="center" valign="top">5,278 (33.0)</td>
<td align="center" valign="top">827 (5.2)</td>
<td align="center" valign="top">921 (5.8)</td>
<td align="center" valign="top">2,763 (17.3)</td>
<td align="center" valign="top">5,160 (32.3)</td>
<td align="center" valign="top">1,028 (6.4)</td>
</tr>
<tr>
<td align="left" valign="top">KPNC</td>
<td align="center" valign="top"><b><b>19,484<br>
(24.9)</b></b></td>
<td align="center" valign="top">1,326<br>
(6.8)</td>
<td align="center" valign="top">18,158<br>
(93.2)</td>
<td colspan="1" align="center" valign="top">2,431<br>
(12.5)</td>
<td align="center" valign="top">2,350<br>
(12.1)</td>
<td align="center" valign="top">3,052<br>
(15.7)</td>
<td align="center" valign="top">4,787<br>
(24.6)</td>
<td align="center" valign="top">5,339<br>
(27.4)</td>
<td align="center" valign="top">1,525<br>
(7.8)</td>
</tr>
<tr>
<td align="left" valign="top">KPCHR</td>
<td align="center" valign="top"><b><b>5,840<br>
(7.5)</b></b></td>
<td align="center" valign="top">736<br>
(12.6)</td>
<td align="center" valign="top">5,104<br>
(87.4)</td>
<td colspan="1" align="center" valign="top">1,405<br>
(24.1)</td>
<td align="center" valign="top">617<br>
(10.6)</td>
<td align="center" valign="top">602<br>
(10.3)</td>
<td align="center" valign="top">1,190<br>
(20.4)</td>
<td align="center" valign="top">1,611<br>
(27.6)</td>
<td align="center" valign="top">415<br>
(7.1)</td>
</tr>
<tr>
<td align="left" valign="top">University of Colorado</td>
<td align="center" valign="top"><b><b>5,896<br>
(7.5)</b></b></td>
<td align="center" valign="top">921<br>
(15.6)</td>
<td align="center" valign="top">4,975<br>
(84.4)</td>
<td colspan="1" align="center" valign="top">3,058<br>
(51.9)</td>
<td align="center" valign="top">143<br>
(2.4)</td>
<td align="center" valign="top">169<br>
(2.9)</td>
<td align="center" valign="top">552<br>
(9.4)</td>
<td align="center" valign="top">1,852<br>
(31.4)</td>
<td align="center" valign="top">122<br>
(2.1)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>Age group, yrs</b></b></td>
</tr>
<tr>
<td align="left" valign="top">18&ndash;49</td>
<td align="center" valign="top"><b><b>39,148 (50.1)</b></b></td>
<td align="center" valign="top">4,031 (10.3)</td>
<td align="center" valign="top">35,117 (89.7)</td>
<td rowspan="5" align="center" valign="top">0.14</td>
<td align="center" valign="top">16,465 (42.1)</td>
<td align="center" valign="top">858 (2.2)</td>
<td align="center" valign="top">1,645 (4.2)</td>
<td align="center" valign="top">7,118 (18.2)</td>
<td align="center" valign="top">11,865 (30.3)</td>
<td align="center" valign="top">1,197 (3.1)</td>
<td rowspan="5" align="center" valign="top">3.38</td>
</tr>
<tr>
<td align="left" valign="top">50&ndash;64</td>
<td align="center" valign="top"><b><b>14,666 (18.8)</b></b></td>
<td align="center" valign="top">1,708 (11.6)</td>
<td align="center" valign="top">12,958 (88.4)</td>
<td colspan="1" align="center" valign="top">3,899 (26.6)</td>
<td align="center" valign="top">1,339 (9.1)</td>
<td align="center" valign="top">1,272 (8.7)</td>
<td align="center" valign="top">3,044 (20.8)</td>
<td align="center" valign="top">4,250 (29.0)</td>
<td align="center" valign="top">862 (5.9)</td>
</tr>
<tr>
<td align="left" valign="top">65&ndash;74</td>
<td align="center" valign="top"><b><b>10,509 (13.4)</b></b></td>
<td align="center" valign="top">1,304 (12.4)</td>
<td align="center" valign="top">9,205 (87.6)</td>
<td colspan="1" align="center" valign="top">1,896 (18.0)</td>
<td align="center" valign="top">1,332 (12.7)</td>
<td align="center" valign="top">1,407 (13.4)</td>
<td align="center" valign="top">1,706 (16.2)</td>
<td align="center" valign="top">3,040 (28.9)</td>
<td align="center" valign="top">1,128 (10.7)</td>
</tr>
<tr>
<td align="left" valign="top">75&ndash;84</td>
<td align="center" valign="top"><b><b>8,812 (11.3)</b></b></td>
<td align="center" valign="top">1,266 (14.4)</td>
<td align="center" valign="top">7,546 (85.6)</td>
<td colspan="1" align="center" valign="top">1,201 (13.6)</td>
<td align="center" valign="top">1,253 (14.2)</td>
<td align="center" valign="top">1,449 (16.4)</td>
<td align="center" valign="top">1,412 (16.0)</td>
<td align="center" valign="top">2,483 (28.2)</td>
<td align="center" valign="top">1,014 (11.5)</td>
</tr>
<tr>
<td align="left" valign="top">&ge;85</td>
<td align="center" valign="top"><b><b>5,035 (6.4)</b></b></td>
<td align="center" valign="top">677 (13.4)</td>
<td align="center" valign="top">4,358 (86.6)</td>
<td colspan="1" align="center" valign="top">669 (13.3)</td>
<td align="center" valign="top">789 (15.7)</td>
<td align="center" valign="top">850 (16.9)</td>
<td align="center" valign="top">770 (15.3)</td>
<td align="center" valign="top">1,461 (29.0)</td>
<td align="center" valign="top">496 (9.9)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>Sex</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Female</td>
<td align="center" valign="top"><b><b>48,262 (61.7)</b></b></td>
<td align="center" valign="top">5,331 (11.0)</td>
<td align="center" valign="top">42,931 (89.0)</td>
<td rowspan="2" align="center" valign="top">0.06</td>
<td align="center" valign="top">14,547 (30.1)</td>
<td align="center" valign="top">3,377 (7.0)</td>
<td align="center" valign="top">4,029 (8.3)</td>
<td align="center" valign="top">8,931 (18.5)</td>
<td align="center" valign="top">14,603 (30.3)</td>
<td align="center" valign="top">2,775 (5.7)</td>
<td rowspan="2" align="center" valign="top">0.15</td>
</tr>
<tr>
<td align="left" valign="top">Male</td>
<td align="center" valign="top"><b><b>29,908 (38.3)</b></b></td>
<td align="center" valign="top">3,655 (12.2)</td>
<td align="center" valign="top">26,253 (87.8)</td>
<td colspan="1" align="center" valign="top">9,583 (32.0)</td>
<td align="center" valign="top">2,194 (7.3)</td>
<td align="center" valign="top">2,594 (8.7)</td>
<td align="center" valign="top">5,119 (17.1)</td>
<td align="center" valign="top">8,496 (28.4)</td>
<td align="center" valign="top">1,922 (6.4)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>Race and ethnicity</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Black or African American, NH</td>
<td align="center" valign="top"><b><b>9,260 (11.8)</b></b></td>
<td align="center" valign="top">823 (8.9)</td>
<td align="center" valign="top">8,437 (91.1)</td>
<td rowspan="5" align="center" valign="top">0.17</td>
<td align="center" valign="top">3,837 (41.4)</td>
<td align="center" valign="top">515 (5.6)</td>
<td align="center" valign="top">694 (7.5)</td>
<td align="center" valign="top">1,420 (15.3)</td>
<td align="center" valign="top">2,547 (27.5)</td>
<td align="center" valign="top">247 (2.7)</td>
<td rowspan="5" align="center" valign="top">1.13</td>
</tr>
<tr>
<td align="left" valign="top">Hispanic or Latino</td>
<td align="center" valign="top"><b><b>14,689 (18.8)</b></b></td>
<td align="center" valign="top">1,345 (9.2)</td>
<td align="center" valign="top">13,344 (90.8)</td>
<td colspan="1" align="center" valign="top">5,118 (34.8)</td>
<td align="center" valign="top">843 (5.7)</td>
<td align="center" valign="top">1,081 (7.4)</td>
<td align="center" valign="top">2,743 (18.7)</td>
<td align="center" valign="top">4,456 (30.3)</td>
<td align="center" valign="top">448 (3.0)</td>
</tr>
<tr>
<td align="left" valign="top">Other, NH**</td>
<td align="center" valign="top"><b><b>7,412 (9.5)</b></b></td>
<td align="center" valign="top">841 (11.3)</td>
<td align="center" valign="top">6,571 (88.7)</td>
<td colspan="1" align="center" valign="top">1,746 (23.6)</td>
<td align="center" valign="top">657 (8.9)</td>
<td align="center" valign="top">780 (10.5)</td>
<td align="center" valign="top">1,732 (23.4)</td>
<td align="center" valign="top">2,013 (27.2)</td>
<td align="center" valign="top">484 (6.5)</td>
</tr>
<tr>
<td align="left" valign="top">Unknown</td>
<td align="center" valign="top"><b><b>1,255 (1.6)</b></b></td>
<td align="center" valign="top">154 (12.3)</td>
<td align="center" valign="top">1,101 (87.7)</td>
<td colspan="1" align="center" valign="top">547 (43.6)</td>
<td align="center" valign="top">46 (3.7)</td>
<td align="center" valign="top">73 (5.8)</td>
<td align="center" valign="top">239 (19.0)</td>
<td align="center" valign="top">317 (25.3)</td>
<td align="center" valign="top">33 (2.6)</td>
</tr>
<tr>
<td align="left" valign="top">White, NH</td>
<td align="center" valign="top"><b><b>45,554 (58.3)</b></b></td>
<td align="center" valign="top">5,823 (12.8)</td>
<td align="center" valign="top">39,731 (87.2)</td>
<td colspan="1" align="center" valign="top">12,882 (28.3)</td>
<td align="center" valign="top">3,510 (7.7)</td>
<td align="center" valign="top">3,995 (8.8)</td>
<td align="center" valign="top">7,916 (17.4)</td>
<td align="center" valign="top">13,766 (30.2)</td>
<td align="center" valign="top">3,485 (7.7)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>Documented previous SARS-CoV-2 infection<sup>&dagger;&dagger;</sup></b></b></td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top"><b><b>15,726 (20.1)</b></b></td>
<td align="center" valign="top">1,244 (7.9)</td>
<td align="center" valign="top">14,482 (92.1)</td>
<td rowspan="2" align="center" valign="top">0.19</td>
<td align="center" valign="top">4,680 (29.8)</td>
<td align="center" valign="top">1,020 (6.5)</td>
<td align="center" valign="top">1,322 (8.4)</td>
<td align="center" valign="top">2,875 (18.3)</td>
<td align="center" valign="top">5,066 (32.2)</td>
<td align="center" valign="top">763 (4.9)</td>
<td rowspan="2" align="center" valign="top">0.15</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top"><b><b>62,444 (79.9)</b></b></td>
<td align="center" valign="top">7,742 (12.4)</td>
<td align="center" valign="top">54,702 (87.6)</td>
<td colspan="1" align="center" valign="top">19,450 (31.1)</td>
<td align="center" valign="top">4,551 (7.3)</td>
<td align="center" valign="top">5,301 (8.5)</td>
<td align="center" valign="top">11,175 (17.9)</td>
<td align="center" valign="top">18,033 (28.9)</td>
<td align="center" valign="top">3,934 (6.3)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>SARS-CoV-2 status</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Positive test result (case-patient)</td>
<td align="center" valign="top"><b><b>8,986 (11.5)</b></b></td>
<td align="center" valign="top">8,986 (100.0)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td rowspan="2" align="center" valign="top">&mdash;</td>
<td align="center" valign="top">3,037 (33.8)</td>
<td align="center" valign="top">531 (5.9)</td>
<td align="center" valign="top">679 (7.6)</td>
<td align="center" valign="top">1,663 (18.5)</td>
<td align="center" valign="top">2,738 (30.5)</td>
<td align="center" valign="top">338 (3.8)</td>
<td rowspan="2" align="center" valign="top">0.25</td>
</tr>
<tr>
<td align="left" valign="top">Negative test result (control patient)</td>
<td align="center" valign="top"><b><b>69,184 (88.5)</b></b></td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">69,184 (100.0)</td>
<td colspan="1" align="center" valign="top">21,093 (30.5)</td>
<td align="center" valign="top">5,040 (7.3)</td>
<td align="center" valign="top">5,944 (8.6)</td>
<td align="center" valign="top">12,387 (17.9)</td>
<td align="center" valign="top">20,361 (29.4)</td>
<td align="center" valign="top">4,359 (6.3)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>No. of MV mRNA vaccine doses received</b></b></td>
</tr>
<tr>
<td align="left" valign="top">None</td>
<td align="center" valign="top"><b><b>24,130 (30.9)</b></b></td>
<td align="center" valign="top">3,037 (12.6)</td>
<td align="center" valign="top">21,093 (87.4)</td>
<td rowspan="4" align="center" valign="top">0.08</td>
<td align="center" valign="top">24,130 (100.0)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td rowspan="4" align="center" valign="top">&mdash;</td>
</tr>
<tr>
<td align="left" valign="top">2</td>
<td align="center" valign="top"><b><b>19,016 (24.3)</b></b></td>
<td align="center" valign="top">2,157 (11.3)</td>
<td align="center" valign="top">16,859 (88.7)</td>
<td colspan="1" align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">274 (1.4)</td>
<td align="center" valign="top">595 (3.1)</td>
<td align="center" valign="top">1,384 (7.3)</td>
<td align="center" valign="top">16,471 (86.6)</td>
<td align="center" valign="top">292 (1.5)</td>
</tr>
<tr>
<td align="left" valign="top">3</td>
<td align="center" valign="top"><b><b>24,654 (31.5)</b></b></td>
<td align="center" valign="top">2,740 (11.1)</td>
<td align="center" valign="top">21,914 (88.9)</td>
<td colspan="1" align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">997 (4.0)</td>
<td align="center" valign="top">2,248 (9.1)</td>
<td align="center" valign="top">12,666 (51.4)</td>
<td align="center" valign="top">6,628 (26.9)</td>
<td align="center" valign="top">2,115 (8.6)</td>
</tr>
<tr>
<td align="left" valign="top">4</td>
<td align="center" valign="top"><b><b>10,370 (13.3)</b></b></td>
<td align="center" valign="top">1,052 (10.1)</td>
<td align="center" valign="top">9,318 (89.9)</td>
<td colspan="1" align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">4,300 (41.5)</td>
<td align="center" valign="top">3,780 (36.5)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">2,290 (22.1)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>Most recent dose product manufacturer</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Pfizer-BioNTech</td>
<td align="center" valign="top"><b><b>34,705 (44.4)</b></b></td>
<td align="center" valign="top">3,825 (11.0)</td>
<td align="center" valign="top">30,880 (89.0)</td>
<td rowspan="3" align="center" valign="top">0.07</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">3,533 (10.2)</td>
<td align="center" valign="top">4,231 (12.2)</td>
<td align="center" valign="top">8,327 (24.0)</td>
<td align="center" valign="top">15,018 (43.3)</td>
<td align="center" valign="top">3,596 (10.4)</td>
<td rowspan="3" align="center" valign="top">&mdash;</td>
</tr>
<tr>
<td align="left" valign="top">Moderna</td>
<td align="center" valign="top"><b><b>19,335 (24.7)</b></b></td>
<td align="center" valign="top">2,124 (11.0)</td>
<td align="center" valign="top">17,211 (89.0)</td>
<td colspan="1" align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">2,038 (10.5)</td>
<td align="center" valign="top">2,392 (12.4)</td>
<td align="center" valign="top">5,723 (29.6)</td>
<td align="center" valign="top">8,081 (41.8)</td>
<td align="center" valign="top">1,101 (5.7)</td>
</tr>
<tr>
<td align="left" valign="top">None</td>
<td align="center" valign="top"><b><b>24,130 (30.9)</b></b></td>
<td align="center" valign="top">3,037 (12.6)</td>
<td align="center" valign="top">21,093 (87.4)</td>
<td colspan="1" align="center" valign="top">24,130 (100.0)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>Any chronic condition</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top"><b><b>23,834 (30.5)</b></b></td>
<td align="center" valign="top">2,307 (9.7)</td>
<td align="center" valign="top">21,527 (90.3)</td>
<td rowspan="2" align="center" valign="top">0.12</td>
<td align="center" valign="top">6,778 (28.4)</td>
<td align="center" valign="top">2,068 (8.7)</td>
<td align="center" valign="top">2,370 (9.9)</td>
<td align="center" valign="top">4,011 (16.8)</td>
<td align="center" valign="top">7,195 (30.2)</td>
<td align="center" valign="top">1,412 (5.9)</td>
<td rowspan="2" align="center" valign="top">0.45</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top"><b><b>54,336 (69.5)</b></b></td>
<td align="center" valign="top">6,679 (12.3)</td>
<td align="center" valign="top">47,657 (87.7)</td>
<td colspan="1" align="center" valign="top">17,352 (31.9)</td>
<td align="center" valign="top">3,503 (6.4)</td>
<td align="center" valign="top">4,253 (7.8)</td>
<td align="center" valign="top">10,039 (18.5)</td>
<td align="center" valign="top">15,904 (29.3)</td>
<td align="center" valign="top">3,285 (6.0)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>&ge;1 chronic respiratory condition</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top"><b><b>12,290 (15.7)</b></b></td>
<td align="center" valign="top">1,057 (8.6)</td>
<td align="center" valign="top">11,233 (91.4)</td>
<td rowspan="2" align="center" valign="top">0.13</td>
<td align="center" valign="top">3,604 (29.3)</td>
<td align="center" valign="top">987 (8.0)</td>
<td align="center" valign="top">1,148 (9.3)</td>
<td align="center" valign="top">2,039 (16.6)</td>
<td align="center" valign="top">3,800 (30.9)</td>
<td align="center" valign="top">712 (5.8)</td>
<td rowspan="2" align="center" valign="top">0.2</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top"><b><b>65,880 (84.3)</b></b></td>
<td align="center" valign="top">7,929 (12.0)</td>
<td align="center" valign="top">57,951 (88.0)</td>
<td colspan="1" align="center" valign="top">20,526 (31.2)</td>
<td align="center" valign="top">4,584 (7.0)</td>
<td align="center" valign="top">5,475 (8.3)</td>
<td align="center" valign="top">12,011 (18.2)</td>
<td align="center" valign="top">19,299 (29.3)</td>
<td align="center" valign="top">3,985 (6.0)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>&ge;1 chronic non-respiratory condition</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top"><b><b>17,215 (22.0)</b></b></td>
<td align="center" valign="top">1,832 (10.6)</td>
<td align="center" valign="top">15,383 (89.4)</td>
<td rowspan="2" align="center" valign="top">0.05</td>
<td align="center" valign="top">4,867 (28.3)</td>
<td align="center" valign="top">1,562 (9.1)</td>
<td align="center" valign="top">1,715 (10.0)</td>
<td align="center" valign="top">2,822 (16.4)</td>
<td align="center" valign="top">5,290 (30.7)</td>
<td align="center" valign="top">959 (5.6)</td>
<td rowspan="2" align="center" valign="top">0.39</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top"><b><b>60,955 (78.0)</b></b></td>
<td align="center" valign="top">7,154 (11.7)</td>
<td align="center" valign="top">53,801 (88.3)</td>
<td colspan="1" align="center" valign="top">19,263 (31.6)</td>
<td align="center" valign="top">4,009 (6.6)</td>
<td align="center" valign="top">4,908 (8.1)</td>
<td align="center" valign="top">11,228 (18.4)</td>
<td align="center" valign="top">17,809 (29.2)</td>
<td align="center" valign="top">3,738 (6.1)</td>
</tr>
</tbody>
</table>
<p class="caption"><b><b>Abbreviations:</b></b> BV&nbsp;=&nbsp;bivalent; ED/UC = emergency department/urgent care; KPNC&nbsp;=&nbsp;Kaiser Permanente Northern California; KPCHR&nbsp;=&nbsp;Kaiser Permanente Center for Health Research; MV&nbsp;=&nbsp;monovalent; NH&nbsp;=&nbsp;non-Hispanic; SMD&nbsp;=&nbsp;standardized mean or proportion difference.<br>
* ED/UC encounters with a discharge code consistent with COVID-19&ndash;like illness were included. COVID-19&ndash;like illness diagnoses included acute respiratory illness, respiratory signs or symptoms, or febrile signs or symptoms using diagnosis codes from the <i><i>International Classification of Diseases, Tenth Revision</i></i>. Clinician-ordered molecular assays (e.g., real-time reverse transcription&ndash;polymerase chain reaction) for SARS-CoV-2 occurring &le;14 days before to &lt;72 hours after the encounter date were included.<br>
<sup>&dagger;</sup> California (Sep 13&ndash;Nov 18, 2022), Colorado (Sep 13&ndash;Nov 7, 2022), Minnesota and Wisconsin (Sep 13&ndash;Nov 18, 2022), New York (Sep 13&ndash;Nov 18, 2022), Oregon and Washington (Sep 13&ndash;Nov 14, 2022), Texas (Sep 13&ndash;Nov 13, 2022), and Utah (Sep 13&ndash;Nov 18, 2022).<br>
<sup>&sect;</sup> Vaccination was defined as having received the last monovalent or bivalent dose within the specified range of months or days before the ED/UC encounter date, which was the date of respiratory specimen collection associated with the most recent positive or negative SARS-CoV-2 test result before the encounter start date or the encounter start date if testing only occurred after the admission.<br>
<sup>&para;</sup> An absolute SMD &gt;0.20 indicates a nonnegligible difference in variable distributions between ED/UC encounters for vaccinated versus unvaccinated patients or for patients with positive SARS-CoV-2 test results versus patients with negative SARS-CoV-2 test results. For mRNA COVID-19 vaccination status, a single SMD was calculated by averaging the absolute SMDs obtained from pairwise comparisons of each vaccinated category versus unvaccinated. Specifically, it was calculated as the average of the absolute value of the SMDs for 1) vaccinated with only monovalent doses, &ge;11 months earlier versus unvaccinated, 2) vaccinated with only monovalent doses, 8&ndash;10 months earlier versus unvaccinated, 3) vaccinated with only monovalent doses 5&ndash;7 months earlier versus unvaccinated, 4) vaccinated with only monovalent doses 2&ndash;4 months earlier versus unvaccinated, and 5) vaccinated with bivalent booster &ge;7 days earlier versus unvaccinated.<br>
** Other race includes Asian, Hawaiian or other Pacific Islander, American Indian or Alaska Native, other not listed, and multiple races. Because of small numbers, these categories were combined.<br>
<b><b><sup>&dagger;&dagger;</sup></b></b> Previous SARS-CoV-2 infection was defined as having a positive SARS-CoV-2 test result (molecular or antigen) documented in the electronic health record &ge;15 days before the hospital admission date. This does not capture previous infections in which testing was not performed or testing was performed but not available in the electronic health record (e.g., at-home testing).</p>
</div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><div class="order-4 w-100"><table class="table table-bordered table-responsive">
<caption class="caption-top h4 text-black" style="text-align: left"><a id="T2_down"></a>
<h5><strong>TABLE 2. Bivalent booster COVID-19 vaccine effectiveness* against laboratory confirmed COVID-19&ndash;associated emergency department and urgent care encounters and hospitalizations among immunocompetent adults aged 18 years &mdash; nine states,<b><b><sup>&dagger;</sup></b></b> September&ndash;November 2022</strong><a href="#T2_up"><img loading="lazy" decoding="async" class="float-right" title="Return to your place in the text" src="//www.cdc.gov/images/arrow_up.gif" alt="Return to your place in the text" width="58" height="34" border="0"></a></h5>
</caption>
<thead>
<tr>
<th class="row1left" scope="col" align="left" valign="bottom">mRNA dosage pattern</th>
<th class="row1" scope="col" align="center" valign="bottom">Total</th>
<th class="row1" scope="col" align="center" valign="bottom">Negative SARS-CoV-2 test result, no. (%)</th>
<th class="row1" scope="col" align="center" valign="bottom">Positive SARS-CoV-2 test result, no. (%)</th>
<th class="row1" scope="col" align="center" valign="bottom">Median interval since last dose, days (IQR)</th>
<th class="row1" scope="col" align="center" valign="bottom">VE %<br>
(95% CI)</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="6" align="left" valign="top"><b><b>ED/UC encounters</b></b></td>
</tr>
<tr>
<td colspan="6" align="left" valign="top"><b><b>Relative VE</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Only MV doses, last dose 2&ndash;4 mos earlier</td>
<td align="center" valign="top"><b><b>5,571</b></b></td>
<td align="center" valign="top">5,040 (91)</td>
<td align="center" valign="top">531 (10)</td>
<td align="center" valign="top">115 (91&ndash;134)</td>
<td align="center" valign="top">Ref</td>
</tr>
<tr>
<td align="left" valign="top">BV booster dose, &ge;7 days earlier</td>
<td align="center" valign="top"><b><b>4,697</b></b></td>
<td align="center" valign="top">4,359 (93)</td>
<td align="center" valign="top">338 (7)</td>
<td align="center" valign="top">25 (16&ndash;37)</td>
<td align="center" valign="top">32 (21&ndash;42)</td>
</tr>
<tr>
<td align="left" valign="top">Only MV doses, last dose 5&ndash;7 mos earlier</td>
<td align="center" valign="top"><b><b>6,623</b></b></td>
<td align="center" valign="top">5,944 (90)</td>
<td align="center" valign="top">679 (10)</td>
<td align="center" valign="top">184 (166&ndash;210)</td>
<td align="center" valign="top">Ref</td>
</tr>
<tr>
<td align="left" valign="top">BV booster dose, &ge;7 days earlier</td>
<td align="center" valign="top"><b><b>4,697</b></b></td>
<td align="center" valign="top">4,359 (93)</td>
<td align="center" valign="top">338 (7)</td>
<td align="center" valign="top">25 (16&ndash;37)</td>
<td align="center" valign="top">43 (34&ndash;50)</td>
</tr>
<tr>
<td align="left" valign="top">Only MV doses, last dose 8&ndash;10 mos earlier</td>
<td align="center" valign="top"><b><b>14,050</b></b></td>
<td align="center" valign="top">12,387 (88)</td>
<td align="center" valign="top">1,663 (12)</td>
<td align="center" valign="top">294 (273&ndash;311)</td>
<td align="center" valign="top">Ref</td>
</tr>
<tr>
<td align="left" valign="top">BV booster dose, &ge;7 days earlier</td>
<td align="center" valign="top"><b><b>4,697</b></b></td>
<td align="center" valign="top">4,359 (93)</td>
<td align="center" valign="top">338 (7)</td>
<td align="center" valign="top">25 (16&ndash;37)</td>
<td align="center" valign="top">54 (48&ndash;59)</td>
</tr>
<tr>
<td align="left" valign="top">Only MV doses, last dose &ge;11 mos earlier</td>
<td align="center" valign="top"><b><b>23,099</b></b></td>
<td align="center" valign="top">20,361 (88)</td>
<td align="center" valign="top">2,738 (12)</td>
<td align="center" valign="top">463 (366&ndash;543)</td>
<td align="center" valign="top">Ref</td>
</tr>
<tr>
<td align="left" valign="top">BV booster dose, &ge;7 days earlier</td>
<td align="center" valign="top"><b><b>4,697</b></b></td>
<td align="center" valign="top">4,359 (93)</td>
<td align="center" valign="top">338 (7)</td>
<td align="center" valign="top">25 (16&ndash;37)</td>
<td align="center" valign="top">50 (44&ndash;56)</td>
</tr>
<tr>
<td colspan="6" align="left" valign="top"><b><b>Absolute VE</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Unvaccinated</td>
<td align="center" valign="top"><b><b>24,130</b></b></td>
<td align="center" valign="top">21,093 (87)</td>
<td align="center" valign="top">3,037 (13)</td>
<td align="center" valign="top">NA</td>
<td align="center" valign="top">Ref</td>
</tr>
<tr>
<td align="left" valign="top">BV booster dose, &ge;7 days earlier</td>
<td align="center" valign="top"><b><b>4,697</b></b></td>
<td align="center" valign="top">4,359 (93)</td>
<td align="center" valign="top">338 (7)</td>
<td align="center" valign="top">25 (16&ndash;37)</td>
<td align="center" valign="top">56 (50&ndash;61)</td>
</tr>
<tr>
<td colspan="6" align="left" valign="top"><b><b>Hospitalizations</b></b></td>
</tr>
<tr>
<td colspan="6" align="left" valign="top"><b><b>Relative VE</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Only MV doses, last dose 2&ndash;4 mos earlier</td>
<td align="center" valign="top"><b><b>&mdash;</b></b><sup>&sect;</sup></td>
<td align="center" valign="top">&mdash;</td>
<td align="center" valign="top">&mdash;</td>
<td align="center" valign="top">&mdash;</td>
<td align="center" valign="top">&mdash;</td>
</tr>
<tr>
<td align="left" valign="top">BV booster dose, &ge;7 days earlier</td>
<td align="center" valign="top"><b><b>&mdash;</b></b></td>
<td align="center" valign="top">&mdash;</td>
<td align="center" valign="top">&mdash;</td>
<td align="center" valign="top">&mdash;</td>
<td align="center" valign="top">&mdash;</td>
</tr>
<tr>
<td align="left" valign="top">Only MV doses, last dose 5&ndash;7 mos earlier</td>
<td align="center" valign="top"><b><b>1,780</b></b></td>
<td align="center" valign="top">1,615 (91)</td>
<td align="center" valign="top">165 (9)</td>
<td align="center" valign="top">178 (164&ndash;201)</td>
<td align="center" valign="top">Ref</td>
</tr>
<tr>
<td align="left" valign="top">BV booster dose, &ge;7 days earlier</td>
<td align="center" valign="top"><b><b>884</b></b></td>
<td align="center" valign="top">828 (94)</td>
<td align="center" valign="top">56 (6)</td>
<td align="center" valign="top">23 (14&ndash;34)</td>
<td align="center" valign="top">42 (20&ndash;58)</td>
</tr>
<tr>
<td align="left" valign="top">Only MV doses, last dose 8&ndash;10 mos earlier</td>
<td align="center" valign="top"><b><b>2,636</b></b></td>
<td align="center" valign="top">2,405 (91)</td>
<td align="center" valign="top">231 (9)</td>
<td align="center" valign="top">294 (273&ndash;313)</td>
<td align="center" valign="top">Ref</td>
</tr>
<tr>
<td align="left" valign="top">BV booster dose, &ge;7 days earlier</td>
<td align="center" valign="top"><b><b>884</b></b></td>
<td align="center" valign="top">828 (94)</td>
<td align="center" valign="top">56 (6)</td>
<td align="center" valign="top">23 (14&ndash;34)</td>
<td align="center" valign="top">44 (23&ndash;59)</td>
</tr>
<tr>
<td align="left" valign="top">Only MV doses, last dose &ge;11 mos earlier</td>
<td align="center" valign="top"><b><b>4,549</b></b></td>
<td align="center" valign="top">4,105 (90)</td>
<td align="center" valign="top">444 (10)</td>
<td align="center" valign="top">474 (362&ndash;556)</td>
<td align="center" valign="top">Ref</td>
</tr>
<tr>
<td align="left" valign="top">BV booster dose, &ge;7 days earlier</td>
<td align="center" valign="top"><b><b>884</b></b></td>
<td align="center" valign="top">828 (94)</td>
<td align="center" valign="top">56 (6)</td>
<td align="center" valign="top">23 (14&ndash;34)</td>
<td align="center" valign="top">48 (30&ndash;62)</td>
</tr>
<tr>
<td colspan="6" align="left" valign="top"><b><b>Absolute VE</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Unvaccinated</td>
<td align="center" valign="top"><b><b>4,092</b></b></td>
<td align="center" valign="top">3,658 (89)</td>
<td align="center" valign="top">434 (11)</td>
<td align="center" valign="top">NA</td>
<td align="center" valign="top">Ref</td>
</tr>
<tr>
<td align="left" valign="top">BV booster dose, &ge;7 days earlier</td>
<td align="center" valign="top"><b><b>884</b></b></td>
<td align="center" valign="top">828 (94)</td>
<td align="center" valign="top">56 (6)</td>
<td align="center" valign="top">23 (14&ndash;34)</td>
<td align="center" valign="top">59 (44&ndash;70)</td>
</tr>
</tbody>
</table>
<p class="caption"><b><b>Abbreviations</b></b>: BV&nbsp;=&nbsp;bivalent; ED/UC&nbsp;=&nbsp;emergency department/urgent care; MV&nbsp;=&nbsp;monovalent; NA = not applicable; Ref&nbsp;=&nbsp;referent group; VE&nbsp;=&nbsp;vaccine effectiveness.<br>
* VE was calculated as ([1 &minus; odds ratio] x 100%), estimated using a test-negative case-control design, adjusted for age, sex, race and ethnicity, geographic region, calendar time (days since January 1, 2021), and local virus circulation (percentage of positive SARS-CoV-2 test results from testing within the counties surrounding the facility on the date of the encounter).<br>
<sup>&dagger;</sup> California (Sep 13, 2022&ndash;Nov 18, 2022), Colorado (Sep 13, 2022&ndash;Nov 7, 2022), Minnesota and Wisconsin (Sep 13, 2022&ndash;Nov 18, 2022), New York (Sep 13, 2022&ndash;Nov 18, 2022), Oregon and Washington (Sep 13, 2022&ndash;Nov 14, 2022), Texas (Sep 13, 2022&ndash;Nov 13, 2022), and Utah (Sep 13, 2022&ndash;Nov 18, 2022).<br>
<sup>&sect;</sup> Dashes indicate that estimated VE had a CI width &ge;50%. Estimates with CI widths &ge;50% are not shown here because of imprecision. The associated data are also omitted.</p>
</div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><div class="order-4 w-100"><table class="table table-bordered table-responsive">
<caption class="caption-top h4 text-black" style="text-align: left"><a id="T3_down"></a>
<h5><strong>TABLE 3. Characteristics of hospitalizations among immunocompetent adults aged &ge;18 years with COVID-19&ndash;like illness,<b><b>*</b></b> by mRNA COVID-19 vaccination status and SARS-CoV-2 test result &mdash; nine states,<b><b><sup>&dagger;</sup></b></b> September&ndash;November 2022</strong><a href="#T3_up"><img loading="lazy" decoding="async" class="float-right" title="Return to your place in the text" src="//www.cdc.gov/images/arrow_up.gif" alt="Return to your place in the text" width="58" height="34" border="0"></a></h5>
</caption>
<thead>
<tr>
<th class="row1left" rowspan="3" scope="col" align="center" valign="bottom">Characteristic</th>
<th class="row1" rowspan="3" scope="col" align="center" valign="bottom">Overall,<br>
no.<br>
(col %)</th>
<th class="row1" colspan="2" scope="col" align="center" valign="bottom">SARS-CoV-2 test result status,<br>
no. (row %)</th>
<th class="row1" rowspan="3" scope="col" align="center" valign="bottom">SMD<sup>&para;</sup></th>
<th class="row1" colspan="6" scope="col" align="center" valign="bottom">mRNA COVID-19 vaccination status.<sup>&sect;</sup> no. (row %)</th>
<th class="row1" rowspan="3" scope="col" align="center" valign="bottom">SMD<sup>&para;</sup></th>
</tr>
<tr>
<th class="row1" colspan="1" rowspan="2" scope="col" align="center" valign="bottom">Case-patients<br>
(positive)</th>
<th class="row1" rowspan="2" scope="col" align="center" valign="bottom">Control patients<br>
(negative)</th>
<th class="row1" colspan="1" rowspan="2" scope="col" align="center" valign="bottom">Unvaccinated</th>
<th class="row1" colspan="4" scope="col" align="center" valign="bottom">Received 2, 3, or 4 MV doses only, interval since last dose (mos)</th>
<th class="row1" rowspan="2" scope="col" align="center" valign="bottom">Received BV booster dose &ge;7 days earlier</th>
</tr>
<tr>
<th class="row1" colspan="1" scope="col" align="center" valign="bottom">2&ndash;4</th>
<th class="row1" scope="col" align="center" valign="bottom">5&ndash;7</th>
<th class="row1" scope="col" align="center" valign="bottom">8&ndash;10</th>
<th class="row1" scope="col" align="center" valign="bottom">&ge;11</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top"><b><b>All hospitalizations</b></b></td>
<td align="center" valign="top"><b><b>15,502 (100.0)</b></b></td>
<td align="center" valign="top"><b><b>1,452 (9.4)</b></b></td>
<td align="center" valign="top"><b><b>14,050 (90.6)</b></b></td>
<td align="center" valign="top"><b><b>&mdash;</b></b></td>
<td align="center" valign="top"><b><b>4,092 (26.4)</b></b></td>
<td align="center" valign="top"><b><b>1,561 (10.1)</b></b></td>
<td align="center" valign="top"><b><b>1,780 (11.5)</b></b></td>
<td align="center" valign="top"><b><b>2,636 (17.0)</b></b></td>
<td align="center" valign="top"><b><b>4,549 (29.3)</b></b></td>
<td align="center" valign="top"><b><b>884 (5.7)</b></b></td>
<td align="center" valign="top"><b><b>&mdash;</b></b></td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>Site</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Baylor Scott &amp; White Health</td>
<td align="center" valign="top"><b><b>3,782<br>
(24.4)</b></b></td>
<td align="center" valign="top">331<br>
(8.8)</td>
<td align="center" valign="top">3,451<br>
(91.2)</td>
<td rowspan="7" align="center" valign="top">0.2</td>
<td align="center" valign="top">1,545<br>
(40.9)</td>
<td align="center" valign="top">117<br>
(3.1)</td>
<td align="center" valign="top">136<br>
(3.6)</td>
<td align="center" valign="top">433<br>
(11.4)</td>
<td align="center" valign="top">1,516<br>
(40.1)</td>
<td align="center" valign="top">35<br>
(0.9)</td>
<td rowspan="7" align="center" valign="top">3.92</td>
</tr>
<tr>
<td align="left" valign="top">Columbia University</td>
<td align="center" valign="top"><b><b>1,125<br>
(7.2)</b></b></td>
<td align="center" valign="top">128<br>
(11.4)</td>
<td align="center" valign="top">997<br>
(88.6)</td>
<td colspan="1" align="center" valign="top">432<br>
(38.4)</td>
<td align="center" valign="top">69<br>
(6.1)</td>
<td align="center" valign="top">109<br>
(9.7)</td>
<td align="center" valign="top">200<br>
(17.8)</td>
<td align="center" valign="top">292<br>
(26.0)</td>
<td align="center" valign="top">23<br>
(2.0)</td>
</tr>
<tr>
<td align="left" valign="top">HealthPartners</td>
<td align="center" valign="top"><b><b>1,504<br>
(9.7)</b></b></td>
<td align="center" valign="top">165<br>
(11.0)</td>
<td align="center" valign="top">1,339<br>
(89.0)</td>
<td colspan="1" align="center" valign="top">311<br>
(20.7)</td>
<td align="center" valign="top">206<br>
(13.7)</td>
<td align="center" valign="top">183<br>
(12.2)</td>
<td align="center" valign="top">267<br>
(17.8)</td>
<td align="center" valign="top">349<br>
(23.2)</td>
<td align="center" valign="top">188<br>
(12.5)</td>
</tr>
<tr>
<td align="left" valign="top">Intermountain Healthcare</td>
<td align="center" valign="top"><b><b>1,668 (10.8)</b></b></td>
<td align="center" valign="top">218 (13.1)</td>
<td align="center" valign="top">1,450 (86.9)</td>
<td colspan="1" align="center" valign="top">506 (30.3)</td>
<td align="center" valign="top">145 (8.7)</td>
<td align="center" valign="top">128 (7.7)</td>
<td align="center" valign="top">266 (15.9)</td>
<td align="center" valign="top">490 (29.4)</td>
<td align="center" valign="top">133 (8.0)</td>
</tr>
<tr>
<td align="left" valign="top">KPNC</td>
<td align="center" valign="top"><b><b>5,489<br>
(35.4)</b></b></td>
<td align="center" valign="top">438<br>
(8.0)</td>
<td align="center" valign="top">5,051<br>
(92.0)</td>
<td colspan="1" align="center" valign="top">582<br>
(10.6)</td>
<td align="center" valign="top">838<br>
(15.3)</td>
<td align="center" valign="top">1,076<br>
(19.6)</td>
<td align="center" valign="top">1,193<br>
(21.7)</td>
<td align="center" valign="top">1,384<br>
(25.2)</td>
<td align="center" valign="top">416<br>
(7.6)</td>
</tr>
<tr>
<td align="left" valign="top">KPNW</td>
<td align="center" valign="top"><b><b>1,028<br>
(6.6)</b></b></td>
<td align="center" valign="top">82<br>
(8.0)</td>
<td align="center" valign="top">946<br>
(92.0)</td>
<td colspan="1" align="center" valign="top">305<br>
(29.7)</td>
<td align="center" valign="top">135<br>
(13.1)</td>
<td align="center" valign="top">104<br>
(10.1)</td>
<td align="center" valign="top">181<br>
(17.6)</td>
<td align="center" valign="top">238<br>
(23.2)</td>
<td align="center" valign="top">65<br>
(6.3)</td>
</tr>
<tr>
<td align="left" valign="top">University of Colorado</td>
<td align="center" valign="top"><b><b>906<br>
(5.8)</b></b></td>
<td align="center" valign="top">90<br>
(9.9)</td>
<td align="center" valign="top">816<br>
(90.1)</td>
<td colspan="1" align="center" valign="top">411<br>
(45.4)</td>
<td align="center" valign="top">51<br>
(5.6)</td>
<td align="center" valign="top">44<br>
(4.9)</td>
<td align="center" valign="top">96<br>
(10.6)</td>
<td align="center" valign="top">280<br>
(30.9)</td>
<td align="center" valign="top">24<br>
(2.6)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>Age group, yrs</b></b></td>
</tr>
<tr>
<td align="left" valign="top">18&ndash;49</td>
<td align="center" valign="top"><b><b>2,925 (18.9)</b></b></td>
<td align="center" valign="top">160 (5.5)</td>
<td align="center" valign="top">2,765 (94.5)</td>
<td rowspan="5" align="center" valign="top">0.34</td>
<td align="center" valign="top">1,315 (45.0)</td>
<td align="center" valign="top">72 (2.5)</td>
<td align="center" valign="top">136 (4.6)</td>
<td align="center" valign="top">502 (17.2)</td>
<td align="center" valign="top">816 (27.9)</td>
<td align="center" valign="top">84 (2.9)</td>
<td rowspan="5" align="center" valign="top">2.73</td>
</tr>
<tr>
<td align="left" valign="top">50&ndash;64</td>
<td align="center" valign="top"><b><b>2,985 (19.3)</b></b></td>
<td align="center" valign="top">212 (7.1)</td>
<td align="center" valign="top">2,773 (92.9)</td>
<td colspan="1" align="center" valign="top">1,006 (33.7)</td>
<td align="center" valign="top">223 (7.5)</td>
<td align="center" valign="top">280 (9.4)</td>
<td align="center" valign="top">567 (19.0)</td>
<td align="center" valign="top">805 (27.0)</td>
<td align="center" valign="top">104 (3.5)</td>
</tr>
<tr>
<td align="left" valign="top">65&ndash;74</td>
<td align="center" valign="top"><b><b>3,240 (20.9)</b></b></td>
<td align="center" valign="top">300 (9.3)</td>
<td align="center" valign="top">2,940 (90.7)</td>
<td colspan="1" align="center" valign="top">717 (22.1)</td>
<td align="center" valign="top">385 (11.9)</td>
<td align="center" valign="top">391 (12.1)</td>
<td align="center" valign="top">526 (16.2)</td>
<td align="center" valign="top">1,007 (31.1)</td>
<td align="center" valign="top">214 (6.6)</td>
</tr>
<tr>
<td align="left" valign="top">75&ndash;84</td>
<td align="center" valign="top"><b><b>3,615 (23.3)</b></b></td>
<td align="center" valign="top">410 (11.3)</td>
<td align="center" valign="top">3,205 (88.7)</td>
<td colspan="1" align="center" valign="top">599 (16.6)</td>
<td align="center" valign="top">475 (13.1)</td>
<td align="center" valign="top">551 (15.2)</td>
<td align="center" valign="top">636 (17.6)</td>
<td align="center" valign="top">1,072 (29.7)</td>
<td align="center" valign="top">282 (7.8)</td>
</tr>
<tr>
<td align="left" valign="top">&ge;85</td>
<td align="center" valign="top"><b><b>2,737 (17.7)</b></b></td>
<td align="center" valign="top">370 (13.5)</td>
<td align="center" valign="top">2,367 (86.5)</td>
<td colspan="1" align="center" valign="top">455 (16.6)</td>
<td align="center" valign="top">406 (14.8)</td>
<td align="center" valign="top">422 (15.4)</td>
<td align="center" valign="top">405 (14.8)</td>
<td align="center" valign="top">849 (31.0)</td>
<td align="center" valign="top">200 (7.3)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>Sex</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Female</td>
<td align="center" valign="top"><b><b>8,393 (54.1)</b></b></td>
<td align="center" valign="top">747 (8.9)</td>
<td align="center" valign="top">7,646 (91.1)</td>
<td rowspan="2" align="center" valign="top">0.06</td>
<td align="center" valign="top">2,147 (25.6)</td>
<td align="center" valign="top">861 (10.3)</td>
<td align="center" valign="top">966 (11.5)</td>
<td align="center" valign="top">1,437 (17.1)</td>
<td align="center" valign="top">2,500 (29.8)</td>
<td align="center" valign="top">482 (5.7)</td>
<td rowspan="2" align="center" valign="top">0.19</td>
</tr>
<tr>
<td align="left" valign="top">Male</td>
<td align="center" valign="top"><b><b>7,109 (45.9)</b></b></td>
<td align="center" valign="top">705 (9.9)</td>
<td align="center" valign="top">6,404 (90.1)</td>
<td colspan="1" align="center" valign="top">1,945 (27.4)</td>
<td align="center" valign="top">700 (9.8)</td>
<td align="center" valign="top">814 (11.5)</td>
<td align="center" valign="top">1,199 (16.9)</td>
<td align="center" valign="top">2,049 (28.8)</td>
<td align="center" valign="top">402 (5.7)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>Race and ethnicity</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Black or African American, NH</td>
<td align="center" valign="top"><b><b>1,788 (11.5)</b></b></td>
<td align="center" valign="top">116 (6.5)</td>
<td align="center" valign="top">1,672 (93.5)</td>
<td rowspan="5" align="center" valign="top">0.2</td>
<td align="center" valign="top">634 (35.5)</td>
<td align="center" valign="top">138 (7.7)</td>
<td align="center" valign="top">171 (9.6)</td>
<td align="center" valign="top">247 (13.8)</td>
<td align="center" valign="top">544 (30.4)</td>
<td align="center" valign="top">54 (3.0)</td>
<td rowspan="5" align="center" valign="top">1.17</td>
</tr>
<tr>
<td align="left" valign="top">Hispanic or Latino</td>
<td align="center" valign="top"><b><b>2,394 (15.4)</b></b></td>
<td align="center" valign="top">178 (7.4)</td>
<td align="center" valign="top">2,216 (92.6)</td>
<td colspan="1" align="center" valign="top">696 (29.1)</td>
<td align="center" valign="top">211 (8.8)</td>
<td align="center" valign="top">248 (10.4)</td>
<td align="center" valign="top">488 (20.4)</td>
<td align="center" valign="top">682 (28.5)</td>
<td align="center" valign="top">69 (2.9)</td>
</tr>
<tr>
<td align="left" valign="top">Other,** NH</td>
<td align="center" valign="top"><b><b>1,500 (9.7)</b></b></td>
<td align="center" valign="top">117 (7.8)</td>
<td align="center" valign="top">1,383 (92.2)</td>
<td colspan="1" align="center" valign="top">279 (18.6)</td>
<td align="center" valign="top">197 (13.1)</td>
<td align="center" valign="top">239 (15.9)</td>
<td align="center" valign="top">301 (20.1)</td>
<td align="center" valign="top">379 (25.3)</td>
<td align="center" valign="top">105 (7.0)</td>
</tr>
<tr>
<td align="left" valign="top">Unknown</td>
<td align="center" valign="top"><b><b>239 (1.5)</b></b></td>
<td align="center" valign="top">21 (8.8)</td>
<td align="center" valign="top">218 (91.2)</td>
<td colspan="1" align="center" valign="top">111 (46.4)</td>
<td align="center" valign="top">13 (5.4)</td>
<td align="center" valign="top">24 (10.0)</td>
<td align="center" valign="top">29 (12.1)</td>
<td align="center" valign="top">56 (23.4)</td>
<td align="center" valign="top">6 (2.5)</td>
</tr>
<tr>
<td align="left" valign="top">White, NH</td>
<td align="center" valign="top"><b><b>9,581 (61.8)</b></b></td>
<td align="center" valign="top">1,020 (10.6)</td>
<td align="center" valign="top">8,561 (89.4)</td>
<td colspan="1" align="center" valign="top">2,372 (24.8)</td>
<td align="center" valign="top">1,002 (10.5)</td>
<td align="center" valign="top">1,098 (11.5)</td>
<td align="center" valign="top">1,571 (16.4)</td>
<td align="center" valign="top">2,888 (30.1)</td>
<td align="center" valign="top">650 (6.8)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>Documented prior SARS-CoV-2 infection<sup>&dagger;&dagger;</sup></b></b></td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top"><b><b>2,444 (15.8)</b></b></td>
<td align="center" valign="top">141 (5.8)</td>
<td align="center" valign="top">2,303 (94.2)</td>
<td rowspan="2" align="center" valign="top">0.2</td>
<td align="center" valign="top">641 (26.2)</td>
<td align="center" valign="top">213 (8.7)</td>
<td align="center" valign="top">251 (10.3)</td>
<td align="center" valign="top">413 (16.9)</td>
<td align="center" valign="top">819 (33.5)</td>
<td align="center" valign="top">107 (4.4)</td>
<td rowspan="2" align="center" valign="top">0.18</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top"><b><b>13,058 (84.2)</b></b></td>
<td align="center" valign="top">1,311 (10.0)</td>
<td align="center" valign="top">11,747 (90.0)</td>
<td colspan="1" align="center" valign="top">3,451 (26.4)</td>
<td align="center" valign="top">1,348 (10.3)</td>
<td align="center" valign="top">1,529 (11.7)</td>
<td align="center" valign="top">2,223 (17.0)</td>
<td align="center" valign="top">3,730 (28.6)</td>
<td align="center" valign="top">777 (6.0)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>SARS-CoV-2 status</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Positive test result (case-patient)</td>
<td align="center" valign="top"><b><b>1,452 (9.4)</b></b></td>
<td align="center" valign="top">1,452 (100.0)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td rowspan="2" align="center" valign="top">&mdash;</td>
<td align="center" valign="top">434 (29.9)</td>
<td align="center" valign="top">122 (8.4)</td>
<td align="center" valign="top">165 (11.4)</td>
<td align="center" valign="top">231 (15.9)</td>
<td align="center" valign="top">444 (30.6)</td>
<td align="center" valign="top">56 (3.9)</td>
<td rowspan="2" align="center" valign="top">0.26</td>
</tr>
<tr>
<td align="left" valign="top">Negative test result (control patient)</td>
<td align="center" valign="top"><b><b>14,050 (90.6)</b></b></td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">14,050 (100.0)</td>
<td colspan="1" align="center" valign="top">3,658 (26.0)</td>
<td align="center" valign="top">1,439 (10.2)</td>
<td align="center" valign="top">1,615 (11.5)</td>
<td align="center" valign="top">2,405 (17.1)</td>
<td align="center" valign="top">4,105 (29.2)</td>
<td align="center" valign="top">828 (5.9)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>No. of monovalent mRNA vaccine doses received</b></b></td>
</tr>
<tr>
<td align="left" valign="top">None</td>
<td align="center" valign="top"><b><b>4,092 (26.4)</b></b></td>
<td align="center" valign="top">434 (10.6)</td>
<td align="center" valign="top">3,658 (89.4)</td>
<td rowspan="4" align="center" valign="top">0.1</td>
<td align="center" valign="top">4,092<br>
(100.0)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">&mdash;</td>
</tr>
<tr>
<td align="left" valign="top">2</td>
<td align="center" valign="top"><b><b>3,401 (21.9)</b></b></td>
<td align="center" valign="top">322 (9.5)</td>
<td align="center" valign="top">3,079 (90.5)</td>
<td colspan="1" align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">48<br>
(1.4)</td>
<td align="center" valign="top">81 (2.4)</td>
<td align="center" valign="top">194 (5.7)</td>
<td align="center" valign="top">3,020 (88.8)</td>
<td align="center" valign="top">58 (1.7)</td>
<td align="left" valign="top"></td>
</tr>
<tr>
<td align="left" valign="top">3</td>
<td align="center" valign="top"><b><b>5,003 (32.3)</b></b></td>
<td align="center" valign="top">442 (8.8)</td>
<td align="center" valign="top">4,561 (91.2)</td>
<td colspan="1" align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">213 (4.3)</td>
<td align="center" valign="top">520 (10.4)</td>
<td align="center" valign="top">2,442 (48.8)</td>
<td align="center" valign="top">1,529 (30.6)</td>
<td align="center" valign="top">299 (6.0)</td>
<td align="left" valign="top"></td>
</tr>
<tr>
<td align="left" valign="top">4</td>
<td align="center" valign="top"><b><b>3,006 (19.4)</b></b></td>
<td align="center" valign="top">254 (8.4)</td>
<td align="center" valign="top">2,752 (91.6)</td>
<td colspan="1" align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">1,300 (43.2)</td>
<td align="center" valign="top">1,179 (39.2)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">527 (17.5)</td>
<td align="left" valign="top"></td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>Most recent dose product manufacturer</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Pfizer-BioNTech</td>
<td align="center" valign="top"><b><b>7,088 (45.7)</b></b></td>
<td align="center" valign="top">622 (8.8)</td>
<td align="center" valign="top">6,466 (91.2)</td>
<td rowspan="3" align="center" valign="top">0.09</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">986 (13.9)</td>
<td align="center" valign="top">1,101 (15.5)</td>
<td align="center" valign="top">1,439 (20.3)</td>
<td align="center" valign="top">2,878 (40.6)</td>
<td align="center" valign="top">684 (9.7)</td>
<td align="center" valign="top">&mdash;</td>
</tr>
<tr>
<td align="left" valign="top">Moderna</td>
<td align="center" valign="top"><b><b>4,322 (27.9)</b></b></td>
<td align="center" valign="top">396 (9.2)</td>
<td align="center" valign="top">3,926 (90.8)</td>
<td colspan="1" align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">575 (13.3)</td>
<td align="center" valign="top">679 (15.7)</td>
<td align="center" valign="top">1,197 (27.7)</td>
<td align="center" valign="top">1,671 (38.7)</td>
<td align="center" valign="top">200<br>
(4.6)</td>
<td align="left" valign="top"></td>
</tr>
<tr>
<td align="left" valign="top">None</td>
<td align="center" valign="top"><b><b>4,092<br>
(26.4)</b></b></td>
<td align="center" valign="top">434<br>
(10.6)</td>
<td align="center" valign="top">3,658<br>
(89.4)</td>
<td colspan="1" align="center" valign="top">4,092<br>
(100.0)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="center" valign="top">0<br>
(&mdash;)</td>
<td align="left" valign="top"></td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>Any chronic condition</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top"><b><b>14,649 (94.5)</b></b></td>
<td align="center" valign="top">1,410 (9.6)</td>
<td align="center" valign="top">13,239 (90.4)</td>
<td rowspan="2" align="center" valign="top">0.14</td>
<td align="center" valign="top">3,748 (25.6)</td>
<td align="center" valign="top">1,536 (10.5)</td>
<td align="center" valign="top">1,743 (11.9)</td>
<td align="center" valign="top">2,454 (16.8)</td>
<td align="center" valign="top">4,322 (29.5)</td>
<td align="center" valign="top">846 (5.8)</td>
<td rowspan="2" align="center" valign="top">0.84</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top"><b><b>853 (5.5)</b></b></td>
<td align="center" valign="top">42<br>
(4.9)</td>
<td align="center" valign="top">811 (95.1)</td>
<td colspan="1" align="center" valign="top">344 (40.3)</td>
<td align="center" valign="top">25<br>
(2.9)</td>
<td align="center" valign="top">37<br>
(4.3)</td>
<td align="center" valign="top">182 (21.3)</td>
<td align="center" valign="top">227 (26.6)</td>
<td align="center" valign="top">38 (4.5)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>&ge;1 chronic respiratory condition</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top"><b><b>9,246 (59.6)</b></b></td>
<td align="center" valign="top">921 (10.0)</td>
<td align="center" valign="top">8,325 (90.0)</td>
<td rowspan="2" align="center" valign="top">0.09</td>
<td align="center" valign="top">2,324<br>
(25.1)</td>
<td align="center" valign="top">1,032 (11.2)</td>
<td align="center" valign="top">1,150 (12.4)</td>
<td align="center" valign="top">1,527 (16.5)</td>
<td align="center" valign="top">2,673 (28.9)</td>
<td align="center" valign="top">540 (5.8)</td>
<td rowspan="2" align="center" valign="top">0.43</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top"><b><b>6,256 (40.4)</b></b></td>
<td align="center" valign="top">531 (8.5)</td>
<td align="center" valign="top">5,725 (91.5)</td>
<td colspan="1" align="center" valign="top">1,768 (28.3)</td>
<td align="center" valign="top">529 (8.5)</td>
<td align="center" valign="top">630 (10.1)</td>
<td align="center" valign="top">1,109 (17.7)</td>
<td align="center" valign="top">1,876 (30.0)</td>
<td align="center" valign="top">344 (5.5)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>&ge;1 chronic non-respiratory condition</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top"><b><b>14,119 (91.1)</b></b></td>
<td align="center" valign="top">1,369 (9.7)</td>
<td align="center" valign="top">12,750 (90.3)</td>
<td rowspan="2" align="center" valign="top">0.13</td>
<td align="center" valign="top">3,530<br>
(25.0)</td>
<td align="center" valign="top">1,514 (10.7)</td>
<td align="center" valign="top">1,707 (12.1)</td>
<td align="center" valign="top">2,385 (16.9)</td>
<td align="center" valign="top">4,157 (29.4)</td>
<td align="center" valign="top">826 (5.9)</td>
<td rowspan="2" align="center" valign="top">1.07</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top"><b><b>1,383 (8.9)</b></b></td>
<td align="center" valign="top">83<br>
(6.0)</td>
<td align="center" valign="top">1,300 (94.0)</td>
<td colspan="1" align="center" valign="top">562 (40.6)</td>
<td align="center" valign="top">47 (3.4)</td>
<td align="center" valign="top">73 (5.3)</td>
<td align="center" valign="top">251 (18.1)</td>
<td align="center" valign="top">392 (28.3)</td>
<td align="center" valign="top">58 (4.2)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>ICU admission</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top"><b><b>2,566 (16.6)</b></b></td>
<td align="center" valign="top">182<br>
(7.1)</td>
<td align="center" valign="top">2,384 (92.9)</td>
<td rowspan="2" align="center" valign="top">0.13</td>
<td align="center" valign="top">751 (29.3)</td>
<td align="center" valign="top">229 (8.9)</td>
<td align="center" valign="top">298 (11.6)</td>
<td align="center" valign="top">447 (17.4)</td>
<td align="center" valign="top">727 (28.3)</td>
<td align="center" valign="top">114 (4.4)</td>
<td rowspan="2" align="center" valign="top">0.27</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top"><b><b>12,936 (83.4)</b></b></td>
<td align="center" valign="top">1,270 (9.8)</td>
<td align="center" valign="top">11,666 (90.2)</td>
<td colspan="1" align="center" valign="top">3,341<br>
(25.8)</td>
<td align="center" valign="top">1,332 (10.3)</td>
<td align="center" valign="top">1,482 (11.5)</td>
<td align="center" valign="top">2,189 (16.9)</td>
<td align="center" valign="top">3,822 (29.5)</td>
<td align="center" valign="top">770 (6.0)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>Receipt of invasive mechanical ventilation</b></b></td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top"><b><b>1,579 (10.2)</b></b></td>
<td align="center" valign="top">97<br>
(6.1)</td>
<td align="center" valign="top">1,482 (93.9)</td>
<td rowspan="2" align="center" valign="top">0.14</td>
<td align="center" valign="top">567<br>
(35.9)</td>
<td align="center" valign="top">111 (7.0)</td>
<td align="center" valign="top">126 (8.0)</td>
<td align="center" valign="top">226 (14.3)</td>
<td align="center" valign="top">497<br>
(31.5)</td>
<td align="center" valign="top">52 (3.3)</td>
<td rowspan="2" align="center" valign="top">0.75</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top"><b><b>13,923 (89.8)</b></b></td>
<td align="center" valign="top">1,355 (9.7)</td>
<td align="center" valign="top">12,568 (90.3)</td>
<td colspan="1" align="center" valign="top">3,525<br>
(25.3)</td>
<td align="center" valign="top">1,450 (10.4)</td>
<td align="center" valign="top">1,654 (11.9)</td>
<td align="center" valign="top">2,410 (17.3)</td>
<td align="center" valign="top">4,052 (29.1)</td>
<td align="center" valign="top">832 (6.0)</td>
</tr>
<tr>
<td colspan="12" align="left" valign="top"><b><b>In-hospital death<sup>&sect;&sect;</sup></b></b></td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top"><b><b>466<br>
(3.0)</b></b></td>
<td align="center" valign="top">51<br>
(10.9)</td>
<td align="center" valign="top">415<br>
(89.1)</td>
<td rowspan="2" align="center" valign="top">0.03</td>
<td align="center" valign="top">129<br>
(27.7)</td>
<td align="center" valign="top">61<br>
(13.1)</td>
<td align="center" valign="top">57<br>
(12.2)</td>
<td align="center" valign="top">56 (12.0)</td>
<td align="center" valign="top">138 (29.6)</td>
<td align="center" valign="top">25 (5.4)</td>
<td rowspan="2" align="center" valign="top">0.11</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top"><b><b>15,036 (97.0)</b></b></td>
<td align="center" valign="top">1,401 (9.3)</td>
<td align="center" valign="top">13,635 (90.7)</td>
<td colspan="1" align="center" valign="top">3,963 (26.4)</td>
<td align="center" valign="top">1,500 (10.0)</td>
<td align="center" valign="top">1,723 (11.5)</td>
<td align="center" valign="top">2,580 (17.2)</td>
<td align="center" valign="top">4,411 (29.3)</td>
<td align="center" valign="top">859 (5.7)</td>
</tr>
</tbody>
</table>
<p class="caption"><b><b>Abbreviations:</b></b> BV&nbsp;=&nbsp;bivalent; ICU = intensive care unit; KPNC&nbsp;=&nbsp;Kaiser Permanente Northern California; KPCHR&nbsp;=&nbsp;Kaiser Permanente Center for Health Research; MV&nbsp;=&nbsp;monovalent; NH&nbsp;=&nbsp;non-Hispanic; SMD&nbsp;=&nbsp;standardized mean or proportion difference.<br>
* Hospitalizations with a discharge code consistent with COVID-19&ndash;like illness were included. COVID-19&ndash;like illness diagnoses included acute respiratory illness, respiratory signs or symptoms or febrile signs or symptoms using diagnosis codes from the <i><i>International Classification of Diseases, Tenth Revision</i></i>. Clinician-ordered molecular assays (e.g., real-time reverse transcription&ndash;polymerase chain reaction) for SARS-CoV-2 occurring &le;14 days before to &lt;72 hours after the encounter date were included.<br>
<sup>&dagger;</sup> California (Sep 13&ndash;Nov 18, 2022), Colorado (Sep 13&ndash;Nov 7, 2022), Minnesota and Wisconsin (Sep 13&ndash;Nov 18, 2022), New York (Sep 13&ndash;Nov 18, 2022), Oregon and Washington (Sep 13&ndash;Nov 14, 2022), Texas (Sep 13&ndash;Nov 13, 2022), and Utah (Sep 13&ndash;Nov 18, 2022).<br>
<sup>&sect;</sup> Vaccination was defined as having received the last monovalent or bivalent dose within the specified range of months/days before the hospitalization encounter date, which was the date of respiratory specimen collection associated with the most recent positive or negative SARS-CoV-2 test result before the admission date or the admission date if testing only occurred after the admission.<br>
<sup>&para;</sup> An absolute SMD &gt;0.20 indicates a nonnegligible difference in variable distributions between hospitalizations for vaccinated versus unvaccinated patients or for patients with a positive SARS-Cov-2 test result versus patients with a negative SARS-CoV-2 test result. For mRNA COVID-19 vaccination status, a single SMD was calculated by averaging the absolute SMDs obtained from pairwise comparisons of each vaccinated category versus unvaccinated. Specifically, it was calculated as the average of the absolute value of the SMDs for 1) vaccinated with only monovalent doses, &ge;11 months earlier versus unvaccinated, 2) vaccinated with only monovalent doses, 8&ndash;10 months earlier versus unvaccinated, 3) vaccinated with only monovalent doses 5&ndash;7 months earlier versus unvaccinated, 4) vaccinated with only monovalent doses 2&ndash;4 months earlier versus unvaccinated, and 5) vaccinated with bivalent booster &ge;7 days earlier versus unvaccinated.<br>
** Other race includes Asian, Hawaiian or other Pacific Islander, American Indian or Alaska Native, other not listed, and multiple races. Because of small numbers, these categories were combined.<br>
<sup>&dagger;&dagger;</sup> Previous SARS-CoV-2 infection was defined as having a positive SARS-CoV-2 test result (molecular or antigen) documented in the electronic health record &ge;15 days before the hospital admission date. This does not capture infections in which testing was not performed or testing was performed but not available in the electronic health record, e.g., at-home testing.<br>
<sup>&sect;&sect;</sup> In-hospital death was identified at each individual site and was defined as a death while hospitalized and &le;28 days after admission.</p>
</div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><br><div class="theme-indigo card bg-tertiary w-100 order-4"><div class="card-body"><p id="suggestedcitation" class="smallgrey"><strong>Suggested citation for this article:</strong> Tenforde MW, Weber ZA, Natarajan K, et al. Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19&ndash;Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults &mdash; VISION Network, Nine States, September&ndash;November 2022. MMWR Morb Mortal Wkly Rep 2023;71:1637&ndash;1646. DOI: <a href="http://dx.doi.org/10.15585/mmwr.mm7153a1" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">http://dx.doi.org/10.15585/mmwr.mm7153a1<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a>.</p>
</div></div><div class="pull-left order-4 w-100"><p><small>
<i>MMWR</i> and <i>Morbidity and Mortality Weekly Report</i> are service marks of the U.S. Department of Health and Human Services.<br />
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of 
Health and Human Services. <br />References to non-CDC sites on the Internet are 
provided as a service to <i>MMWR</i> readers and do not constitute or imply 
endorsement of these organizations or their programs by CDC or the U.S. 
Department of Health and Human Services. CDC is not responsible for the content 
of pages found at these sites. URL addresses listed in <i>MMWR</i> were current as of 
the date of publication.</small></p>
<p><small>All HTML versions of <i>MMWR</i> articles are generated from final proofs through an automated process. 
This conversion might result in character translation or format errors in the HTML version. 
Users are referred to the electronic PDF version (<a href="https://www.cdc.gov/mmwr">https://www.cdc.gov/mmwr</a>) 
and/or the original <i>MMWR</i> paper copy for printable versions of official text, figures, and tables. 
</small></p> 
<p><small>Questions or messages regarding errors in formatting should be addressed to 
<a href="https://www.cdc.gov/mmwr/form/index.html">mmwrq@cdc.gov</a>.</small></div></div>				</div>

													</div>
		</div>
					<div class="row"><div class="col page-format">View Page In:<a href="/mmwr/volumes/71/wr/pdfs/mm7153a1-H.pdf" target="_blank" rel="noopener noreferrer"><span class="icon x24"><span aria-label="pdf icon" class="sr-only" role="img"></span><span class="fi cdc-icon-pdf  fill-pdf" alt="" aria-hidden="true"></span></span> Article PDF</a></div></div>		
					<div class="row d-none d-lg-block">
				<div class="col pca">
														</div>
			</div>
							<div class="row share-row last-reviewed-row">
					<div class="col-md last-reviewed">
						Last Reviewed:  <span id="last-reviewed-date">March 17, 2023</span>						<div class="d-none d-lg-block content-source">Source: 	<a href="//www.cdc.gov/" class="td-none">Centers for Disease Control and Prevention</a>
</div>
					</div>
					<div class="col-md page-share ml-auto">
						<nav id="share-nav" class="page-share-wrapper" role="navigation" aria-label="Social Media">
    <ul>
        <li><a target="_blank" title="Share to Facebook" rel="noreferrer noopener" class="page-share-facebook metrics-share-facebook" href="https://api.addthis.com/oexchange/0.8/forward/facebook/offer?url=https%3A%2F%2Fwww.cdc.gov%2Findex.htm&title=CDC%20Works%2024/7&description=As%20the%20nation%27s%20health%20protection%20agency,%20CDC%20saves%20lives%20and%20protects%20people%20from%20health,%20safety,%20and%20security%20threats.&via=CDCgov&ct=0&media=https://www.cdc.gov/homepage/images/centers-for-disease-control-and-prevention.png"><span class="sr-only">Facebook</span><span class="fi cdc-icon-fb-round"></span></a></li>
        <li><a target="_blank" title="Share to Twitter" rel="noreferrer noopener" class="page-share-twitter metrics-share-twitter" href="https://api.addthis.com/oexchange/0.8/forward/twitter/offer?url=https%3A%2F%2Fwww.cdc.gov%2Findex.htm&title=CDC%20Works%2024/7&description=As%20the%20nation%27s%20health%20protection%20agency,%20CDC%20saves%20lives%20and%20protects%20people%20from%20health,%20safety,%20and%20security%20threats.&via=CDCgov&ct=0&media=https://www.cdc.gov/homepage/images/centers-for-disease-control-and-prevention.png"><span class="sr-only">Twitter</span><span class="fi cdc-icon-twitter-round"></span></a></li>
        <li><a target="_blank" title="Share to LinkedIn" rel="noreferrer noopener" class="page-share-linkedin metrics-share-linkedin" href="https://api.addthis.com/oexchange/0.8/forward/linkedin/offer?url=https%3A%2F%2Fwww.cdc.gov%2Findex.htm&title=CDC%20Works%2024/7&description=As%20the%20nation%27s%20health%20protection%20agency,%20CDC%20saves%20lives%20and%20protects%20people%20from%20health,%20safety,%20and%20security%20threats.&via=CDCgov&ct=0&media=https://www.cdc.gov/homepage/images/centers-for-disease-control-and-prevention.png"><span class="sr-only">LinkedIn</span><span class="fi cdc-icon-linkedin-round"></span></a></li>
        <li><a target="_blank" title="Embed this Page" rel="noreferrer noopener" class="page-share-syndication metrics-share-syndicate" href="https://tools.cdc.gov/medialibrary/index.aspx#/sharecontent/https%3A%2F%2Fwww.cdc.gov%2Findex.htm"><span class="sr-only">Syndicate</span><span class="fi cdc-icon-syndication-round"></span></a></li>
    </ul>
</nav>
					</div>
				</div>
						</main>

				<div class="col-12 d-lg-none leftnav-wrapper">
			<nav role="navigation" aria-label="Left Navigation Menu">
				<div id="cdc-left-nav-menu" data-menu-id="455"><ul class="list-group tp-nav-main"><li class="list-group-item nav-lvl1"><a href="/mmwr/index.html">MMWR</a></li><li class="list-group-item nav-lvl1"><a href="/mmwr/mmwr_additional_resources.html">Reports by Topic</a></li><li class="list-group-item nav-lvl1"><a href="/mmwr/publications/index.html">Publications</a><a href="#nav-group-e2099" class="nav-plus nav-expandcollapse" data-toggle="collapse" aria-controls="nav-group-e2099"><span class="sr-only">plus icon</span><span class="fi cdc-icon-plus" aria-hidden="true"></span></a><ul id="nav-group-e2099" class="collapse"><li class="list-group-item nav-lvl2"><a href="/mmwr/index2025.html">Weekly Report</a><a href="#nav-group-51546" class="nav-plus nav-expandcollapse" data-toggle="collapse" aria-controls="nav-group-51546"><span class="sr-only">plus icon</span><span class="fi cdc-icon-plus" aria-hidden="true"></span></a><ul id="nav-group-51546" class="collapse"><li class="list-group-item nav-lvl3"><a href="/mmwr/mmwr_wk/wk_pvol.html">Past Volumes (1982-2024)</a></li></ul></li><li class="list-group-item nav-lvl2"><a href="/mmwr/indrr_2025.html">Recommendations and Reports</a><a href="#nav-group-dfe78" class="nav-plus nav-expandcollapse" data-toggle="collapse" aria-controls="nav-group-dfe78"><span class="sr-only">plus icon</span><span class="fi cdc-icon-plus" aria-hidden="true"></span></a><ul id="nav-group-dfe78" class="collapse"><li class="list-group-item nav-lvl3"><a href="/mmwr/mmwr_rr/rr_pvol.html">Past Volumes (1990-2024)</a></li></ul></li><li class="list-group-item nav-lvl2"><a href="/mmwr/indss_2025.html">Surveillance Summaries</a><a href="#nav-group-a7b23" class="nav-plus nav-expandcollapse" data-toggle="collapse" aria-controls="nav-group-a7b23"><span class="sr-only">plus icon</span><span class="fi cdc-icon-plus" aria-hidden="true"></span></a><ul id="nav-group-a7b23" class="collapse"><li class="list-group-item nav-lvl3"><a href="/mmwr/mmwr_ss/ss_pvol.html">Past Volumes (1983-2024)</a></li></ul></li><li class="list-group-item nav-lvl2"><a href="/mmwr/ind2024_su.html">Supplements</a><a href="#nav-group-4094d" class="nav-plus nav-expandcollapse" data-toggle="collapse" aria-controls="nav-group-4094d"><span class="sr-only">plus icon</span><span class="fi cdc-icon-plus" aria-hidden="true"></span></a><ul id="nav-group-4094d" class="collapse"><li class="list-group-item nav-lvl3"><a href="/mmwr/mmwr_su/index.html">Past Volumes (1985-2023)</a></li></ul></li><li class="list-group-item nav-lvl2"><a href="https://stacks.cdc.gov/cbrowse/?parentId=cdc:101&amp;pid=cdc:101">Archive (1952-1981)</a></li><li class="list-group-item nav-lvl2"><a href="/mmwr/mmwr_nd/index.html">Notifiable Infectious Diseases</a></li><li class="list-group-item nav-lvl2"><a href="/mmwr/mmwr_nnc/index.html">Notifiable Noninfectious Conditions</a></li></ul></li><li class="list-group-item nav-lvl1"><a href="https://www.cdc.gov/vitalsigns/index.html">Vital Signs</a></li><li class="list-group-item nav-lvl1"><a href="/mmwr/va-search/visualAbstract.htm?Sort=Date%3A%3Adesc">Infographics</a></li><li class="list-group-item nav-lvl1"><a href="/mmwr/mmwrpodcasts.html">Podcasts</a></li><li class="list-group-item nav-lvl1"><a href="/mmwr/cme/medscape_cme.html">Continuing Education</a></li><li class="list-group-item nav-lvl1"><a href="/mmwr/newsletter/cmo/index2024.html">MMWR Clinical Pearls</a></li><li class="list-group-item nav-lvl1"><a href="/mmwr/contributors/index.html">For Authors</a></li><li class="list-group-item nav-lvl1"><a href="/mmwr/about.html">About &nbsp;</a><a href="#nav-group-43a01" class="nav-plus nav-expandcollapse" data-toggle="collapse" aria-controls="nav-group-43a01"><span class="sr-only">plus icon</span><span class="fi cdc-icon-plus" aria-hidden="true"></span></a><ul id="nav-group-43a01" class="collapse"><li class="list-group-item nav-lvl2"><a href="/mmwr/staff/staff.html">Staff</a></li><li class="list-group-item nav-lvl2"><a href="/mmwr/editorial_board.html">Editorial Board</a></li></ul></li><li class="list-group-item nav-lvl1"><a href="/mmwr/mmwrsubscribe.html">Subscribe</a><a href="#nav-group-bcc53" class="nav-plus nav-expandcollapse" data-toggle="collapse" aria-controls="nav-group-bcc53"><span class="sr-only">plus icon</span><span class="fi cdc-icon-plus" aria-hidden="true"></span></a><ul id="nav-group-bcc53" class="collapse"><li class="list-group-item nav-lvl2"><a href="https://tools.cdc.gov/api/v2/resources/media/342778.rss">RSS Feed</a></li></ul></li></ul></div>			</nav>
			<div class="col-12 mt-5">
							</div>
		</div>
				</div>

		

				<footer class="" role="contentinfo" aria-label="Footer">
								<div class="container-fluid footer-wrapper">
						<div class="container">

							 <div class="footer-2022">
	<div class="footer-desktop">
		<div class="row">
			<div class="col-6 about">
				<ul class="d-flex">
					<li><a href="https://www.cdc.gov/about/">About CDC</a></li>
					<li><a href="https://www.cdc.gov/cdc-info/index.html">Contact Us</a></li>
					<li><a href="tel:8002324636">800-232-4636</a></li>
				</ul>
			</div>
			<div class="col-6 social">
				<div class="d-flex flex-nowrap">
					<a href="https://www.facebook.com/CDC" target="_blank" rel="noreferrer noopener"><span class="cdc-icon-facebook-inverse"></span><span class="sr-only">Facebook</span></a>
					<a href="https://twitter.com/CDCgov" target="_blank" rel="noreferrer noopener"><span class="cdc-icon-twitter-inverse"></span><span class="sr-only">Twitter</span></a>
					<a href="https://www.instagram.com/CDCgov/" target="_blank" rel="noreferrer noopener"><span class="cdc-icon-instagram-inverse"></span><span class="sr-only">Instagram</span></a>
					<a href="https://www.linkedin.com/company/centers-for-disease-control-and-prevention" target="_blank" rel="noreferrer noopener"><span class="cdc-icon-linkedin-inverse"></span><span class="sr-only">LinkedIn</span></a>
					<a href="https://www.youtube.com/c/cdc/" target="_blank" rel="noreferrer noopener"><span class="cdc-icon-youtube-inverse"></span><span class="sr-only">Youtube</span></a>
					<a href="https://www.pinterest.com/cdcgov/" target="_blank" rel="noreferrer noopener"><span class="cdc-icon-pinterest-inverse"></span><span class="sr-only">Pinterest</span></a>
					<a href="https://www.snapchat.com/add/cdcgov" target="_blank" rel="noreferrer noopener"><span class="cdc-icon-snapchat-inverse"></span><span class="sr-only">Snapchat</span></a>
					<a href="https://tools.cdc.gov/medialibrary/index.aspx" target="_blank" rel="noreferrer noopener"><span class="cdc-icon-rss-inverse" aria-hidden="true"></span><span class="sr-only">RSS</span></a>

				</div>
			</div>
		</div>
	</div>
	<div class="footer-mobile" aria-label="Footer" role="contentinfo">
		<ul class="accordion indicator-arrow mb-3" role="tablist" aria-busy="true">
			<li class="card footer-mobile_contact" role="presentation">
				<button role="tab" class="card-header tab collapsed" data-target="#footer-mobile-collapse-1" data-toggle="collapse"  aria-expanded="false" id="footer-mobile-card-1" >CONTACT CDC</button>
				<div class="collapse" id="footer-mobile-collapse-1" role="tabpanel" aria-hidden="true">
					<div class="card-body">
						<address itemscope="itemscope" itemtype="https://schema.org/Organization">
							<div class="row mt-2">
								<div class="col-1">
									<span aria-hidden="true" class="fi cdc-icon-desktop x24"></span>
								</div>
								<div class="col">
									<span class="pl-1"><a href="https://www.cdc.gov/cdc-info/index.html">Contact Us</a></span>
								</div>
							</div>
							<div class="row mt-2">
								<div class="col-1">
									<span class="fi cdc-icon-phone x24"></span>
								</div>
								<div class="col">
									<span class="pl-1" itemprop="telephone">Call 800-232-4636</span>
								</div>
							</div>
							<div class="row mt-2">
								<div class="col-1">
									<span class="fi cdc-icon-email x24"></span>
								</div>
								<div class="col">
									<span class="pl-1" itemprop="url"><a href="https://www.cdc.gov/cdc-info/index.html">Email Us</a></span>
								</div>
							</div>
						</address>
					</div>
				</div>
			</li>
			<li class="card footer-mobile_about" role="presentation">
				<button role="tab" class="card-header tab collapsed " data-target="#footer-mobile-collapse-2" data-toggle="collapse"  aria-expanded="false" id="footer-mobile-card-2" >ABOUT CDC</button>
				<div class="collapse" id="footer-mobile-collapse-2" role="tabpanel"  aria-hidden="true">
					<div class="card-body">
						<ul>
							<li><a href="https://www.cdc.gov/about/">About CDC</a></li>
							<li><a href="https://jobs.cdc.gov">Jobs</a></li>
							<li><a href="https://www.cdc.gov/funding">Funding</a></li>
						</ul>
					</div>
				</div>
			</li>
			<li class="card footer-mobile_policies" role="presentation">
				<button role="tab" class="card-header tab collapsed " data-target="#footer-mobile-collapse-3" data-toggle="collapse"  aria-expanded="false" id="footer-mobile-card-3">POLICIES</button>
				<div class="collapse" id="footer-mobile-collapse-3" role="tabpanel"  aria-hidden="true">
					<div class="card-body">
						<ul>
							<li><a href="https://www.cdc.gov/other/accessibility.html">Accessibility</a></li>
							<li><a href="https://www.cdc.gov/Other/disclaimer.html">External Links</a></li>
							<li><a href="https://www.cdc.gov/other/privacy.html">Privacy</a></li>
							<li><a href="https://www.cdc.gov/Other/policies.html">Web Policies</a></li>
							<li><a href="https://www.cdc.gov/od/foia">FOIA</a></li>
							<li><a href="https://oig.hhs.gov">OIG</a></li>
							<li><a href="https://www.cdc.gov/oeeowe/no-fear-act/">No Fear Act</a></li>
							<li><a href="https://www.cdc.gov/other/nondiscrimination.html">Nondiscrimination</a></li>
							<li><a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html">Vulnerability Disclosure Policy</a></li>
							<li><a href="https://archive.cdc.gov/">CDC Archive</a></li>
							<li><a href="https://stacks.cdc.gov/ ">Public Health Publications</a></li>
							<li><a href="https://hhs.gov/">HHS.gov</a></li>
							<li><a href="https://www.usa.gov/">USA.gov</a></li>
						</ul>
					</div>
				</div>
			</li>
			<li class="card footer-mobile_connect" role="presentation">
				<button role="tab" class="card-header tab collapsed " data-target="#footer-mobile-collapse-4" data-toggle="collapse"  aria-expanded="false" id="footer-mobile-card-4">CONNECT WITH US</button>
				<div class="collapse" id="footer-mobile-collapse-4" role="tabpanel" aria-hidden="true">
					<div class="card-body">
						<ul class="bullet-list cc-4 lsp-out row">
							<div class="col-12">
								<li><a href="https://www.facebook.com/CDC" target="_blank" rel="noreferrer noopener"><span class="sr-only">Facebook</span><span class="fi cdc-icon-fb-white x24" aria-hidden="true"></span></a></li>
								<li><a href="https://twitter.com/CDCgov" target="_blank" rel="noreferrer noopener"><span class="sr-only">Twitter</span><span class="fi cdc-icon-twitter-white x24" aria-hidden="true"></span></a></li>
								<li><a href="https://www.instagram.com/CDCgov/" target="_blank" rel="noreferrer noopener"><span class="sr-only">Instagram</span><span class="fi cdc-icon-ig-white x24" aria-hidden="true"></span></a></li>
								<li><a href="https://www.linkedin.com/company/centers-for-disease-control-and-prevention" target="_blank" rel="noreferrer noopener"><span class="sr-only">LinkedIn</span><span class="fi cdc-icon-linkedin-white x24" aria-hidden="true"></span></a></li>
							</div>
							<div class="col-12">
								<li><a href="https://www.youtube.com/c/cdc/" target="_blank" rel="noreferrer noopener"><span class="sr-only">Youtube</span><span class="fi cdc-icon-youtube-white x24" aria-hidden="true"></span></a></li>
								<li><a href="https://www.pinterest.com/cdcgov/" target="_blank" rel="noreferrer noopener"><span class="sr-only">Pinterest</span><span class="fi cdc-icon-pinterest-white x24" aria-hidden="true"></span></a></li>
								<li><a href="https://www.snapchat.com/add/cdcgov" target="_blank" rel="noreferrer noopener"><span class="sr-only">Snapchat</span><span class="fi cdc-icon-snapchat x24" aria-hidden="true"></span></a></li>
								<li><a href="https://wwwn.cdc.gov/dcs/RequestForm.aspx"><span class="sr-only">Email</span><span class="fi cdc-icon-email x24" aria-hidden="true"></span></a></li>
							</div>
						</ul>
					</div>
				</div>
			</li>
			<li class="card footer-mobile_language" role="presentation">
				<button role="tab" class="card-header tab collapsed " data-target="#footer-mobile-collapse-5" data-toggle="collapse"  aria-expanded="false" id="footer-mobile-card-5">LANGUAGES</button>
				<div class="collapse" id="footer-mobile-collapse-5" role="tabpanel" aria-hidden="true">
					<div class="card-body">
						<ul class="bullet-list cc-2 lsp-out">
							<li lang="es"><a href="https://www.cdc.gov/other/language-assistance.html#Spanish" title="Spanish">EspaÃ±ol</a></li>
							<li lang="zh"><a href="https://www.cdc.gov/other/language-assistance.html#Chinese" title="Chinese">ç¹é«ä¸­æ</a></li>
							<li lang="vi"><a href="https://www.cdc.gov/other/language-assistance.html#Vietnamese" title="Vietnamese">Tiáº¿ng Viá»t</a></li>
							<li lang="ko"><a href="https://www.cdc.gov/other/language-assistance.html#Korean" title="Korean">íêµ­ì´</a></li>
							<li lang="tl"><a href="https://www.cdc.gov/other/language-assistance.html#Tagalog" title="Tagalog">Tagalog</a></li>
							<li lang="ru"><a href="https://www.cdc.gov/other/language-assistance.html#Russian" title="Russian">Ð ÑÑÑÐºÐ¸Ð¹</a></li>
							<li lang="ar"><a href="https://www.cdc.gov/other/language-assistance.html#Arabic" title="Arabic">Ø§ÙØ¹Ø±Ø¨ÙØ©</a></li>
							<li lang="ht"><a href="https://www.cdc.gov/other/language-assistance.html#Haitian" title="Haitian">KreyÃ²l Ayisyen</a></li>
							<li lang="fr"><a href="https://www.cdc.gov/other/language-assistance.html#French" title="French">FranÃ§ais</a></li>
							<li lang="pl"><a href="https://www.cdc.gov/other/language-assistance.html#Polish" title="Polish">Polski</a></li>
							<li lang="pt"><a href="https://www.cdc.gov/other/language-assistance.html#Portuguese" title="Portuguese">PortuguÃªs</a></li>
							<li lang="it"><a href="https://www.cdc.gov/other/language-assistance.html#Italian" title="Italian">Italiano</a></li>
							<li lang="de"><a href="https://www.cdc.gov/other/language-assistance.html#German" title="German">Deutsch</a></li>
							<li lang="ja"><a href="https://www.cdc.gov/other/language-assistance.html#Japanese" title="Japanese">æ¥æ¬èª</a></li>
							<li lang="fa"><a href="https://www.cdc.gov/other/language-assistance.html#Farsi" title="Farsi">ÙØ§Ø±Ø³Û</a></li>
							<li lang="en"><a href="https://www.cdc.gov/other/language-assistance.html#English" title="English">English</a></li>
						</ul>
					</div>
				</div>
			</li>
		</ul>
	</div>
</div>

						</div>
					</div>
											<div class="container-fluid agency-footer">
							<div class="container">
								<div class="footer-2022 footer-agency row">
	<div class="col">
		<ul>
			<li class="d-none d-md-block"><a href="https://www.cdc.gov/other/accessibility.html">Accessibility</a></li>
			<li class="d-none d-md-block"><a href="https://www.cdc.gov/Other/disclaimer.html">External Links</a></li>
			<li class="d-none d-md-block"><a href="https://www.cdc.gov/other/privacy.html">Privacy</a></li>
			<li class="d-none d-md-block"><a href="https://www.cdc.gov/Other/policies.html">Web Policies</a></li>
			<li class="d-none d-md-block"><a href="https://www.cdc.gov/od/foia">FOIA</a></li>
			<li class="d-none d-md-block"><a href="https://oig.hhs.gov">OIG</a></li>
			<li class="d-none d-md-block"><a href="https://www.cdc.gov/oeeowe/no-fear-act/">No Fear Act</a></li>
			<li class="d-none d-md-block"><a href="https://www.cdc.gov/other/nondiscrimination.html">Nondiscrimination</a></li>
			<li class="d-none d-md-block"><a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html">Vulnerability Disclosure Policy</a></li>
			<li class="d-none d-md-block"><a href="https://archive.cdc.gov/">CDC Archive</a></li>
			<li class="d-none d-md-block"><a href="https://stacks.cdc.gov/ ">Public Health Publications</a></li>
			<li><a href="https://hhs.gov/">HHS.gov</a></li>
			<li><a href="https://www.usa.gov/">USA.gov</a></li>
		</ul>
	</div>
</div>

							</div>
						</div>
								</footer>
		<!-- social media footer removed -->
<script src="/config/cdc_config.js"></script>
<script>var CDC_POST={"id":"826_103292","type":"cdc_mmwr","tax":{"cdc_topics":["88f3e122-1304-415c-adff-4a35740d79c0"],"cdc_categories":["2b55e648-eaa5-4e53-9b50-833393d2da21"]}};</script>
<script src="/TemplatePackage/contrib/libs/jquery/latest/jquery.min.js?_=35435"></script>
<script src="/TemplatePackage/contrib/libs/bootstrap/latest/js/bootstrap.bundle.min.js?_=35435"></script>
<!-- @axejs@ -->
<!-- @prismjs@ -->
<!-- @typeaheadjs@ -->
<script src="/TemplatePackage/contrib/libs/cdc/ab/4.0.0/ab.js"></script>
<script src="/TemplatePackage/4.0/assets/js/app.min.js?_=35435"></script>
<script src="/TemplatePackage/contrib/libs/cdc/c2r/c2r.js" type="module"></script>

<svg viewBox="0 0 40 40" class="d-none">
	<radialGradient id="svg_ig_1" cx="-3.0686" cy="30.0001" r="39.8188" gradientTransform="matrix(0.9138 -0.3831 0.3831 0.9138 -6.346 8.975)" gradientUnits="userSpaceOnUse">
		<stop  offset="0" style="stop-color:#FFDD55"/>
		<stop  offset="0.1" style="stop-color:#FFDD55"/>
		<stop  offset="0.5" style="stop-color:#FF543E"/>
		<stop  offset="1" style="stop-color:#C837AB"/>
	</radialGradient>
	<circle style="fill:url(#svg_ig_1);" cx="20" cy="20" r="20"/>
	<radialGradient id="svg_ig_2" cx="9.873329e-02" cy="-0.6373" r="22.6462" gradientTransform="matrix(0.9909 0 0 0.9909 -0.2262 -0.2261)" gradientUnits="userSpaceOnUse">
		<stop  offset="0" style="stop-color:#3771C8"/>
		<stop  offset="0.128" style="stop-color:#3771C8"/>
		<stop  offset="1" style="stop-color:#6600FF;stop-opacity:0"/>
	</radialGradient>
	<circle style="fill:url(#svg_ig_2);" cx="20" cy="20" r="20"/>
	<path class="fill-w" d="M20,5.5c-4,0-4.5,0-6.1,0.1c-1.6,0.1-2.6,0.3-3.6,0.7C9.4,6.7,8.5,7.2,7.7,8C6.9,8.8,6.4,9.7,6,10.6c-0.4,0.9-0.6,2-0.7,3.6c-0.1,1.6-0.1,2.1-0.1,6.1s0,4.5,0.1,6.1C5.4,28,5.6,29,6,30c0.4,1,0.9,1.8,1.7,2.6c0.8,0.8,1.6,1.3,2.6,1.7c0.9,0.4,2,0.6,3.6,0.7c1.6,0.1,2.1,0.1,6.1,0.1c4,0,4.5,0,6.1-0.1c1.6-0.1,2.6-0.3,3.6-0.7c1-0.4,1.8-0.9,2.6-1.7c0.8-0.8,1.3-1.6,1.7-2.6c0.4-0.9,0.6-2,0.7-3.6c0.1-1.6,0.1-2.1,0.1-6.1s0-4.5-0.1-6.1c-0.1-1.6-0.3-2.6-0.7-3.6c-0.4-1-0.9-1.8-1.7-2.6c-0.8-0.8-1.6-1.3-2.6-1.7c-0.9-0.4-2-0.6-3.6-0.7C24.5,5.6,24,5.5,20,5.5L20,5.5z M18.7,8.2c0.4,0,0.8,0,1.3,0c3.9,0,4.4,0,6,0.1c1.4,0.1,2.2,0.3,2.7,0.5c0.7,0.3,1.2,0.6,1.7,1.1c0.5,0.5,0.8,1,1.1,1.7c0.2,0.5,0.4,1.3,0.5,2.7c0.1,1.6,0.1,2,0.1,6s0,4.4-0.1,6c-0.1,1.4-0.3,2.2-0.5,2.7c-0.3,0.7-0.6,1.2-1.1,1.7c-0.5,0.5-1,0.8-1.7,1.1c-0.5,0.2-1.3,0.4-2.7,0.5c-1.6,0.1-2,0.1-6,0.1c-3.9,0-4.4,0-6-0.1c-1.4-0.1-2.2-0.3-2.7-0.5c-0.7-0.3-1.2-0.6-1.7-1.1c-0.5-0.5-0.8-1-1.1-1.7C8.3,28.5,8,27.7,8,26.3c-0.1-1.6-0.1-2-0.1-6s0-4.4,0.1-6c0.1-1.4,0.3-2.2,0.5-2.7c0.3-0.7,0.6-1.2,1.1-1.7c0.5-0.5,1-0.8,1.7-1.1c0.5-0.2,1.3-0.4,2.7-0.5C15.4,8.2,15.9,8.2,18.7,8.2L18.7,8.2z M27.9,10.7c-1,0-1.8,0.8-1.8,1.8c0,1,0.8,1.8,1.8,1.8s1.8-0.8,1.8-1.8S28.9,10.7,27.9,10.7L27.9,10.7z M20,12.7c-4.2,0-7.6,3.4-7.6,7.6s3.4,7.6,7.6,7.6c4.2,0,7.6-3.4,7.6-7.6S24.2,12.7,20,12.7L20,12.7z M20,15.4c2.7,0,4.9,2.2,4.9,4.9c0,2.7-2.2,4.9-4.9,4.9c-2.7,0-4.9-2.2-4.9-4.9C15.1,17.6,17.3,15.4,20,15.4z"/>
</svg>
<svg id="multicolor_icons" style="display:none" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
	<!-- file types -->
	<symbol id="powerpoint" viewBox="0 0 40 40">
		<path class="fill-ppt-1" d="M21,1.5h2.45V5.39c4.61,0,9.23,0,13.84,0A1.5,1.5,0,0,1,39,7.08c.07,8.06,0,16.13,0,24.2a5.07,5.07,0,0,1-.41,2.61,3.88,3.88,0,0,1-2.19.43c-4.32,0-8.63,0-13,0v4.32H20.76C14.18,37.43,7.59,36.33,1,35.17Q1,20.07,1,5C7.66,3.81,14.32,2.64,21,1.5Z"></path>
		<path class="fill-ppt-2" d="M23.44,6.68H37.69V33H23.44V29.56H33.8V27.83H23.44V25.68H33.8V23.95H23.45c0-.85,0-1.69,0-2.54a6.06,6.06,0,0,0,5.18-.51,5.91,5.91,0,0,0,2.66-4.71c-1.9,0-3.79,0-5.68,0,0-1.88,0-3.76,0-5.63L23.44,11Z"></path>
		<path class="fill-ppt-1" d="M26.47,9.65a6.07,6.07,0,0,1,5.68,5.66c-1.9,0-3.79,0-5.69,0C26.46,13.42,26.46,11.53,26.47,9.65Z"></path>
		<path class="fill-ppt-2" d="M7.93,12.91c2.34.11,5.18-.93,7.13.83,1.86,2.26,1.37,6.41-1.39,7.76a6.37,6.37,0,0,1-3.17.4q0,2.53,0,5.06l-2.57-.22C7.88,22.13,7.87,17.52,7.93,12.91Z"></path>
		<path class="fill-ppt-1" d="M10.49,15.24c.85,0,1.9-.19,2.48.6A3.13,3.13,0,0,1,13,18.68c-.49.89-1.61.8-2.47.91C10.47,18.14,10.48,16.69,10.49,15.24Z"></path>
	</symbol>
	<symbol id="pdf" viewBox="0 0 40 40">
		<path class="fill-pdf-1" d="M32.52,1H1.45V38.68h38V7.42Z"></path>
		<polygon class="fill-op-2" points="39.38 7.49 32.96 7.49 32.52 1.06 39.38 7.49"></polygon>
		<path class="fill-pdf-2" d="M16.28,23C17,21.57,17.84,20,18.5,18.33h0l.26-.64c-.86-3.3-1.38-6-.92-7.67h0A1.19,1.19,0,0,1,19,9.31h.4c.75,0,1.11.95,1.15,1.33h0a6,6,0,0,1-.22,1.68h0a4.1,4.1,0,0,0-.25-1.71h0c-.32-.69-.62-1.1-.88-1.17h0a.85.85,0,0,0-.32.64h0a9.59,9.59,0,0,0-.12,1.47h0a16.43,16.43,0,0,0,.68,4.28h0c.08-.24.16-.48.22-.7h0l.68-2.65h0s-.15,3.07-.36,4h0c0,.2-.09.39-.14.59h0a13.5,13.5,0,0,0,3.36,5.25h0a10.46,10.46,0,0,0,1.94,1.34h0a26.93,26.93,0,0,1,3.95-.3h0a5,5,0,0,1,3,.68h0a1.2,1.2,0,0,1,.33.76h0a2.6,2.6,0,0,1-.06.44h0c0-.08,0-.47-1.19-.86h0a14,14,0,0,0-4.84-.06h0c2.46,1.2,4.85,1.79,5.61,1.44h0a1.69,1.69,0,0,0,.41-.4h0a3.92,3.92,0,0,1-.23.76h0a1.2,1.2,0,0,1-.59.4h0c-1.2.32-4.31-.42-7-2h0a57.18,57.18,0,0,0-9,2.15h0c-2.63,4.6-4.6,6.71-6.21,5.91h0l-.59-.3a.69.69,0,0,1-.22-.74h0c.19-.92,1.34-2.3,3.65-3.67h0c.24-.16,1.35-.74,1.35-.74h0s-.82.79-1,1h0c-1.84,1.51-3.2,3.41-3.17,4.14h0v.07c1.56-.23,3.91-3.41,6.93-9.31m.95.49c-.5,1-1,1.83-1.45,2.63h0a38.68,38.68,0,0,1,7.8-2.2h0c-.35-.24-.68-.5-1-.76h0a13.42,13.42,0,0,1-3.29-4.28h0a35.21,35.21,0,0,1-2.06,4.61"></path>
	</symbol>
	<symbol id="zip" viewBox="0 0 40 40">
		<path class="fill-zip-1" d="M32.17,1.09H1V38.77H39V7.44Z"></path>
		<polygon class="fill-zip-2" points="39 7.47 32.6 7.47 32.17 1.09 39 7.47"></polygon>
		<rect class="fill-zip-3" height="13.48" width="0.56" x="17.75" y="1.09"></rect>
		<rect class="fill-zip-3" height="13.48" width="0.56" x="21.69" y="1.09"></rect>
		<rect class="fill-zip-3" height="1.69" width="1.78" x="18.22" y="1.09"></rect>
		<rect class="fill-zip-3" height="1.69" width="1.78" x="20" y="2.77"></rect>
		<rect class="fill-zip-3" height="1.69" width="1.78" x="18.22" y="4.46"></rect>
		<rect class="fill-zip-3" height="1.69" width="1.78" x="20" y="6.15"></rect>
		<rect class="fill-zip-3" height="1.69" width="1.78" x="18.22" y="7.83"></rect>
		<rect class="fill-zip-3" height="1.69" width="1.78" x="20" y="9.52"></rect>
		<rect class="fill-zip-3" height="1.69" width="1.78" x="18.22" y="11.19"></rect>
		<rect class="fill-zip-3" height="1.69" width="1.78" x="20" y="12.87"></rect>
		<path class="fill-zip-3" d="M22.53,14.56H17.47a1,1,0,0,0-1,1V18.4a1,1,0,0,0,1,1h.84V16.51h3.38v2.85h.84a1,1,0,0,0,1-1V15.53A1,1,0,0,0,22.53,14.56Z"></path>
		<rect class="fill-zip-3" height="7.2" width="1.97" x="19.02" y="17.56"></rect>
		<path class="fill-zip-3" d="M22.32,22.67h-.63v4.19H18.31V22.67h-.63a1.14,1.14,0,0,0-1.13,1.14V35a1.13,1.13,0,0,0,1.13,1.13h4.64A1.13,1.13,0,0,0,23.45,35V23.81A1.14,1.14,0,0,0,22.32,22.67Zm-.63,11.38H18.31V31h3.38Z"></path>
	</symbol>
	<symbol id="word" viewBox="0 0 40 40">
		<path class="word-fill-1" d="M20.86,1.5h2.58V5c4.62,0,9.23,0,13.85,0A1.49,1.49,0,0,1,39,6.63c.07,8.5,0,17,0,25.52a5,5,0,0,1-.42,2.61,3.93,3.93,0,0,1-2.18.43c-4.32,0-8.64,0-13,0v3.45h-2.7C14.17,37.43,7.59,36.32,1,35.17Q1,20.07,1,5C7.62,3.81,14.24,2.68,20.86,1.5Z"></path>
		<path class="word-fill-2" d="M23.44,6.25H37.69V33.88H23.44V30.42H34.67V28.7H23.44V26.54H34.67V24.81H23.44V22.65H34.67V20.93H23.44V18.77H34.67V17H23.44V14.88H34.67V13.16H23.44V11H34.67V9.27H23.44Z"></path>
		<path class="word-fill-2" d="M9.92,13.88l2.46-.13c.57,2.91,1.16,5.82,1.78,8.72.49-3,1-6,1.55-9,.86,0,1.73-.08,2.59-.13-1,4.18-1.83,8.4-2.9,12.56-.72.38-1.8,0-2.65,0-.57-2.86-1.24-5.7-1.76-8.57-.5,2.79-1.16,5.55-1.74,8.32l-2.5-.15C6,21.78,5.2,18,4.53,14.2l2.22-.09c.44,2.75.95,5.49,1.34,8.24C8.69,19.52,9.32,16.7,9.92,13.88Z"></path>
	</symbol>
	<symbol id="txt" viewBox="0 0 40 40">
		<path class="fill-txt-1" d="M32.1,1.09H.67v38H39V7.5Z"></path>
		<polygon class="fill-txt-2" points="39 7.47 32.6 7.47 32.1 1.09 39 7.47"></polygon>
		<path class="fill-txt-3" d="M33.78,30.22h.92a2.13,2.13,0,0,0,2.13-2.13V17.27a2.13,2.13,0,0,0-2.13-2.13H5.3a2.13,2.13,0,0,0-2.13,2.13V28.09A2.13,2.13,0,0,0,5.3,30.22H33.78Z"></path>
		<polygon class="fill-txt-4" points="9.47 19.4 9.47 17.74 15.96 17.74 15.96 19.4 13.54 19.4 13.54 27.53 11.9 27.53 11.9 19.4 9.47 19.4"></polygon>
		<polygon class="fill-txt-4" points="16.45 17.74 18.38 17.74 20.02 20.89 21.62 17.74 23.53 17.74 20.99 22.5 23.78 27.53 21.79 27.53 19.98 24.15 18.17 27.53 16.19 27.53 18.98 22.43 16.45 17.74"></polygon>
		<polygon class="fill-txt-4" points="24.04 19.4 24.04 17.74 30.53 17.74 30.53 19.4 28.11 19.4 28.11 27.53 26.46 27.53 26.46 19.4 24.04 19.4"></polygon>
	</symbol>
	<symbol id="media" viewBox="0 0 40 40">
		<circle class="media-fill-1" cx="20" cy="20" r="19"></circle>
		<circle class="media-fill-2" cx="20" cy="20" r="15"></circle>
		<polygon class="media-fill-3" points="28.96 20 15.04 12.5 15.04 27.5 28.96 20"></polygon>
	</symbol>

	<symbol id="info-circle" viewBox="0 0 40 40">
		<path d="M20,0A20,20,0,1,0,40,20,20,20,0,0,0,20,0Zm3.14,27.36c-1.51,2.27-3,4-5.63,4-1.76-.29-2.49-1.55-2.1-2.84l3.32-11a.52.52,0,0,0-.3-.64c-.25-.08-.73.23-1.14.69l-2,2.42a10.92,10.92,0,0,1,0-1.35c1.51-2.27,4-4.05,5.67-4.05A2.26,2.26,0,0,1,23,17.48L19.67,28.54a.52.52,0,0,0,.31.58c.25.08.76-.23,1.18-.69l2-2.42A10.84,10.84,0,0,1,23.14,27.41ZM22.69,13a2.23,2.23,0,0,1-2.3-2.29,2.3,2.3,0,0,1,4.6,0A2.23,2.23,0,0,1,22.69,13Z" class="fr-evenodd"></path>
	</symbol>

	<symbol id="alert_06">
		<path d="M15,0C6.8,0,0,6.8,0,15s6.8,15,15,15s15-6.8,15-15S23.3,0,15,0z M15,22.5c-0.8,0-1.5-0.7-1.5-1.5
			s0.7-1.5,1.5-1.5s1.5,0.7,1.5,1.5S15.8,22.5,15,22.5z M16.5,16c0,0.8-0.7,1.5-1.5,1.5s-1.5-0.7-1.5-1.5V9c0-0.8,0.7-1.5,1.5-1.5
			s1.5,0.7,1.5,1.5V16z"/>
	</symbol>

	<!-- timeline -->
	<symbol id="timelineicon">
		<path d="M12,8A4,4 0 0,1 16,12A4,4 0 0,1 12,16A4,4 0 0,1 8,12A4,4 0 0,1 12,8M3.05,13H1V11H3.05C3.5,6.83 6.83,3.5 11,3.05V1H13V3.05C17.17,3.5 20.5,6.83 20.95,11H23V13H20.95C20.5,17.17 17.17,20.5 13,20.95V23H11V20.95C6.83,20.5 3.5,17.17 3.05,13M12,5A7,7 0 0,0 5,12A7,7 0 0,0 12,19A7,7 0 0,0 19,12A7,7 0 0,0 12,5Z" />
	</symbol>

	<!-- Alerts -->
	<symbol id="alert-circle" viewBox="0 0 24.00 24.00">
		<path d="M 12.9994,12.998L 10.9994,12.998L 10.9994,6.99805L 12.9994,6.99805M 12.9994,16.998L 10.9994,16.998L 10.9994,14.998L 12.9994,14.998M 11.9994,1.99805C 6.47639,1.99805 1.99939,6.47504 1.99939,11.998C 1.99939,17.5211 6.47639,21.998 11.9994,21.998C 17.5224,21.998 21.9994,17.5211 21.9994,11.998C 21.9994,6.47504 17.5224,1.99805 11.9994,1.99805 Z "/>
	</symbol>

	<!-- external link icon -->
	<symbol id="ext" viewBox="0 0 40 40">
		<polygon points="36 17.97 36 36 4 36 4 4 22.03 4 22.03 1 1 1 1 39 39 39 39 17.97 36 17.97" />
		<polygon points="39 1 26.27 1 31 5.73 17.52 19.21 20.8 22.48 34.27 9 39 13.73 39 1" />
	</symbol>

	<symbol id="presentation_01" viewBox="0 0 40 40">
		<path d="M35,5.21H5A1.29,1.29,0,1,1,5,2.63h13.7V1.34a1.3,1.3,0,0,1,2.6,0V2.63H35a1.29,1.29,0,1,1,0,2.58Zm0,20.64H5V6.5H35ZM9,15.57a5.2,5.2,0,0,0,10.4,0h-5.2V10.4A5.19,5.19,0,0,0,9,15.57Zm14.33-5.2H22v1.29h1.3Zm0,2.58H22v1.29h1.3Zm0,2.58H22v1.29h1.3Zm0,2.58H22V19.4h1.3Zm0,2.58H22V22h1.3Zm7.78-10.32H24.58v1.29h6.48Zm0,2.58H24.58v1.29h6.48Zm0,2.58H24.58v1.29h6.48Zm0,2.58H24.58V19.4h6.48Zm0,2.58H24.58V22h6.48ZM16.46,32.31h2.93V25.85h1.3v6.45h2.88l-2.88-6.45h2.6l5.18,11.61H25.88L24.15,33.6H20.69V40h-1.3V33.6H15.88l-1.76,3.87H11.53L16.8,25.85h2.59Zm4.22-6.45Zm-1.3,0Z" class="fill-a"></path>
	</symbol>

	<symbol id="excel" viewBox="0 0 40 40">
		<path class="fill-excel-1" d="M20.87,1.5h2.56V5c4.32,0,8.64,0,13,0a4,4,0,0,1,2.17.41A4,4,0,0,1,39,7.54Q39,18.78,39,30a19.69,19.69,0,0,1-.15,3.78c-.17.9-1.25.92-2,.95-4.47,0-8.95,0-13.43,0v3.89H20.76C14.18,37.43,7.59,36.32,1,35.17V5C7.63,3.81,14.25,2.67,20.87,1.5Z"></path>
		<path class="fill-excel-2" d="M23.44,6.25H37.68v27.2H23.44V30.85h3.45v-3H23.44V26.11h3.45v-3H23.44V21.36h3.45v-3H23.44V16.61h3.45v-3H23.44V11.86h3.45v-3H23.44Z"></path>
		<path class="fill-excel-1" d="M28.62,8.84h6v3h-6Z"></path>
		<path class="fill-excel-2" d="M13.79,12.88q1.46-.1,2.94-.18Q15,16.25,13.24,19.78c1.19,2.42,2.4,4.82,3.59,7.23l-3.12-.2a51,51,0,0,1-2.15-5.42c-.59,1.75-1.42,3.41-2.1,5.12-.95,0-1.89-.05-2.84-.09,1.11-2.17,2.18-4.36,3.32-6.52-1-2.22-2-4.4-3-6.61l2.85-.16c.64,1.69,1.35,3.35,1.88,5.08C12.21,16.38,13.06,14.66,13.79,12.88Z"></path>
		<path class="fill-excel-1" d="M28.62,13.59h6v3h-6Z"></path>
		<path class="fill-excel-1" d="M28.62,18.34h6v3h-6Z"></path>
		<path class="fill-excel-1" d="M28.62,23.08h6v3h-6Z"></path>
		<path class="fill-excel-1" d="M28.62,27.83h6v3h-6Z"></path>
	</symbol>
	<symbol id="epub" viewBox="0 0 40 40">
		<path class="fill-epub-1" d="M32.64,1H1.45V38.68h38V7.36Z"></path>
		<polygon class="fill-epub-2" points="39.47 7.39 33.07 7.39 32.64 1 39.47 7.39"></polygon>
		<path class="fill-epub-3" d="M20,27.23,12.77,20,20,12.77l2.41,2.41L17.59,20,20,22.41l7.23-7.23-6.3-6.29a1.3,1.3,0,0,0-1.86,0L8.89,19.07a1.3,1.3,0,0,0,0,1.86L19.07,31.11a1.3,1.3,0,0,0,1.86,0L31.11,20.93a1.3,1.3,0,0,0,0-1.86l-1.47-1.48Z"></path>
	</symbol>
	<symbol id="imgft" viewBox="0 0 40 40">
		<path class="fill-svgimgfile" d="M32.58,1H1.39V38.68h38V7.36Z"></path>
		<polygon class="fill-op-2" points="39.41 7.39 33.01 7.39 32.58 1 39.41 7.39"></polygon>
		<path class="fill-w" d="M8.52,15.32a4,4,0,1,1,4,4A4,4,0,0,1,8.52,15.32ZM33.27,33.25H7.73V29.18l4.79-4.07,3.19,2.71,9.58-8.14,8,6.78Z"></path>
	</symbol>
	<symbol id="sas" viewBox="0 0 40 40">
		<title>SAS</title>
		<path class="fill-sas" d="M32.58,1H1.39V38.68h38V7.36Zm-15,6.32A10.77,10.77,0,0,1,20.38,7a8.72,8.72,0,0,1,8.22,5.71C26.85,9.84,21.74,9.22,19,11c-3.16,2-4.2,5.47-1.87,8.3,0,0,1.32,1.61,2.48,3,.24.29.29.33.52.61h0l.36.44a1.74,1.74,0,0,1-2.66,2.22l-.9-1.1-3.2-3.87C8.31,14.06,13.22,8.42,17.61,7.32Zm4.78,25.36c-5.06,1.27-9.63-1.37-11-5.39C13.15,30.16,18.26,30.78,21,29c3.16-2,4.2-5.46,1.87-8.29l-3.23-3.9c-.13-.15-.2-.25-.2-.25a1.61,1.61,0,0,1,.34-2.32A1.84,1.84,0,0,1,21,13.83a1.51,1.51,0,0,1,1.11.55l.43.54,3.75,4.53C31.69,26,26.78,31.58,22.39,32.68Z"></path>
		<polygon style="opacity: 0.2;" points="39.41 7.39 33.01 7.39 32.58 1 39.41 7.39"></polygon>
	</symbol>
	<symbol id="stats" viewBox="0 0 40 40">
		<title>stats</title>
		<path class="fill-txt-3" d="M32.58,1H1.39V38.68h38V7.36ZM27.22,14.61h4V29.12h-4Zm-6,3.46h4V29.12h-4Zm-6-11h4v22.1h-4Zm-6,4.58h4V29.12h-4Zm25,21.61H6.2a1,1,0,0,1,0-2h28a1,1,0,0,1,0,2Z"></path>
		<polygon style="opacity: 0.3;" points="39.41 7.39 33.01 7.39 32.58 1 39.41 7.39"></polygon>
	</symbol>

	<symbol id="cdc-tv" viewBox="0 0 40 40">
		<defs>
			<linearGradient id="linear-gradient" x1="-1374.15" y1="10.03" x2="-1354.09" y2="25.47" gradientTransform="matrix(-1, 0, 0, 1, -1343.57, 0)" gradientUnits="userSpaceOnUse">
				<stop offset="0" stop-color="#b8bab9"></stop>
				<stop offset="1" stop-color="#414042"></stop>
			</linearGradient>
		</defs>
		<path d="M38.61,6.5H1.3A.29.29,0,0,0,1,6.78v23a.29.29,0,0,0,.29.29H18.48v.64a1.51,1.51,0,0,1-.15.67H11.08L8.77,32.81v.33H31.15v-.33l-2.3-1.41H21.62a1.72,1.72,0,0,1-.15-.72v-.59H38.61a.29.29,0,0,0,.29-.29v-23A.29.29,0,0,0,38.61,6.5Z"></path>
		<polygon style="fill:url(#linear-gradient);" points="37.78 7.61 2.13 7.61 2.13 28.92 37.78 28.8 37.78 7.61"></polygon>
		<rect class="fill-w" x="2.16" y="7.64" width="35.6" height="21.31"></rect>
		<rect class="fill-cdc-tv" x="2.12" y="7.51" width="35.8" height="21.57"></rect>
		<polygon class="fill-w" points="16.82 29.08 37.92 7.71 37.92 7.5 37.81 7.5 16.51 29.08 16.82 29.08"></polygon>
		<polygon class="fill-w" points="3.52 29.08 4.95 7.5 4.73 7.5 3.3 29.08 3.52 29.08"></polygon>
		<polygon class="fill-w" points="4.66 29.08 7.74 7.5 7.52 7.5 4.44 29.08 4.66 29.08"></polygon>
		<polygon class="fill-w" points="5.88 29.08 10.7 7.5 10.47 7.5 5.65 29.08 5.88 29.08"></polygon>
		<polygon class="fill-w" points="7.22 29.08 14.1 7.5 13.87 7.5 6.99 29.08 7.22 29.08"></polygon>
		<polygon class="fill-w" points="8.49 29.08 17.32 7.5 17.08 7.5 8.25 29.08 8.49 29.08"></polygon>
		<polygon class="fill-w" points="9.94 29.08 20.99 7.5 20.74 7.5 9.69 29.08 9.94 29.08"></polygon>
		<polygon class="fill-w" points="26.51 7.5 26.25 7.5 11.94 29.08 12.21 29.08 26.51 7.5"></polygon>
		<polygon class="fill-w" points="31.61 7.5 31.33 7.5 13.94 29.08 14.23 29.08 31.61 7.5"></polygon>
		<polygon class="fill-w" points="37.92 15.67 37.92 15.38 20.67 29.08 21.03 29.08 37.92 15.67"></polygon>
		<polygon class="fill-w" points="37.92 21.61 37.92 21.34 25.53 29.08 25.95 29.08 37.92 21.61"></polygon>
		<polygon class="fill-w" points="37.92 27.2 37.92 26.96 33.36 29.08 33.89 29.08 37.92 27.2"></polygon>
		<path class="fill-w" d="M10.14,22.51c-3.72,0-6.25-2.3-6.25-6a6,6,0,0,1,6.28-6.17,7,7,0,0,1,2.8.56v1.78a3.3,3.3,0,0,0-2.77-1.46c-2.24,0-3.51,2.06-3.51,5,0,3.13,1.19,5.35,3.75,5.35A4.3,4.3,0,0,0,13,20.66l.43.93A5.05,5.05,0,0,1,10.14,22.51Z"></path>
		<path class="fill-w" d="M22.31,16.43c0,4.6-2.83,4.92-5,4.92V11.44C19.53,11.44,22.31,11.71,22.31,16.43Zm-2.95,5.86a5.54,5.54,0,0,0,5.7-5.91c0-4.77-3.41-5.84-6-5.84H14.79V22.29Z"></path>
		<path class="fill-w" d="M32.69,22.51c-3.72,0-6.25-2.3-6.25-6a6,6,0,0,1,6.28-6.17,7,7,0,0,1,2.8.56v1.78a3.3,3.3,0,0,0-2.76-1.46c-2.25,0-3.52,2.06-3.52,5,0,3.13,1.19,5.35,3.75,5.35a4.3,4.3,0,0,0,2.53-.93l.43.93A5,5,0,0,1,32.69,22.51Z"></path>
	</symbol>

	<symbol id="flickr" viewBox="0 0 40 40">
		<rect class="fill-flickr flr-bg" x="1" y="1" width="38" height="38" rx="6.23"></rect>
		<path class="fill-flickr flr-dot-1" d="M32.89,20a5.62,5.62,0,1,1-5.62-5.62A5.62,5.62,0,0,1,32.89,20Z"></path>
		<path class="fill-flickr flr-dot-2" d="M18.35,20a5.62,5.62,0,1,1-5.62-5.62A5.62,5.62,0,0,1,18.35,20Z"></path>
	</symbol>

	<!-- FILL FIX ICONS
	     These are most likely font icons now but there were issues with some because a fill class was embedded in these and the svgs are on some older pages -->

	<symbol id="pinterest" viewBox="0 0 40 40">
		<circle class="fill-w" cx="20" cy="20" r="19"></circle>
		<path class="fill-pinterest" d="M20,1a19,19,0,0,0-6.92,36.69,18.15,18.15,0,0,1,.06-5.45l2.23-9.44A6.85,6.85,0,0,1,14.8,20c0-2.64,1.53-4.62,3.44-4.62A2.39,2.39,0,0,1,20.64,18c0,1.63-1,4.07-1.57,6.33a2.76,2.76,0,0,0,2.81,3.43c3.38,0,6-3.56,6-8.7,0-4.55-3.27-7.73-7.94-7.73a8.22,8.22,0,0,0-8.58,8.24A7.41,7.41,0,0,0,12.75,24a.57.57,0,0,1,.14.54c-.15.6-.47,1.9-.53,2.16s-.28.42-.64.25c-2.37-1.1-3.85-4.57-3.85-7.36,0-6,4.35-11.49,12.55-11.49,6.59,0,11.71,4.69,11.71,11,0,6.55-4.13,11.82-9.86,11.82a5.09,5.09,0,0,1-4.35-2.18s-1,3.62-1.18,4.51a21,21,0,0,1-2.37,5A19,19,0,1,0,20,1Z"></path>
	</symbol>
	<symbol id="social_govd" viewBox="0 0 40 40" xmlns:xlink="http://www.w3.org/1999/xlink">
		<path d="M9.42,27.77h-3a5.23,5.23,0,0,1-2.6-.63A5.16,5.16,0,0,1,1,22.45C1,17.06,1,11.67,1,6.28A5.32,5.32,0,0,1,6.27,1c9.08,0,18.17,0,27.25,0A5.42,5.42,0,0,1,39,6.41q0,8,0,15.93a5.38,5.38,0,0,1-5.48,5.43H24.31a1.55,1.55,0,0,0-.93.28L6.93,39.19a1.2,1.2,0,0,1-2-.78,2,2,0,0,1,.22-.92q2-4.64,4.09-9.28Zm6.1-14,3.62,2.68a1.26,1.26,0,0,0,1.7,0l3.08-2.29.52-.38.16.17,4.31,5.19,4.14,5a.8.8,0,1,0,1.21-1l-6.73-8.11L25.74,12.8l.24-.19,8.62-6.4a1.28,1.28,0,1,0-1.53-2q-6.36,4.72-12.72,9.45a.5.5,0,0,1-.72,0q-5-3.77-10.11-7.51c-.91-.68-1.82-1.36-2.74-2a1.23,1.23,0,0,0-1.61.06,1.22,1.22,0,0,0-.3,1.51,2.1,2.1,0,0,0,.57.61l8.37,6.22.4.31-.21.28L6.26,22.4c-.22.27-.46.53-.66.81a.79.79,0,0,0,1.2,1A3,3,0,0,0,7,24l6.16-7.42Z" class="fill-govd"></path>
	</symbol>

	<!-- ROUND ICONS
	     Could be moved to font icons -->
	<symbol id="social_round_bookmark" viewBox="0 0 40 40">
		<path class="fill-bookmark" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1ZM29.8,29.8a1.67,1.67,0,0,1-1.09,1.56,1.53,1.53,0,0,1-.67.12A1.84,1.84,0,0,1,26.78,31l-6.71-6.45L13.37,31a1.86,1.86,0,0,1-1.26.5,1.55,1.55,0,0,1-.67-.14,1.67,1.67,0,0,1-1.09-1.56V10.2a1.68,1.68,0,0,1,1.09-1.56,1.71,1.71,0,0,1,.67-.14H28a1.71,1.71,0,0,1,.67.14A1.68,1.68,0,0,1,29.8,10.2Z"></path>
	</symbol>
	<symbol id="social_round_cdc-tv" viewBox="0 0 40 40">
		<path class="fill-cdc-tv" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1Zm14.3,28H21.12v1.39a1.21,1.21,0,0,0,.12.55h5.55L28.55,32v.24H11.36V32l1.78-1.09H18.7a1,1,0,0,0,.12-.51V29H5.63a.27.27,0,0,1-.27-.27V11.05a.27.27,0,0,1,.27-.27H34.29a.27.27,0,0,1,.26.27V28.73A.27.27,0,0,1,34.29,29Z"></path>
		<path class="fill-cdc-tv" d="M17.9,15.6v7.62c1.69,0,3.87-.25,3.87-3.79S19.63,15.6,17.9,15.6Z"></path>
		<path class="fill-cdc-tv" d="M6.79,12V27.77H33.12V12ZM12.41,24.1c-2.85,0-4.8-1.76-4.8-4.61a4.64,4.64,0,0,1,4.83-4.74,5.26,5.26,0,0,1,2.15.43v1.37a2.53,2.53,0,0,0-2.12-1.12c-1.73,0-2.7,1.58-2.7,3.86s.91,4.11,2.88,4.11a3.24,3.24,0,0,0,1.94-.72l.33.72A3.84,3.84,0,0,1,12.41,24.1Zm7.09-.17H16v-9h3.28c2,0,4.61.82,4.61,4.48A4.26,4.26,0,0,1,19.5,23.93Zm10.24.17c-2.86,0-4.8-1.76-4.8-4.61a4.63,4.63,0,0,1,4.82-4.74,5.26,5.26,0,0,1,2.15.43v1.37a2.53,2.53,0,0,0-2.12-1.12c-1.72,0-2.7,1.58-2.7,3.86S28,23.4,30,23.4a3.24,3.24,0,0,0,1.94-.72l.33.72A3.83,3.83,0,0,1,29.74,24.1Z"></path>
	</symbol>
	<symbol id="social_round_email" viewBox="0 0 40 40">
		<path class="fill-email" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1ZM32,11,20,20.71,8,11ZM8,13.56l6.58,5.33L8,26.06ZM8,29l8.11-8.85L20,23.29l3.87-3.14L32,29Zm24-2.94-6.58-7.17L32,13.56Z"></path>
	</symbol>
	<symbol id="social_round_fb" viewBox="0 0 40 40">
		<circle class="fill-fb" cx="19.99" cy="20" r="19"></circle>
		<path class="fill-w" d="M30.9,24.42l.68-5.28H26.36V15.77c0-1.53.42-2.57,2.61-2.57h2.8V8.48a35.84,35.84,0,0,0-4.08-.21c-4,0-6.79,2.46-6.79,7v3.89H16.34v5.28H20.9V39a18.64,18.64,0,0,0,5.46-1.07V24.42Z"></path>
	</symbol>
	<symbol id="social_round_facebook" viewBox="0 0 40 40">
		<circle class="fill-fb" cx="19.99" cy="20" r="19"></circle>
		<path class="fill-w" d="M30.9,24.42l.68-5.28H26.36V15.77c0-1.53.42-2.57,2.61-2.57h2.8V8.48a35.84,35.84,0,0,0-4.08-.21c-4,0-6.79,2.46-6.79,7v3.89H16.34v5.28H20.9V39a18.64,18.64,0,0,0,5.46-1.07V24.42Z"></path>
	</symbol>
	<symbol id="social_round_flickr" viewBox="0 0 40 40">
		<circle class="fill-flickr flr-bg" cx="19.99" cy="20" r="19"></circle>
		<path class="fill-flickr flr-dot-1" d="M32.89,20a5.62,5.62,0,1,1-5.62-5.62A5.62,5.62,0,0,1,32.89,20Z"></path>
		<path class="fill-flickr flr-dot-2" d="M18.35,20a5.62,5.62,0,1,1-5.62-5.62A5.62,5.62,0,0,1,18.35,20Z"></path>
	</symbol>
	<svg id="social_round_googleplus" viewBox="0 0 40 40">
		<path class="fill-googleplus" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1ZM14.55,29.5A9.5,9.5,0,1,1,20.94,13c-2,1.88-1.92,2-2.71,2.77a5.39,5.39,0,0,0-3.68-1.38,5.64,5.64,0,0,0,0,11.28c3.08,0,4.33-1.32,5.13-3.76H14.55V18.12h9.12C24.3,22.67,22.39,29.5,14.55,29.5Zm17.11-8.84V24H29.31V20.66H25.93V18.31h3.38V15h2.35v3.3H35v2.35Z"></path>
	</svg>
	<symbol id="social_round_govd" viewBox="0 0 40 40">
		<path class="fill-govd" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1Zm8.43,25.94H22.69a.93.93,0,0,0-.58.18l-10.27,7a.75.75,0,0,1-1.24-.49,1.2,1.2,0,0,1,.14-.57c.84-1.93,1.7-3.86,2.55-5.79,0-.08.06-.16.11-.27H11.56a3.28,3.28,0,0,1-1.63-.4,3.24,3.24,0,0,1-1.78-2.93c0-3.36,0-6.72,0-10.08a3.32,3.32,0,0,1,3.28-3.29c5.67,0,11.34,0,17,0a3.37,3.37,0,0,1,3.4,3.38q0,5,0,9.94A3.36,3.36,0,0,1,28.42,26.94Z"></path>
		<path class="fill-govd" d="M28.16,12.21l-7.94,5.9a.32.32,0,0,1-.45,0l-6.31-4.69c-.56-.42-1.13-.85-1.7-1.26a.79.79,0,0,0-1,0,.76.76,0,0,0-.18.94,1.44,1.44,0,0,0,.35.39l5.23,3.88.24.19-.13.17-4.83,5.82c-.14.17-.29.33-.42.51a.48.48,0,0,0,.1.67.47.47,0,0,0,.65,0,1.14,1.14,0,0,0,.15-.16c1.28-1.54,2.56-3.09,3.85-4.63.47-.58,1-1.15,1.45-1.74.77.56,1.51,1.12,2.25,1.67a.81.81,0,0,0,1.07,0l1.92-1.43.32-.24a.47.47,0,0,1,.1.11c.9,1.07,1.79,2.15,2.69,3.23l2.58,3.11a.5.5,0,1,0,.75-.65c-1.39-1.69-2.8-3.37-4.2-5.06l-1.11-1.34.15-.12,5.38-4a.8.8,0,1,0-.95-1.27Z"></path>
	</symbol>
	<symbol id="social_round_instagram" viewBox="0 0 40 40">
		<circle style="fill:url(#svg_ig_1);" cx="20" cy="20" r="20"></circle>
		<circle style="fill:url(#svg_ig_2);" cx="20" cy="20" r="20"></circle>
		<path class="fill-w" d="M20,5.5c-4,0-4.5,0-6.1,0.1c-1.6,0.1-2.6,0.3-3.6,0.7C9.4,6.7,8.5,7.2,7.7,8C6.9,8.8,6.4,9.7,6,10.6c-0.4,0.9-0.6,2-0.7,3.6c-0.1,1.6-0.1,2.1-0.1,6.1s0,4.5,0.1,6.1C5.4,28,5.6,29,6,30c0.4,1,0.9,1.8,1.7,2.6c0.8,0.8,1.6,1.3,2.6,1.7c0.9,0.4,2,0.6,3.6,0.7c1.6,0.1,2.1,0.1,6.1,0.1c4,0,4.5,0,6.1-0.1c1.6-0.1,2.6-0.3,3.6-0.7c1-0.4,1.8-0.9,2.6-1.7c0.8-0.8,1.3-1.6,1.7-2.6c0.4-0.9,0.6-2,0.7-3.6c0.1-1.6,0.1-2.1,0.1-6.1s0-4.5-0.1-6.1c-0.1-1.6-0.3-2.6-0.7-3.6c-0.4-1-0.9-1.8-1.7-2.6c-0.8-0.8-1.6-1.3-2.6-1.7c-0.9-0.4-2-0.6-3.6-0.7C24.5,5.6,24,5.5,20,5.5L20,5.5z M18.7,8.2c0.4,0,0.8,0,1.3,0c3.9,0,4.4,0,6,0.1c1.4,0.1,2.2,0.3,2.7,0.5c0.7,0.3,1.2,0.6,1.7,1.1c0.5,0.5,0.8,1,1.1,1.7c0.2,0.5,0.4,1.3,0.5,2.7c0.1,1.6,0.1,2,0.1,6s0,4.4-0.1,6c-0.1,1.4-0.3,2.2-0.5,2.7c-0.3,0.7-0.6,1.2-1.1,1.7c-0.5,0.5-1,0.8-1.7,1.1c-0.5,0.2-1.3,0.4-2.7,0.5c-1.6,0.1-2,0.1-6,0.1c-3.9,0-4.4,0-6-0.1c-1.4-0.1-2.2-0.3-2.7-0.5c-0.7-0.3-1.2-0.6-1.7-1.1c-0.5-0.5-0.8-1-1.1-1.7C8.3,28.5,8,27.7,8,26.3c-0.1-1.6-0.1-2-0.1-6s0-4.4,0.1-6c0.1-1.4,0.3-2.2,0.5-2.7c0.3-0.7,0.6-1.2,1.1-1.7c0.5-0.5,1-0.8,1.7-1.1c0.5-0.2,1.3-0.4,2.7-0.5C15.4,8.2,15.9,8.2,18.7,8.2L18.7,8.2z M27.9,10.7c-1,0-1.8,0.8-1.8,1.8c0,1,0.8,1.8,1.8,1.8s1.8-0.8,1.8-1.8S28.9,10.7,27.9,10.7L27.9,10.7z M20,12.7c-4.2,0-7.6,3.4-7.6,7.6s3.4,7.6,7.6,7.6c4.2,0,7.6-3.4,7.6-7.6S24.2,12.7,20,12.7L20,12.7z M20,15.4c2.7,0,4.9,2.2,4.9,4.9c0,2.7-2.2,4.9-4.9,4.9c-2.7,0-4.9-2.2-4.9-4.9C15.1,17.6,17.3,15.4,20,15.4z"></path>
	</symbol>
	<symbol id="social_round_ig" viewBox="0 0 40 40">
		<circle style="fill:url(#svg_ig_1);" cx="20" cy="20" r="20"></circle>
		<circle style="fill:url(#svg_ig_2);" cx="20" cy="20" r="20"></circle>
		<path class="fill-w" d="M20,5.5c-4,0-4.5,0-6.1,0.1c-1.6,0.1-2.6,0.3-3.6,0.7C9.4,6.7,8.5,7.2,7.7,8C6.9,8.8,6.4,9.7,6,10.6c-0.4,0.9-0.6,2-0.7,3.6c-0.1,1.6-0.1,2.1-0.1,6.1s0,4.5,0.1,6.1C5.4,28,5.6,29,6,30c0.4,1,0.9,1.8,1.7,2.6c0.8,0.8,1.6,1.3,2.6,1.7c0.9,0.4,2,0.6,3.6,0.7c1.6,0.1,2.1,0.1,6.1,0.1c4,0,4.5,0,6.1-0.1c1.6-0.1,2.6-0.3,3.6-0.7c1-0.4,1.8-0.9,2.6-1.7c0.8-0.8,1.3-1.6,1.7-2.6c0.4-0.9,0.6-2,0.7-3.6c0.1-1.6,0.1-2.1,0.1-6.1s0-4.5-0.1-6.1c-0.1-1.6-0.3-2.6-0.7-3.6c-0.4-1-0.9-1.8-1.7-2.6c-0.8-0.8-1.6-1.3-2.6-1.7c-0.9-0.4-2-0.6-3.6-0.7C24.5,5.6,24,5.5,20,5.5L20,5.5z M18.7,8.2c0.4,0,0.8,0,1.3,0c3.9,0,4.4,0,6,0.1c1.4,0.1,2.2,0.3,2.7,0.5c0.7,0.3,1.2,0.6,1.7,1.1c0.5,0.5,0.8,1,1.1,1.7c0.2,0.5,0.4,1.3,0.5,2.7c0.1,1.6,0.1,2,0.1,6s0,4.4-0.1,6c-0.1,1.4-0.3,2.2-0.5,2.7c-0.3,0.7-0.6,1.2-1.1,1.7c-0.5,0.5-1,0.8-1.7,1.1c-0.5,0.2-1.3,0.4-2.7,0.5c-1.6,0.1-2,0.1-6,0.1c-3.9,0-4.4,0-6-0.1c-1.4-0.1-2.2-0.3-2.7-0.5c-0.7-0.3-1.2-0.6-1.7-1.1c-0.5-0.5-0.8-1-1.1-1.7C8.3,28.5,8,27.7,8,26.3c-0.1-1.6-0.1-2-0.1-6s0-4.4,0.1-6c0.1-1.4,0.3-2.2,0.5-2.7c0.3-0.7,0.6-1.2,1.1-1.7c0.5-0.5,1-0.8,1.7-1.1c0.5-0.2,1.3-0.4,2.7-0.5C15.4,8.2,15.9,8.2,18.7,8.2L18.7,8.2z M27.9,10.7c-1,0-1.8,0.8-1.8,1.8c0,1,0.8,1.8,1.8,1.8s1.8-0.8,1.8-1.8S28.9,10.7,27.9,10.7L27.9,10.7z M20,12.7c-4.2,0-7.6,3.4-7.6,7.6s3.4,7.6,7.6,7.6c4.2,0,7.6-3.4,7.6-7.6S24.2,12.7,20,12.7L20,12.7z M20,15.4c2.7,0,4.9,2.2,4.9,4.9c0,2.7-2.2,4.9-4.9,4.9c-2.7,0-4.9-2.2-4.9-4.9C15.1,17.6,17.3,15.4,20,15.4z"></path>
	</symbol>
	<symbol id="social_round_linkedin" viewBox="0 0 40 40">
		<path class="fill-linkin" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1ZM13.58,31H8.92V16h4.66ZM11.25,14a2.7,2.7,0,1,1,2.7-2.7A2.7,2.7,0,0,1,11.25,14ZM31,31H26.36V23.73c0-1.73,0-4-2.42-4s-2.79,1.9-2.79,3.85V31H16.5V16H21v2.05H21a4.88,4.88,0,0,1,4.4-2.42c4.72,0,5.59,3.1,5.59,7.13Z"></path>
	</symbol>
	<symbol id="social_round_pinterest" viewBox="0 0 40 40">
		<circle class="fill-w" cx="20" cy="20" r="19"></circle>
		<path class="fill-pinterest" d="M20,1a19,19,0,0,0-6.92,36.69,18.15,18.15,0,0,1,.06-5.45l2.23-9.44A6.85,6.85,0,0,1,14.8,20c0-2.64,1.53-4.62,3.44-4.62A2.39,2.39,0,0,1,20.64,18c0,1.63-1,4.07-1.57,6.33a2.76,2.76,0,0,0,2.81,3.43c3.38,0,6-3.56,6-8.7,0-4.55-3.27-7.73-7.94-7.73a8.22,8.22,0,0,0-8.58,8.24A7.41,7.41,0,0,0,12.75,24a.57.57,0,0,1,.14.54c-.15.6-.47,1.9-.53,2.16s-.28.42-.64.25c-2.37-1.1-3.85-4.57-3.85-7.36,0-6,4.35-11.49,12.55-11.49,6.59,0,11.71,4.69,11.71,11,0,6.55-4.13,11.82-9.86,11.82a5.09,5.09,0,0,1-4.35-2.18s-1,3.62-1.18,4.51a21,21,0,0,1-2.37,5A19,19,0,1,0,20,1Z"></path>
	</symbol>
	<symbol id="social_round_podcast" viewBox="0 0 40 40">
		<path class="fill-podcast" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1Zm2.8,33.33a.67.67,0,0,1-.67.67H17.84a.67.67,0,0,1-.67-.67V23.2a.67.67,0,0,1,.67-.67h4.28a.67.67,0,0,1,.67.67ZM17.27,19.16A2.73,2.73,0,1,1,20,21.89,2.73,2.73,0,0,1,17.27,19.16Zm8,4.37a6.89,6.89,0,1,0-10.59-.16l-.44,2a8.61,8.61,0,1,1,11.54.05Zm1.56,5.72-.49-1.74-.08-.28a10.19,10.19,0,1,0-12.42,0l-.12.58-.35,1.5a12.16,12.16,0,1,1,13.46-.08Z"></path>
	</symbol>
	<symbol id="social_round_rss" viewBox="0 0 40 40">
		<path class="fill-rss" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1ZM12.08,31.06a3.14,3.14,0,1,1,3.13-3.14A3.14,3.14,0,0,1,12.08,31.06Zm11.22-.34a1,1,0,0,1-.77.34h-2.2a1,1,0,0,1-1-.95A10.46,10.46,0,0,0,9.89,20.7a1,1,0,0,1-1-1v-2.2a1,1,0,0,1,.34-.77,1,1,0,0,1,.71-.28h.08A14.79,14.79,0,0,1,23.58,29.93,1.1,1.1,0,0,1,23.3,30.72Zm8.35,0a1,1,0,0,1-.76.33H28.56a1.05,1.05,0,0,1-1-1A18.7,18.7,0,0,0,9.92,12.47a1,1,0,0,1-1-1V9.1a1,1,0,0,1,.33-.75A1,1,0,0,1,10,8.06h0A23.2,23.2,0,0,1,31.94,30,1,1,0,0,1,31.65,30.73Z"></path>
	</symbol>
	<symbol id="social_round_syndication" viewBox="0 0 40 40">
		<path class="fill-synd" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1Zm1.33,9.94a1,1,0,0,1,1.27-.71,10.47,10.47,0,0,1,2.37,1,10.11,10.11,0,0,1,4.83,6.42A1,1,0,0,1,29,18.89a1,1,0,0,1-1.24-.75A8.17,8.17,0,0,0,22,12.21,1,1,0,0,1,21.32,10.94Zm8,12.86a9,9,0,0,1-.66,1.36,10.13,10.13,0,0,1-7.55,5H21a1,1,0,0,1-1-.89,1,1,0,0,1,.89-1.15,8.1,8.1,0,0,0,6-4A7.31,7.31,0,0,0,27.45,23a1,1,0,0,1,1.91.76Zm-9-8.72a1,1,0,0,1,1.3-.66,5.91,5.91,0,0,1,3.85,3.94,1,1,0,0,1-.68,1.27,1,1,0,0,1-1.29-.69,3.86,3.86,0,0,0-2.52-2.57A1,1,0,0,1,20.39,15.08Zm-1.76.12a1,1,0,0,1-.48,1.37,4,4,0,0,0-2.1,2.67,1,1,0,0,1-1,.81.83.83,0,0,1-.22,0A1,1,0,0,1,14,18.8a6,6,0,0,1,3.22-4.07A1,1,0,0,1,18.63,15.2Zm-.8-4.15a1,1,0,0,1-.64,1.31A8.14,8.14,0,0,0,12.78,16a8,8,0,0,0-1,2.72,1,1,0,0,1-1,.85h-.18a1,1,0,0,1-.84-1.18A10,10,0,0,1,11,15a10.2,10.2,0,0,1,5.53-4.54A1,1,0,0,1,17.83,11.05ZM6.93,19H6.77a1,1,0,0,1-.86-1.17A14.11,14.11,0,0,1,14.84,6.9a1,1,0,0,1,1.33.6,1,1,0,0,1-.6,1.32,12.14,12.14,0,0,0-6.16,5.23A11.7,11.7,0,0,0,8,18.16,1,1,0,0,1,6.93,19Zm7.37,6.31-6-.84L19.8,19.85,15.2,31.23Zm6.12-1.44a3.89,3.89,0,0,0,2.94-2.17,1,1,0,0,1,1.38-.49,1,1,0,0,1,.49,1.37,5.93,5.93,0,0,1-4.51,3.32h-.15a1,1,0,0,1-.15-2Zm12.51,1.46a14.92,14.92,0,0,1-.86,1.75,14.11,14.11,0,0,1-11.24,7h-.07a1,1,0,0,1-.07-2.05A12,12,0,0,0,31,24.58a1,1,0,0,1,1.91.77ZM32.8,18a1,1,0,0,1-.24,0,1,1,0,0,1-1-.78,11.93,11.93,0,0,0-5.68-7.55,12.09,12.09,0,0,0-3-1.22,1,1,0,0,1-.73-1.26,1,1,0,0,1,1.26-.73,14.12,14.12,0,0,1,3.46,1.43,14,14,0,0,1,6.65,8.84A1,1,0,0,1,32.8,18Z"></path>
	</symbol>
	<symbol id="social_round_tumblr" viewBox="0 0 40 40">
		<path class="fill-tumblr" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1Zm7.59,29.88a7.34,7.34,0,0,1-4.74,1.6h-.2c-6.14,0-7.47-4.5-7.47-7.14V18H12.75a.5.5,0,0,1-.5-.51V14.07a.86.86,0,0,1,.57-.81A6.46,6.46,0,0,0,17.1,7.31c0-.55.33-.83.82-.83h3.6A.51.51,0,0,1,22,7v5.85h4.21a.51.51,0,0,1,.51.51V17.5a.5.5,0,0,1-.51.5H22v6.77a1.89,1.89,0,0,0,1.81,2.16,5,5,0,0,0,1.64-.35,1.13,1.13,0,0,1,.65-.11c.18,0,.29.17.37.4l1.12,3.26C27.69,30.39,27.77,30.68,27.58,30.88Z"></path>
	</symbol>
	<symbol id="social_round_twitter" viewBox="0 0 40 40">
		<circle class="fill-tw" cx="19.99" cy="20" r="19"></circle>
		<path class="fill-w" d="M15.59,29.65A13.77,13.77,0,0,0,29.46,15.79c0-.21,0-.42,0-.63a10,10,0,0,0,2.44-2.53,9.85,9.85,0,0,1-2.8.77,4.9,4.9,0,0,0,2.14-2.69,10,10,0,0,1-3.09,1.18,4.87,4.87,0,0,0-8.43,3.33,5,5,0,0,0,.12,1.11,13.8,13.8,0,0,1-10-5.09,4.88,4.88,0,0,0,1.51,6.51,5,5,0,0,1-2.21-.61v.06A4.88,4.88,0,0,0,13,22a5,5,0,0,1-1.29.17,4.53,4.53,0,0,1-.91-.09,4.87,4.87,0,0,0,4.55,3.38,9.77,9.77,0,0,1-6.05,2.09,8.82,8.82,0,0,1-1.16-.07,13.77,13.77,0,0,0,7.46,2.19"></path>
	</symbol>
	<symbol id="social_round_youtube" viewBox="0 0 40 40">
		<path class="fill-youtube" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1ZM13.85,27V13l12.3,7Z"></path>
	</symbol>
	<symbol id="intranet-connects-cdc">
		<style type="text/css">
			.st0 {
				fill: #FFFFFF;
			}

			.st1 {
				fill: none;
				stroke: #FFFFFF;
				stroke-width: 2.1206;
			}

			.st2 {
				fill: #005DA9;
			}

			.st3 {
				fill: none;
				stroke: #FFFFFF;
				stroke-width: 1.8943;
			}

			.st4 {
				fill: #607171;
			}
		</style>
		<g>
			<rect x="1.3" y="9.6" class="st0" width="157.9" height="96.4"/>
			<rect x="1.3" y="9.6" class="st1" width="157.9" height="96.4"/>
			<rect x="2.8" y="11" class="st2" width="155" height="93.4"/>
			<polygon class="st0" points="66.5,104.5 157.8,11.9 157.8,11 157.3,11 65.1,104.5 	"/>
			<polygon class="st0" points="8.8,104.5 15,11 14.1,11 7.9,104.5 	"/>
			<polygon class="st0" points="13.8,104.5 27.1,11 26.1,11 12.8,104.5 	"/>
			<polygon class="st0" points="19.1,104.5 39.9,11 39,11 18.1,104.5 	"/>
			<polygon class="st0" points="24.9,104.5 54.7,11 53.7,11 23.9,104.5 	"/>
			<polygon class="st0" points="30.4,104.5 68.6,11 67.6,11 29.3,104.5 	"/>
			<polygon class="st0" points="36.7,104.5 84.5,11 83.4,11 35.6,104.5 	"/>
			<polygon class="st0" points="108.4,11 107.3,11 45.3,104.5 46.5,104.5 	"/>
			<polygon class="st0" points="130.5,11 129.3,11 54,104.5 55.2,104.5 	"/>
			<polygon class="st0" points="157.8,46.4 157.8,45.2 83.1,104.5 84.7,104.5 	"/>
			<polygon class="st0" points="157.8,72.1 157.8,71 104.2,104.5 106,104.5 	"/>
			<polygon class="st0" points="157.8,96.4 157.8,95.3 138.1,104.5 140.3,104.5 	"/>
			<g>
				<path class="st0" d="M37.5,76C21.4,76,10.4,66.1,10.4,50c0-15.7,11.7-26.7,27.2-26.7c4.1,0,8.7,0.8,12.2,2.4v7.7
								c-1.7-2.3-5.2-6.3-12-6.3c-9.7,0-15.2,8.9-15.2,21.8c0,13.5,5.1,23.2,16.2,23.2c3.9,0,8.8-2,11-4.1l1.8,4.1
								C49.5,73.7,45.6,76,37.5,76"/>
				<path class="st3" d="M37.5,76C21.4,76,10.4,66.1,10.4,50c0-15.7,11.7-26.7,27.2-26.7c4.1,0,8.7,0.8,12.2,2.4v7.7
								c-1.7-2.3-5.2-6.3-12-6.3c-9.7,0-15.2,8.9-15.2,21.8c0,13.5,5.1,23.2,16.2,23.2c3.9,0,8.8-2,11-4.1l1.8,4.1
								C49.5,73.7,45.6,76,37.5,76z"/>
				<path class="st0" d="M77.4,75.1c9.8,0,24.7-6.1,24.7-25.6c0-20.7-14.8-25.3-26-25.3H57.6v50.9H77.4z M90.2,49.7
								C90.2,69.6,78,71,68.4,71V28C78.2,28,90.2,29.2,90.2,49.7"/>
				<path class="st3" d="M77.4,75.1c9.8,0,24.7-6.1,24.7-25.6c0-20.7-14.8-25.3-26-25.3H57.6v50.9H77.4z M90.2,49.7
								C90.2,69.6,78,71,68.4,71V28C78.2,28,90.2,29.2,90.2,49.7z"/>
				<path class="st0" d="M135.2,76c-16.1,0-27.1-9.9-27.1-26.1c0-15.7,11.7-26.7,27.2-26.7c4.2,0,8.7,0.8,12.2,2.4v7.7
								c-1.7-2.3-5.2-6.3-12-6.3c-9.7,0-15.2,8.9-15.2,21.8c0,13.5,5.1,23.2,16.2,23.2c3.9,0,8.8-2,11-4.1l1.8,4.1
								C147.2,73.7,143.2,76,135.2,76"/>
				<path class="st3" d="M135.2,76c-16.1,0-27.1-9.9-27.1-26.1c0-15.7,11.7-26.7,27.2-26.7c4.2,0,8.7,0.8,12.2,2.4v7.7
								c-1.7-2.3-5.2-6.3-12-6.3c-9.7,0-15.2,8.9-15.2,21.8c0,13.5,5.1,23.2,16.2,23.2c3.9,0,8.8-2,11-4.1l1.8,4.1
								C147.2,73.7,143.2,76,135.2,76z"/>
			</g>
		</g>
		<circle fill="transparent" cx="291.9" cy="61.5" r="30.6"/>
		<path class="st4" d="M267.9,97.4c-8.5,8-20,12.9-32.6,12.9c-26.3,0-47.8-21.4-47.8-47.8c0-26.3,21.4-47.8,47.8-47.8
						c12.6,0,24,4.9,32.6,12.9c3.7-2.6,7.9-4.7,12.4-6C269.1,9.4,253.1,1.7,235.3,1.7c-33.5,0-60.8,27.3-60.8,60.8s27.3,60.8,60.8,60.8
						c17.8,0,33.8-7.7,44.9-19.9C275.8,102,271.6,100,267.9,97.4z"/>
		<g>
			<path class="st4" d="M255.5,62.4c0-20.4,16.5-36.9,37-36.9c20.4,0,37,16.5,37,36.9c0,20.5-16.5,37-37,37
							C272,99.5,255.5,83,255.5,62.4z M316.4,62.5c0-13.6-10.7-24.6-24-24.6c-13.2,0-24,11-24,24.6c0,13.7,10.7,24.7,24,24.7
							C305.7,87.2,316.4,76.1,316.4,62.5z"/>
			<path class="st4" d="M404.9,57.2V98h-13V60.3c0-12.4-9.7-22.5-21.8-22.5c-12,0-21.8,10.1-21.8,22.5V98h-13V27h13v10.5
							c5.8-7.3,14.8-12,24.8-12C390.7,25.5,404.9,39.7,404.9,57.2z"/>
			<path class="st4" d="M482.9,57.2V98h-13V60.3c0-12.4-9.7-22.5-21.8-22.5c-12,0-21.8,10.1-21.8,22.5V98h-13V27h13v10.5
							c5.8-7.3,14.8-12,24.8-12C468.7,25.5,482.9,39.7,482.9,57.2z"/>
			<path class="st4" d="M526.7,87.2c8.3,0,18.1-2.9,25.7-7.3l5.6,10.9c-9.4,5.4-20.9,8.7-31.3,8.7c-22.3,0-37.4-14.3-37.5-37
							c0-20.4,15.9-37,35.5-37c19.6,0,35.5,16.5,35.5,36.9c0,2.4-0.3,4.8-0.7,7.1H503C505.5,80.9,514.3,87.2,526.7,87.2z M546.8,57.5
							c-2.1-11.2-11.2-19.7-22.1-19.7c-10.9,0-20,8.5-22.1,19.7H546.8z"/>
			<path class="st4" d="M622.7,77.1l8.9,8.2c-6.7,8.5-17.2,14-29,14c-20.4,0-37-16.5-37-36.9c0-20.4,16.5-36.9,37-36.9
							c11.8,0,22.2,5.5,29,14l-8.9,8.2c-4.5-5.6-12-9.9-20-9.9c-13.1,0-24,11-24,24.6c0,13.6,10.9,24.6,24,24.6
							C610.8,87.1,618.2,82.8,622.7,77.1z"/>
			<path class="st4" d="M689,95.8c-10.7,4.7-22.8,5.3-31.4,0c-6.2-3.8-10-10.4-10-19.6V39.3H634V27h13.6V7.1h13V27h22.7v12.3h-22.7
							v35.5c0,4.9,1.4,8.4,4.5,10.4c4.9,3,12.9,1.9,20.1-0.9L689,95.8z"/>
			<path class="st4" d="M690.5,89.6l5.7-10.3c4.6,2.9,13.8,7.6,24.9,7.5c8.3-0.1,16.2-2.9,16.1-8.5c-0.1-6.5-8-8-15.5-9.3
							c-13.2-2.4-27.8-6.8-27.9-22.4c-0.1-14.9,15.6-21.3,28.4-21.4c9.7-0.1,21.6,4.3,29.5,9.7L746,45.1c-5.1-3.6-15.1-7.6-23.6-7.5
							c-8.8,0.1-14.5,3.5-14.4,8.6c0.1,6.8,7.5,8.5,13.8,9.8c15.7,3.1,29.5,6.8,29.6,21.6c0.1,15.8-18,21.6-29.9,21.6
							C711.1,99.3,698.6,94.9,690.5,89.6z"/>
		</g>
	</symbol>
	<symbol id="intranet-connects-text">
		<style type="text/css">
			.st0 {
				fill: #FFFFFF;
			}

			.st1 {
				fill: none;
				stroke: #FFFFFF;
				stroke-width: 2.1206;
			}

			.st2 {
				fill: #005DA9;
			}

			.st3 {
				fill: none;
				stroke: #FFFFFF;
				stroke-width: 1.8943;
			}

			.st4 {
				fill: #607171;
			}
		</style>
		<g>
			<rect x="1.3" y="9.6" class="st0" width="157.9" height="96.4"/>
			<rect x="1.3" y="9.6" class="st1" width="157.9" height="96.4"/>
			<rect x="2.8" y="11" class="st2" width="155" height="93.4"/>
			<polygon class="st0" points="66.5,104.5 157.8,11.9 157.8,11 157.3,11 65.1,104.5 	"/>
			<polygon class="st0" points="8.8,104.5 15,11 14.1,11 7.9,104.5 	"/>
			<polygon class="st0" points="13.8,104.5 27.1,11 26.1,11 12.8,104.5 	"/>
			<polygon class="st0" points="19.1,104.5 39.9,11 39,11 18.1,104.5 	"/>
			<polygon class="st0" points="24.9,104.5 54.7,11 53.7,11 23.9,104.5 	"/>
			<polygon class="st0" points="30.4,104.5 68.6,11 67.6,11 29.3,104.5 	"/>
			<polygon class="st0" points="36.7,104.5 84.5,11 83.4,11 35.6,104.5 	"/>
			<polygon class="st0" points="108.4,11 107.3,11 45.3,104.5 46.5,104.5 	"/>
			<polygon class="st0" points="130.5,11 129.3,11 54,104.5 55.2,104.5 	"/>
			<polygon class="st0" points="157.8,46.4 157.8,45.2 83.1,104.5 84.7,104.5 	"/>
			<polygon class="st0" points="157.8,72.1 157.8,71 104.2,104.5 106,104.5 	"/>
			<polygon class="st0" points="157.8,96.4 157.8,95.3 138.1,104.5 140.3,104.5 	"/>
			<g>
				<path class="st0" d="M37.5,76C21.4,76,10.4,66.1,10.4,50c0-15.7,11.7-26.7,27.2-26.7c4.1,0,8.7,0.8,12.2,2.4v7.7
								c-1.7-2.3-5.2-6.3-12-6.3c-9.7,0-15.2,8.9-15.2,21.8c0,13.5,5.1,23.2,16.2,23.2c3.9,0,8.8-2,11-4.1l1.8,4.1
								C49.5,73.7,45.6,76,37.5,76"/>
				<path class="st3" d="M37.5,76C21.4,76,10.4,66.1,10.4,50c0-15.7,11.7-26.7,27.2-26.7c4.1,0,8.7,0.8,12.2,2.4v7.7
								c-1.7-2.3-5.2-6.3-12-6.3c-9.7,0-15.2,8.9-15.2,21.8c0,13.5,5.1,23.2,16.2,23.2c3.9,0,8.8-2,11-4.1l1.8,4.1
								C49.5,73.7,45.6,76,37.5,76z"/>
				<path class="st0" d="M77.4,75.1c9.8,0,24.7-6.1,24.7-25.6c0-20.7-14.8-25.3-26-25.3H57.6v50.9H77.4z M90.2,49.7
								C90.2,69.6,78,71,68.4,71V28C78.2,28,90.2,29.2,90.2,49.7"/>
				<path class="st3" d="M77.4,75.1c9.8,0,24.7-6.1,24.7-25.6c0-20.7-14.8-25.3-26-25.3H57.6v50.9H77.4z M90.2,49.7
								C90.2,69.6,78,71,68.4,71V28C78.2,28,90.2,29.2,90.2,49.7z"/>
				<path class="st0" d="M135.2,76c-16.1,0-27.1-9.9-27.1-26.1c0-15.7,11.7-26.7,27.2-26.7c4.2,0,8.7,0.8,12.2,2.4v7.7
								c-1.7-2.3-5.2-6.3-12-6.3c-9.7,0-15.2,8.9-15.2,21.8c0,13.5,5.1,23.2,16.2,23.2c3.9,0,8.8-2,11-4.1l1.8,4.1
								C147.2,73.7,143.2,76,135.2,76"/>
				<path class="st3" d="M135.2,76c-16.1,0-27.1-9.9-27.1-26.1c0-15.7,11.7-26.7,27.2-26.7c4.2,0,8.7,0.8,12.2,2.4v7.7
								c-1.7-2.3-5.2-6.3-12-6.3c-9.7,0-15.2,8.9-15.2,21.8c0,13.5,5.1,23.2,16.2,23.2c3.9,0,8.8-2,11-4.1l1.8,4.1
								C147.2,73.7,143.2,76,135.2,76z"/>
			</g>
		</g>
		<circle fill="transparent" cx="291.9" cy="61.5" r="30.6"/>
		<path class="st4" d="M267.9,97.4c-8.5,8-20,12.9-32.6,12.9c-26.3,0-47.8-21.4-47.8-47.8c0-26.3,21.4-47.8,47.8-47.8
						c12.6,0,24,4.9,32.6,12.9c3.7-2.6,7.9-4.7,12.4-6C269.1,9.4,253.1,1.7,235.3,1.7c-33.5,0-60.8,27.3-60.8,60.8s27.3,60.8,60.8,60.8
						c17.8,0,33.8-7.7,44.9-19.9C275.8,102,271.6,100,267.9,97.4z"/>
		<g>
			<path class="st4" d="M255.5,62.4c0-20.4,16.5-36.9,37-36.9c20.4,0,37,16.5,37,36.9c0,20.5-16.5,37-37,37
							C272,99.5,255.5,83,255.5,62.4z M316.4,62.5c0-13.6-10.7-24.6-24-24.6c-13.2,0-24,11-24,24.6c0,13.7,10.7,24.7,24,24.7
							C305.7,87.2,316.4,76.1,316.4,62.5z"/>
			<path class="st4" d="M404.9,57.2V98h-13V60.3c0-12.4-9.7-22.5-21.8-22.5c-12,0-21.8,10.1-21.8,22.5V98h-13V27h13v10.5
							c5.8-7.3,14.8-12,24.8-12C390.7,25.5,404.9,39.7,404.9,57.2z"/>
			<path class="st4" d="M482.9,57.2V98h-13V60.3c0-12.4-9.7-22.5-21.8-22.5c-12,0-21.8,10.1-21.8,22.5V98h-13V27h13v10.5
							c5.8-7.3,14.8-12,24.8-12C468.7,25.5,482.9,39.7,482.9,57.2z"/>
			<path class="st4" d="M526.7,87.2c8.3,0,18.1-2.9,25.7-7.3l5.6,10.9c-9.4,5.4-20.9,8.7-31.3,8.7c-22.3,0-37.4-14.3-37.5-37
							c0-20.4,15.9-37,35.5-37c19.6,0,35.5,16.5,35.5,36.9c0,2.4-0.3,4.8-0.7,7.1H503C505.5,80.9,514.3,87.2,526.7,87.2z M546.8,57.5
							c-2.1-11.2-11.2-19.7-22.1-19.7c-10.9,0-20,8.5-22.1,19.7H546.8z"/>
			<path class="st4" d="M622.7,77.1l8.9,8.2c-6.7,8.5-17.2,14-29,14c-20.4,0-37-16.5-37-36.9c0-20.4,16.5-36.9,37-36.9
							c11.8,0,22.2,5.5,29,14l-8.9,8.2c-4.5-5.6-12-9.9-20-9.9c-13.1,0-24,11-24,24.6c0,13.6,10.9,24.6,24,24.6
							C610.8,87.1,618.2,82.8,622.7,77.1z"/>
			<path class="st4" d="M689,95.8c-10.7,4.7-22.8,5.3-31.4,0c-6.2-3.8-10-10.4-10-19.6V39.3H634V27h13.6V7.1h13V27h22.7v12.3h-22.7
							v35.5c0,4.9,1.4,8.4,4.5,10.4c4.9,3,12.9,1.9,20.1-0.9L689,95.8z"/>
			<path class="st4" d="M690.5,89.6l5.7-10.3c4.6,2.9,13.8,7.6,24.9,7.5c8.3-0.1,16.2-2.9,16.1-8.5c-0.1-6.5-8-8-15.5-9.3
							c-13.2-2.4-27.8-6.8-27.9-22.4c-0.1-14.9,15.6-21.3,28.4-21.4c9.7-0.1,21.6,4.3,29.5,9.7L746,45.1c-5.1-3.6-15.1-7.6-23.6-7.5
							c-8.8,0.1-14.5,3.5-14.4,8.6c0.1,6.8,7.5,8.5,13.8,9.8c15.7,3.1,29.5,6.8,29.6,21.6c0.1,15.8-18,21.6-29.9,21.6
							C711.1,99.3,698.6,94.9,690.5,89.6z"/>
		</g>
	</symbol>
</svg>


<!-- JS Added Dynamically Here -->
<script>var MP = {
<!--mp_trans_disable_start -->
	Version: '3.1.1.1',
	SrcLang: 'en',
<!--mp_trans_disable_end -->
	UrlLang: 'mp_js_current_lang',
	SrcUrl: decodeURIComponent('mp_js_orgin_url'),
	oSite: decodeURIComponent('mp_js_origin_baseUrl'),
	tSite: decodeURIComponent('mp_js_translated_baseUrl'),
<!--mp_trans_disable_start -->
	init: function() {
		if (MP.oSite.indexOf('p_js_') == 1) {
			MP.SrcUrl = window.top.document.location.href;
			MP.oSite = MP.tSite = window.top.document.location.host;
			MP.UrlLang = MP.SrcLang;
		}
	},
	switchLanguage: function(url,pref,sync) {
		var sync = sync;
		var oSite=MP.oSite.replace('http://','').replace('https://','').replace(/\/?$/, '');
		var tSite=MP.tSite.replace('http://','').replace('https://','').replace(/\/?$/, '');
		url=url.replace('http://','').replace('https://','').replace(/\/?$/, '');
		if(sync && (typeof MpStorage !== 'undefined')&&(typeof MpStorage.updatePref !== 'undefined')){
			if(pref){
			var lang = pref.substring(0, 2);
			pref = lang == MP.UrlLang ? MP.SrcLang+pref.substring(2):pref;
			}
			MpStorage.updatePref(url,pref);
		}
		setTimeout(function() {
			var script = document.createElement('SCRIPT');
			if (url == oSite) {
				tSite = tSite.split(/[/?#]/)[0];
				script.src = location.protocol + '//' + tSite +'?1023749634;' + encodeURIComponent(location.href);
			} else {
				url = url.split(/[/?#]/)[0];
				script.src = location.protocol + '//' + url +'?1023749632;' + encodeURIComponent(MP.SrcUrl);
			}
			var target = document.getElementsByTagName('script')[0];
			target.parentNode.insertBefore(script, target);
		}, 500);
		return false;
	},
	switchToLang: function(url) {
		if(window.top.location.href == url){
			if((typeof MpStorage !== 'undefined')&&(typeof MpStorage.updatePref !== 'undefined'))
			MpStorage.updatePref(MP.oSite,MP.SrcLang);
		}else{
			window.top.location.href = url;
		}
	}
	<!-- mp_trans_disable_end -->   
};</script><script>function switchLanguage(lang) {
MP.UrlLang='mp_js_current_lang';
MP.SrcUrl=decodeURIComponent('mp_js_orgin_url');
MP.oSite=decodeURIComponent('mp_js_origin_baseUrl');
MP.tSite=decodeURIComponent('mp_js_translated_baseUrl');
MP.init();
}
</script><script src="/TemplatePackage/contrib/libs/d3/d3.min.js"></script>
<script src="/TemplatePackage/contrib/libs/c3/c3.js"></script>
<script src="/TemplatePackage/contrib/libs/mmwr/mmwr_metrics.min.js"></script>
<script>window.CDC.Policy.External.init();</script>
<script>
	
	s.pageName=document.title; 
siteCatalyst.setChannel("MMWR");
siteCatalyst.setLevel1("OS");
siteCatalyst.setLevel2("OSD");	
	</script>
<script>
	window.shortTitle = "Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19&ndash;Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults &mdash; VISION Network, Nine States, September&ndash;November 2022";
	window.pageOptions = window.pageOptions || {};
	window.pageOptions.navigation = window.pageOptions.navigation || { fourthLevelCollapsed: false, showFourthLevel: true	}; 	</script>
<script>
	window.pageOptions.navigation.breadcrumbs = { mode: 'auto', showCurrentPage: false , prefix: [{"text":"CDC","href":"https:\/\/www.cdc.gov\/"}] }; </script>
<script>
	window.CDC.tp4.public.appInit( window.pageOptions );
</script>



</body>
</html>


